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Abstract 
Characterisation and identification of brown adipose tissue on positron-emission 
tomography and magnetic resonance imaging 
 
Since the first published description of brown adipose tissue (BAT) in 1551 its 
reputation has changed from that of a mere curiosity of little physiological significance 
in adult humans, to meriting reclassification as a metabolic organ in its own right. 
Obesity is a major global public health problem. Modulation of non-shivering 
thermogenesis through BAT manipulation presents an attractive therapeutic target for 
inducing weight loss. Testing the efficacy of such pharmacological agents requires the 
development of a reliable imaging biomarker to enable BAT quantification. 
In this thesis we have evaluated the effectiveness of positron-emission tomography 
(PET) and magnetic resonance (MR) imaging in quantifying BAT. 
Retrospective analysis of 3,295 consecutive PET scans performed at University 
Hospitals Coventry & Warwickshire NHS Trust (Coventry, UK) in 2007-2012 showed 
18F-FDG uptake consistent with BAT in 5.3% of scans. Gender (female), age (younger), 
BMI (lower), serum glucose (lower), time of day (earlier), and temperature (lower) were 
all significant predictors of BAT prevalence. Regression analysis showed patients’ age 
and preceding day’s minimum temperature to correlate most strongly with BAT 
volume, while the impact of other factors is less clear. 
We also showed the pattern of BAT uptake within individuals to be consistent across 
serial PET scans. Quantitative colocalisation techniques showed this degree of 
colocalisation to be significant in 14/15 patients, implying fixed BAT deposits in adult 
humans. 
Concerns over the high ionising radiation dose of PET scans has stimulated research 
into MR as an alternative means of detecting BAT, with the potential to identify BAT 
irrespective of its activation state. 
Using IDEAL FSE sequences acquired on a 3 Tesla clinical MR scanner, we found 
BAT to have a significantly lower fat fraction than white adipose tissue in rats post 
mortem and adult humans in vivo. Our efforts to identify BAT prospectively using fat 
fraction yielded inconsistent results. 
 
 
Terence Alan Jones 
For the degree of Doctor of Philosophy (PhD), the University of Warwick, 
March 2015 
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Chapter 1: Introduction 
This thesis is based on some aspects of physiology and the imaging of brown adipose 
tissue (BAT). In this introductory chapter I shall explain what BAT is and why it is 
important to image it. 
BAT is a discrete type of fat found exclusively in mammals [1] which is anatomically, 
biochemically, embryologically and functionally distinct from its more prevalent 
counterpart white adipose tissue (WAT) [2]. Brown and white adipose tissue have 
essentially antagonistic functions, which have evolved in response to external threats 
[3]. WAT acts as a reservoir to store excess energy (in the form of triglycerides) to 
protect against starvation, as well as being an insulator, and a source of cytokines and 
hormones that modulate metabolic activity and insulin resistance. BAT, in contrast, is a 
specialised thermogenic tissue which metabolises fatty acids and dissipates the energy 
as heat [2, 4, 5].  
BAT was first described in 1551 by the Swiss physician and naturalist Konrad Gessner 
[6] who observed that hibernating European marmots (Muris alpines) “… have a lot of 
fat on their back, although the other parts of the body are lean. In truth it can be called 
neither fat nor flesh, but similar to the bovine mammary gland, it is something in 
between” (Dorsum præpingue habent, quũ cæteræ corporis partes sint macræ. Quanʤ 
hæc vere nec pinguitudo nec caro dici potest: sed ut mamillarũ caro in bubus, inter eas 
est medium quidda) [7]. 
Enerbäck [5] credits the first description of BAT in humans to Shinkishi Hatai in 1905 
when he wrote that embryos contained “…a gland which corresponded closely in 
position, general appearances and to some extent in structure, to the hibernating gland 
of lower mammals” [8]. As Bonnot [9] pointed out, Hatai was preceded by Merkel [10] 
who described a structure called “Fettpolster”, and Charpy [11] who called it “coussinet 
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adipeux” (fat pad). Nevertheless its metabolic significance as a thermogenic organ was 
not elucidated until 1961 [12]. 
BAT has been considered distinct from WAT in other cultures; in Mongolian folk 
medicine BAT (хүний мах translating loosely as ‘human meat’) has been used as 
remedy for pancreatitis (washed down with vodka), and to assist in the healing of 
wounds and fractures [13]. 
1.1 Biological significance of BAT 
In temperate environments, heat generated by basal metabolism is generally sufficient to 
maintain body temperature. At lower temperatures, additional mechanisms are required 
to maintain thermal homeostasis and avoid hypothermia. These mechanisms include 
shivering and non-shivering thermogenesis. Shivering thermogenesis generates heat 
through sustained episodic contractions of antagonistic muscles, increasing ATP 
turnover and dissipating heat [14]. Non-shivering thermogenesis maintains core body 
temperature during periods of sustained cold [5] when thermal homeostasis cannot be 
maintained by shivering thermogenesis alone, and is exemplified by hibernation. The 
primary effector organ for non-shivering thermogenesis is BAT [15]. BAT tends to be 
abundant in small mammals including human neonates, who are predisposed to heat 
loss due to their high surface area to volume ratio, and in whom shivering 
thermogenesis and insulation by WAT are insufficient to maintain core body 
temperature [3]. 
At resting metabolic rate, non-shivering thermogenesis is thought to account for an 
average of 11.8% of total energy expenditure, albeit with high individual variation [16], 
but may be as high as 50% in small mammals when exposed to cold. Following cold 
exposure BAT is able to adaptively increase its capacity for thermogenesis such that if 
maximally stimulated (e.g. following administration of noradrenaline to cold-
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acclimatised rodents), can generate 300 times more heat per unit mass than any other 
tissue [17]. The rate of heat dissipation by BAT is approximately 160-190 mW and 330-
480 mW per gram of BAT for warm and cold conditions respectively [18, 19]. It has 
been postulated that as little as 50g of brown adipose tissue, if maximally stimulated, 
could account for up to 20% of daily energy expenditure in an adult humans, equivalent 
to 20 kg of body weight per annum [20]. 
BAT may also have a role in dissipating excess chemical energy to maintain energy 
balance (i.e. diet-induced thermogenesis) and thereby help humans deal with a 
dangerously hypercaloric environment and still remain in good health, effectively acting 
as an energy buffer [5, 21]. In addition to metabolising glucose, activated BAT also has 
a role in lipoprotein homeostasis, and therapeutic manipulation of BAT may serve to 
reduce elevated serum triglycerides to combat obesity [22]. It has been suggested that 
BAT dysfunction may have a role in obesity [21, 23, 24] and predisposition to 
metabolic syndrome [25]. In humans, however, it is not clear whether decreased BAT 
activity causes obesity or vice versa [26]. The suggestion that BAT lowers susceptibility 
to obesity has, however, been criticised as being unphysiological [27-29]. 
Although BAT persists throughout life in rodents, in humans it was thought to be 
largely confined to neonates in whom it provided non-shivering thermogenesis to 
maintain core body temperature in the tumultuous immediate postnatal period [30-32]. 
BAT development commences in the 5th month in utero [33] reaching its peak at birth, 
before largely involuting in the first 9 months post partum [34]. In contrast WAT 
develops later and typically continues throughout life [35]. A histological study of 
adipose tissue excised from the neck of 35 patients undergoing thyroid surgery 
identified distinct islands of BAT in a third (typically those who were younger and 
leaner), indicating that BAT does involute with age [36]. Various mechanisms for the 
involution of BAT have been suggested [36] including infiltration of BAT depots by 
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WAT, transdifferentiation of brown adipocytes into white (but retaining the ability to 
revert to the BAT phenotype), or brown adipocytes merely disguising themselves as 
white. 
Post mortem anatomical studies identified BAT in human adults in a similar distribution 
as in human neonates, i.e. supraclavicular fossa, axillae, neck and lesser quantities in the 
mediastinum and peritoneal cavity [37, 38]. BAT has also been reported in individuals 
exposed to low temperatures for prolonged periods [39], or those with hyper-adrenergic 
stimulation due to phaeochromocytoma [40, 41]. For the most part BAT was considered 
to be largely non-existent in adult humans under normal circumstances, and of little or 
no physiological relevance [2, 27]. It is now known, largely thanks to integrated 
positron-emission tomography with computed tomography (PET/CT), that BAT in 
humans is much more prevalent than previously thought [36, 42-44]. 
Therefore, modulation of adaptive thermogenesis through the manipulation of BAT 
presents a potential pharmacological target which may reduce elevated triglyceride 
levels and combat obesity [22, 45]. To test the efficacy of such pharmacological agents 
would require the development of a reliable biomarker to enable quantification of BAT. 
As a result there has been a resurgence in interest in brown adipose tissue in recent 
years. 
1.2 Origins of BAT 
1.2.1 Evolutionary origins 
BAT is largely confined to endothermic placental (Eutherian) mammals, and was 
therefore believed to have originated approximately 140 million years ago (mya). More 
recently BAT has been identified in species of South American and Australian 
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marsupials including the fat-tailed dunnart (Sminthopsis crassicaudata) implying the 
existence of a common primitive BAT organ by at least 150 mya [46]. 
1.2.2 Embryological origins 
The embryological origin of BAT is a subject of on-going debate, though the consensus 
is that classical BAT and WAT are separate entities. Although brown adipocytes, 
together with white adipocytes, myocytes and chondrocytes, are of mesodermal origin 
[47], BAT and skeletal muscle precursors both express Engrailed-1 (En1). This implies 
that both are derived from the central dermomyotome (derived from paraxial 
mesoderm) [48], while WAT is derived from lateral plate mesoderm [49]. Similarly 
brown adipocytes and myocytes also express the marker Myogenic factor 5 (Myf5) 
while white adipocytes do not, implying a shared lineage for BAT and skeletal muscle 
with both being derived from a bi-potent precursor cell [47, 50, 51], although two 
separate lineages of Myf5 positive cells is a possibility [3]. The Zn-finger transcriptional 
regulator PRD1-BF1-RIZ1 homologous domain containing 16 (PRDM16) is thought to 
control a bidirectional cell fate switch that determines whether the Myf5+ progenitor 
cells differentiate into skeletal muscle myoblasts or brown adipocytes [50, 52]. 
PRDM16 stimulates differentiation of brown adipocytes by binding to PPAR-γ 
(peroxisome proliferator-activated receptor-γ) receptors. Loss of PRDM16 from brown 
adipocyte precursors results in them differentiating into skeletal muscle myocytes, while 
ectopic production of PRDM16 has been shown to induce de-differentiation of skeletal 
muscle myocytes into brown adipocytes [50]. 
Bone morphogenetic protein 7 (BMP7) has also been shown to be a potent activator of 
brown adipocyte differentiation [53], and appears to regulate the PRDM16 master 
switch [52]. 
  32 
A third class of adipocyte has also been described [52, 54, 55], which show a mixed 
morphology intermediate to that of BAT and WAT, scattered throughout areas of WAT 
These ‘paucicellular adipocytes’ have an mRNA signature which partly overlaps with 
that of classical BAT in humans [56]. They resemble white adipocytes insofar as they 
express low levels of the proton UCP1 (discussed below) which hitherto was considered 
characteristic of BAT, but do not express Myf5, implying that they are derived from a 
different cell lineage than the myoblast precursors [50], and are probably derived from 
pericytes surrounding blood vessels traversing WAT [47, 49] but not the vasculature of 
other tissues. Stimulation with cAMP results in high UCP1 levels, however, which is a 
characteristic of brown adipocytes [57]. 
Several mechanisms for the occurrence of these ‘brown-like’ adipocytes have been 
postulated [58, 59], including a dedicated lineage of brown adipocyte precursors derived 
from the WAT lineage, differentiation of white preadipocytes, and transdifferentiation 
of terminally differentiated mature white adipocytes to produce recruitable adipocytes. 
The consensus is that these recruitable ‘brite’ [60] or ‘beige’ [61] adipocytes are derived 
from transdifferentiated mature white adipocytes [62], and the process by which this 
occurs as ‘browning’. Indeed it has been proposed that (in mice at least) most brown 
adipocytes scattered within WAT are in fact transdifferentiated beige adipocytes [62]. 
Supraclavicular BAT deposits in adult humans show some genetic similarities to murine 
beige adipose tissue, therefore it has been suggested that human adult BAT 
predominantly consists of beige rather than classical brown adipose tissue [57, 63], 
although it is now clear that they in fact co-exist [64]. Whether all white adipocytes 
possess the ability to undergo browning, or whether this is confined to a small sub-
population remains unclear [65]. 
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1.3 Anatomical distribution and histology of BAT 
For the most part BAT is found in distinct anatomical sites [5, 37]; in children BAT 
occurs as a kite-shaped layer between the scapulae, axillae, supraclavicular fossae 
extending into the neck and beneath the clavicles. Smaller deposits also occur within the 
thorax deposits (in close proximity to the heart, trachea and mediastinal vessels) and 
upper abdomen including peri-renal and peri-adrenal regions [38, 66]. This distribution 
has been likened to a ‘heating jacket’ [14] which acts as a warming mechanism for 
blood supplying the vital organs [3]. In addition peri-renal and suprarenal BAT deposits 
are recognised. The distribution of BAT in human adults is largely derived from 18F-
FDG PET/CT studies, and tends to occurs within supraclavicular fossae, neck, 
paravertebral and suprarenal regions [38, 43, 44]. 
As described above, in addition to classical BAT depots, brown adipocyte-like cells 
have been identified scattered throughout larger areas of WAT. These comprise a 
distinct group of adipose tissue which share some of the histological characteristics of 
BAT, but appear to be derived from WAT. These beige adipocytes appear to be derived 
from the pericytes surrounding blood vessels in WAT [36] and may therefore occur in 
atypical sites unlike classical BAT. 
1.3.1 Histology 
There are macroscopic and microscopic differences between BAT and WAT. White 
adipocytes are typically large (25-200 µm) unilocular spherical cells featuring a single 
large vacuole containing triglycerides which comprises more than 90% of the cell 
volume. Brown adipocytes are comparatively smaller (15-60 µm) multilocular 
polygonal cells which contain multiple small lipid vacuoles, and characteristically 
contain numerous large mitochondria [67], which give rise to the eponymous brown 
colouration of BAT [68]. In addition the mitochondria show a high density of laminar 
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cristae, increasing the available surface area on the inner membrane [69], implying high 
metabolic activity. Mitochondria in white adipocytes tend to be thin, elongated and 
variable in number. 
Brown adipocytes typically occur in clusters forming islands interspersed within WAT 
in both rodents [70] and humans [36], but do not necessarily occupy an entire fat lobule, 
which may explain why BAT may not always be visible macroscopically. In addition 
BAT was thought to involute with increasing age, eventually becoming largely 
indistinguishable from WAT [30]. 
BAT has a rich matrix of capillaries, up to 4-6 times denser than in WAT [36, 71]. This 
likely reflects the increased demand for oxygen and substrates necessary for non-
shivering thermogenesis, and to redistribute and dissipate heat [72]. When 
thermogenesis is activated, blood flow through interscapular BAT increases more than 
ten-fold, which together with other BAT deposits can take up 25% of cardiac output 
[18]. In rodents, activated BAT can account for up to 50% of total oxygen consumption 
in the cold [73]. 
BAT characteristically has dense sympathetic innervation, at least 10-fold higher than in 
WAT [36]. β1-, β2- and β3-adrenoceptors have been identified, of which β3 are the most 
significant [2, 74], which enable BAT to respond to fluctuations in temperature. The 
exception to this is pericardial and mediastinal BAT which also has parasympathetic 
innervation [75]. 
In addition, cells characterised by a distinct basal membrane, glycogen particles, and 
mitochondria devoid of cristae have been identified within BAT islands in human 
adults, which could potentially represent brown adipocyte precursors in adult humans 
[36]. 
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1.4 Physiology including non-shivering thermogenesis 
In eukaryotic cells mitochondria store energy in the form of a proton gradient across the 
inner mitochondrial membrane. The energy released when protons flow along this 
gradient (proton motive force) is used to synthesise adenosine triphosphate (ATP) and is 
mediated by the enzyme ATP synthase which forms the basis of oxidative 
phosphorylation. The proton gradient is maintained by electron-driven proton pumps, 
leading to oxygen consumption. Inevitably some protons leak through the mitochondrial 
membrane, following the proton gradient by-passing ATP synthesis (uncoupling), 
instead being dissipated as heat [2]. This is a normal phenomenon in all mitochondria 
and accounts for approximately 15% of oxygen consumption in mammals in vivo [76]. 
BAT is unique in that it is able to totally uncouple oxidative phosphorylation and 
dissipate all proton motive force generated from fatty acid metabolism as heat [77]. This 
is mediated by uncoupling protein 1 (UCP1 or ‘thermogenin’), a 32 kDa transmembrane 
protein which increases permeability of the mitochondrial inner membrane thereby 
dissipating the proton gradient [2, 78, 79]. This process is very inefficient, and requires 
uptake of substrate from the surrounding tissues and circulation, in particular free fatty 
acids and glucose. 
UCP1 is activated by noradrenaline release from sympathetic nerve endings which 
activate β3-adrenergic receptors on the plasma membranes of brown adipocytes. This 
triggers an intracellular cascade in which adenylyl cyclase catalyses conversion of ATP 
to cyclic AMP (cAMP), which in turn activates protein kinase A. Protein kinase A 
phosphorylates triacylglycerol lipase, which catalyses the conversion of triacylglycerols 
into free fatty acids, which in turn activates UCP1 in the mitochondrial membrane [2]. 
The mechanism by which fatty acids activate UCP1 is unclear, but they may act as 
allosteric regulators, co-factors or proton shuttles [2]. 
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Catecholamines and thyroid hormones have also been implicated in BAT activation. 
Activated protein kinase A phosphorylates deiodinases, resulting in local conversion of 
thyroxine (T4) into its active form tri-iodothyronine (T3) [80]. T3 binds to intracellular 
thyroid hormone-sensitive receptors in brown adipocytes to further amplify 
catecholamine-induced UCP1 transcription [81]. Stimulation of β3-adrenergic receptors 
on the cell membrane further increases the intracellular concentration of T3 by means of 
type 2 5’ deiodinase [82]. The importance of sympathetic innervation in BAT function 
is highlighted by the discovery that surgical sympathetic denervation abolishes glucose 
uptake within BAT [83, 84]. Sympathetic innervation to BAT is regulated by the lateral 
hypothalamus, through melanocortin signalling [85]. Consequently central nervous 
system depressants including volatile anaesthetic agents suppress BAT [86]. 
UCP1 was once considered to be the unique immunohistochemical protein marker for 
BAT [87], with other genetic markers showing only relative quantitative differences 
between BAT and WAT, for example the homeobox genes HoxC8 and HoxC9 are more 
highly expressed in WAT (and beige) fat than BAT [51, 64]. HoxC9 is much more 
abundant in beige fat than WAT.  
Differences in the genetic expression profiles between human adult and neonatal BAT 
have also been reported, with HoxA1 and HoxC4 being preferentially expressed in 
human foetal BAT, and HoxA4 and HoxC8 being more abundant in human adult BAT 
[35]. Furthermore, UCP1 differs between mammals, with the human protein being 1 
kdalton smaller than that of the rat [79]. 
Increasingly the reliability of UCP1 as a marker of BAT activity has been called into 
question. In several species of domestic pigs and wild boars, for example, the UCP1 
gene is non-functional [88]. Furthermore UCP1 is not specific to BAT, as it is also 
expressed in beige adipocytes [56]. Novel genetic makers, specifically Zic1 show 
greater specificity for classical BAT than does UCP1 [64]. 
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1.5 The dynamic nature of BAT 
The plasticity of adipose tissue in response to external stress is recognised. In this 
instance the term plasticity refers to the variable phenotype and fluctuating metabolic 
activity of BAT. In mice, retroperitoneal adipose tissue changes from a white 
phenotype, to brown, and then back to white during the first few weeks post partum 
[89]. Administration of the β3-adrenoceptor agonist CL316,243 has been shown to 
induce transdifferentiation of terminally differentiated mature white adipocytes into 
brown in mice [62]. Administration of PPAR-γ (peroxisome proliferator-activated 
receptor-γ) agonists (e.g. rosiglitazone) has also been shown to induce UCP1 expression 
in human white adipocytes, leading to the ‘browning’ of white adipocytes [90, 91]. 
Transdifferentiation of white adipocytes to brown has also been shown in vivo in 
phaeochromocytoma [92]. 
As described above, both BAT and the newly discovered beige fat are not fixed depots, 
but are highly dynamic and plastic which greatly affects the total capacity for non-
shivering thermogenesis. Apoptosis plays a major role of BAT degeneration, and is 
induced by tumour necrosis factor α (TNFα) [93]. It is noteworthy that TNFα levels are 
elevated in obese humans, and that resulting BAT dysfunction may be causative in 
obesity and metabolic syndrome [94, 95]. Conversely obese rats, when exposed to 
prolonged cold, showed a reduced level of apoptotic brown adipocytes than at 
thermoneutrality [93]. To date no direct evidence of BAT apoptosis in human adults has 
been reported. 
1.5.1 Cold and BAT activity 
The amount of BAT is dependent on tissue recruitment which may require days or 
weeks and requires chronic sympathetic stimulation, whereas activity is regulated by 
acute sympathetic stimulation [2]. Acute cold exposure has been shown to induce UCP1 
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mRNA expression [96, 97]. Meyer et al. [98] showed that a 23g wild type B6 mouse 
increased its maximal heat production to 750 mW at thermoneutrality, which when 
housed at 18°C for 3 weeks this increased to 1,000 mW, and increased further to 1,200 
mW when housed at 5°C. This suggests that, at least in mice, BAT undergoes adaptive 
hyperplasia in response to sustained cold [99]. 
The same pattern has been identified in beige adipocytes. The appearance of UCP1-
immunoreactive brown adipocytes has been reported within WAT after sustained cold 
exposure (6°C for 10 days) without a corresponding increase in the number of adipocyte 
precursors. This implies that beige adipocytes are derived from terminally differentiated 
white adipocytes, and like classical brown adipocytes, are also stimulated by cold 
exposure mediated by β3-adrenoceptor stimulation [62].  
Conversely loss of UCP1 in mice has been shown to result in an increase in cold 
sensitivity and an inability to maintain body temperature during 24 hours of cold 
exposure [100]. 
Cold-exposure has been shown to mediate BAT throughout β-adrenergic activation [2, 
101, 102]; sustained cold exposure over the course of days or weeks increases the total 
capacity for thermogenesis [95, 103]. In hamsters, ATPase activity in BAT 
mitochondria increases within brown adipocytes in response to cold [104]. 
The mechanism of BAT activation is likely a combination of transdifferentiation of 
WAT and recruitment of latent brown adipocytes. The speed with which BAT can be 
activated following short periods of cold exposure implies latent BAT deposits, as it is 
unlikely that BAT (or brown fat) can proliferate in such a short period of time [105]. 
Other stimuli which stimulate sympathetic outflow to BAT (e.g. baclofen) have also 
been shown to lead to increased metabolic rate and thermogenesis [106]. 
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1.5.2 Age and BAT activity 
Thermoregulation diminishes with age in both humans [107] and rodents [108, 109], 
which may manifest as decreased cold tolerance [110]. Reduced expression of UCP1 
mRNA has been reported with increasing age [111, 112], implying a decrease in BAT 
thermogenic capacity [113]. This has been attributed to age-related BAT atrophy, which 
appears, at least in part, to be due to abnormalities in adrenergic signalling [114]. The 
age-related decline in BAT functionality is less pronounced in females than males 
[115]. 
Gene profiling studies suggest that UCP1 mRNA expression is an unreliable marker of 
BAT activity [116]. 
1.5.3 Obesity and BAT activity 
There is compelling evidence of a link between obesity and BAT status. Individuals 
with low BMI are more prone to feeling cold, and as a result more likely to induce non-
shivering thermogenesis by sympathetic nervous system stimulation [117]. Post mortem 
studies have shown larger accumulations in BAT in individuals with low BMIs [118]. 
BAT dysfunction or absence has not only been shown to lead to impaired non-shivering 
thermogenesis but also an increased propensity to obesity in rodents [119], which may 
persist into adulthood [120]. BAT ablation in mice has been shown to induce obesity 
[121] and abolish diet-induced thermogenesis [119].  
There is also evidence of a blunted cold-induced non-shivering thermogenesis in obesity 
implying differences in BAT activity [16]. 
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1.6 Therapeutic importance of BAT 
Obesity is major global public health problem [122]. The prevalence of obesity has 
doubled since 1980, with approximately 1.4 billion adults being overweight (i.e. body 
mass index >25 kg/m2) in 2008, of whom 500 million were obese (body mass index >30 
kg/m2) [123]. The problem is increasingly common in low- and middle-income 
countries, such that 65% of the world’s population now live in countries where being 
overweight or obese kill more people than malnutrition. Furthermore, 44% of diabetes 
cases, 23% of ischaemic heart disease and 7-41% of cancers are attributable to being 
overweight or obese [123]. 
Obesity occurs as a result of chronic imbalance between energy intake and expenditure. 
It has been suggested that humans are evolutionarily maladapted to the modern 
obesogenic and thermo-regulated environment. This has lead to an abundance of food 
and the adoption of a sedentary lifestyle resulting in accumulation of excess WAT 
[124]. 
It has been suggested that BAT evolved to safely dissipate large amounts of chemical 
energy from excess food intake (a process known as diet-induced thermogenesis) [5], 
including clearance of glucose [125] and triglycerides [22]. This role for BAT as an 
energy sink affording protection against obesity has been criticised as being 
unphysiological [27-29]. 
This phenomenon might be harnessed to help humans deal with a dangerously 
hypercaloric environment and still remain in good health [5]. Recruitment and 
activation of BAT may be used as a means of protecting the animal against obesity [23, 
117]. 
Although some studies have suggested that the impact of BAT mediated non-shivering 
thermogenesis is small in adult humans [126], the increasing prevalence of obesity 
throughout the world, and the possibility that BAT is much more prevalent than was 
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previously thought, may be sufficient to contribute to weight loss over time. This has 
triggered a resurgence of interest in BAT modulation as a potential anti-obesity strategy. 
Much of the work evaluating BAT prevalence on imaging has involved PET/CT, and 
more recently magnetic resonance (MR) imaging. These imaging techniques will be 
discussed in more detail in their respective chapters. 
Multiple retrospective observational studies of BAT prevalence on 18F-FDG PET/CT 
scans suggest a point prevalence under 10% [38, 127-136], while dedicated prospective 
studies indicate a much higher prevalence of between 36% and 96% [42, 43, 113, 125]. 
Age, sex, BMI and temperature have been shown to be significant determinants of BAT 
prevalence of 18F-FDG PET/CT. These will be explored in further detail later in this 
thesis. 
Some patients may have a genetic predisposition to BAT thermogenesis, which would 
explain why some individuals maintain a lean body habitus with minimal effort [117]. 
Following the recent discovery of beige fat, and the discovery of brown adipocyte 
precursors in adult humans there is the potential for stimulating non-shivering 
thermogenesis in individuals lacking classical BAT. 
1.7 Overview of the thesis 
In this thesis we shall explore the role of two imaging modalities: 18F-FDG PET/CT and 
MR imaging. 
After introducing the basic principles of positron emission tomography in chapter 2, we 
shall analyse retrospective PET/CT data to determine the demographics of the patient 
group, predictors that influence the prevalence, volume and activity of BAT. Following 
on from this, we shall analyse patterns of BAT uptake on sequential PET/CT scans to 
determine whether BAT occurs in fixed depots. These will comprise chapters 2-6. 
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The basic principles of MR imaging, and their application in BAT imaging will be 
introduced in chapter 7. In chapter 8 we shall attempt to characterise the appearances of 
BAT on MR, and in chapter 9 we shall explore whether these characteristics can be used 
to prospectively identify BAT on MR. 
Each chapter will be followed by a brief summary of the results, but more detailed 
discussion will take place in chapter 10. 
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Chapter 2: Identification and quantification of brown 
adipose tissue (BAT) on positron emission tomography 
with computed tomography (PET/CT) 
2.1 Basic principles of 18F-FDG PET/CT 
Positron emission tomography (PET) is a functional imaging modality that measures 
metabolic activity within the body following injection of a radionuclide-labelled tracer 
molecule. The commonest tracer is 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG), 
comprising the glucose analogue deoxyglucose attached to a radioactive positron-
emitter (18F) substituted for a hydroxyl group at the 2’ position (Figure 2-1). Like 
glucose, 18F-FDG is taken up by mitochondria, within all metabolically active tissues. 
where it becomes phosphorylated by hexokinase as part of the glycolytic metabolism 
pathway. Unlike glucose, which undergoes further glycolysis by phosphohexokinase 
isomerase, 18F-FDG becomes trapped intracellularly as FDG-6-PO4 (Figure 2-2) as it 
lacks the requisite hydroxyl group at position 2’ [137]. 
 
Figure 2-1: Chemical structure of D-glucose and 18F-FDG. 
                               
 D-glucose 18F-FDG 
18F$
  44 
 
Malignant tumours typically have normal to low levels of glucose-6-phosphatase 
activity [138]. Glucose-6-phosphatase activity is higher in BAT than in WAT, 
particularly following cold exposure [139]. If high levels of glucose-6-phosphatase are 
present, the phosphate group may be cleaved off from the molecule to regenerate 18F-
FDG which then diffuses back out of the cell to be taken up by the bloodstream for 
uptake elsewhere.  
Figure 2-2: Facilitated transport and metabolism of 18F-FDG. The dephosphorylation 
reaction involving glucose-6-phosphatase occurs slowly within malignant cells, resulting 
in intracellular accumulation of 18F-FDG (Glut-1 = glucose transporter). Adapted from 
Kapoor et al. [140] and Kelloff et al. [141]. 
  
 
18F is the preferred radioisotope due to its relatively long half-life of 110 minutes, which 
allows adequate time for preparation, testing and transport, although 11C, 13N, 15O and 
82Rb have been also used. Being radioactive, 18F is unstable and decays by emitting 
positrons (positively charged electrons, β+) from the nucleus. The positrons travel a 
short distance through tissue before interacting with their antiparticle (an electron), 
resulting in the annihilation of both. Their combined mass is converted into two 511 
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keV photons (according to Einstein’s mass-energy equivalence formula E = mc2) at 
180° (± 0.5° depending on the speed of the positrons) to each other [142] (Figure 2-3). 
 
Figure 2-3: The basic 
principle of PET: a 
positron interacts with 
an electron resulting in 
their mutual 
annihilation, which 
emits two 511 keV 
photons in opposite 
directions. 
  
 
 
The simultaneous detection of two coincident photons in opposite detectors along the 
line of response (a straight line connecting two photons and the detectors) allows the 
source of the positron emission to be triangulated (Figure 2-4). The necessity for 
simultaneous detection (within a window of approximately 10 x 10-9 seconds) of two 
photons in opposite detectors for a signal to be registered is termed ‘electronic 
collimation’, and affords a much greater spatial resolution than the traditional 
mechanical collimation provided by lead filters used in SPECT (single-photon emission 
computed tomography) scanners for example. 
The gamma rays interact with a circular array of detectors comprising multiple (10,000 
– 20,000) scintillation detectors (which convert the gamma rays to visible light) and 
photomultiplier tubes. The scintillation crystals are most commonly bismuth germinate 
(BGO), but lutetium oxyorthosilicate (LSO), gadolinium orthosilicate (GSO) are also 
used. The visible light is then converted to electrons by photomultiplier tubes (the 
β+"
e#"
511"keV"photon"
511"keV"photon"
180°"±"0.5°""
18F 
  46 
number of electrons produced being proportional to the energy of the incident photons), 
which are processed digitally to form the image.  
The spatial resolution of PET is therefore determined by three factors: the distance 
travelled by the positron prior to annihilation (typically 0.5 – 2 mm depending on 
energy), the variation in angle of incidence of the two 511 keV photons generated 
following annihilation, and the size of the detectors (1 – 3 mm). As a result, modern 
PET scanners have a resolution of approximately 4 – 7 mm, resulting in slightly blurred 
images [143]. 
 
 
Figure 2-4: Diagram of a PET detector ring 
array showing two photons from a single 
annihilation event interacting 
simultaneously with opposing scintillation 
crystals along a single 'line of response'. By 
convention axial images are displayed as if 
standing at the patient’s feet. 
 
2.2 Integration of PET with CT 
To enable more accurate anatomical localisation of 18F-FDG uptake, PET scanners are 
now combined with a multi-detector computed tomography (CT) scanner mounted on a 
single gantry. This enables the functional PET data an anatomical CT data to be 
acquired in rapid succession thereby minimising patient movement, allowing image co-
registration and fusion to be performed. 
Furthermore, the integration of CT enables attenuation correction to be performed upon 
the PET data [144]. This corrects for the fact that photons produced in the centre of the 
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body are attenuated or scattered to a greater degree than those produced superficially, 
resulting in a spuriously low measurement of radioactivity. 
Although the concept of tomography was conceived in 1826, the first CT examination 
and the development of the first functional CT scanner are credited to Sir Godfrey 
Hounsfield in 1971 and 1973 respectively [145, 146]. The term ‘tomography’ is derived 
from the Greek adjective tomos (τοµμώώτερος, slice) and the verb graphein (γράάφω, 
to write). CT provides high-resolution structural imaging by acquiring multiple x-ray 
projections of cross-sectional slices through an object. 
The scanner comprises an x-ray tube mounted on a rotating gantry and an arc housing 
hundreds of x-ray detectors (or multiple arcs in the case of multiple slice scanners). The 
x-rays are produced by applying a high voltage across the cathode, is mounted within 
the evacuated x-ray tube, which in turn emits electrons. These bombard an anode 
composed of tungsten, rhenium or molybdenum to produce x-rays. The x-ray tube and 
detector bank rotates around the subject, emitting x-rays throughout from multiple 
angles - approximately 1,000 projections in every 360° rotation [147]. The x-rays are 
differentially attenuated by tissues according to the atomic mass of their constituent 
atoms, and transmitted x-rays are then detected by photosensitive diodes in the 
detectors. 
Images are digitally reconstructed, typically using a form of filtered back projection, in 
which the x-ray attenuation for each voxel (‘linear attenuation coefficient’) is averaged 
and calibrated with respect to the attenuation of water (Equation 2-1). The resulting 
averaged CT attenuation values (eponymously called ‘Hounsfield units’ in honour of 
the CT pioneer Sir Godfrey Hounsfield) for each voxel are presented graphically as an 
image. This technique almost abolishes the effects of x-ray scatter, which would 
otherwise cause blurring of the image. As a result, even the earliest commercially 
available CT scanners had a contrast resolution (the ability to distinguish between 
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objects of similar densities) approximately 100 times greater than plain x-rays [145]. 
Consequently tissues may oftentimes be differentiated on the basis of their CT 
attenuation (Table 2-1).  
Equation 2-1: Equation for calculating CT number (CTn); µt = linear attenuation coefficient 
of tissues, µW = linear attenuation coefficient of water [147]. 
 𝐶𝑇! = 1000  ×   𝜇! −   𝜇!𝜇!  
Table 2-1: Range of CT attenuation values for various tissues [147]. 
Tissue Range of CT numbers 
(Hounsfield units) 
Bone 500-1,500 
Muscle 40-60 
Brain (grey matter) 35-45 
Brain (white matter) 20-30 
Water 0 
Adipose tissue -60 to -150 
Lung -300 to -800 
Air -1,000 
2.3 Scanning protocol 
Adequate preparation is required to maximise the diagnostic yield of PET scanning 
[137]. Serum glucose should be within normal range, as high levels of free glucose 
compete with 18F-FDG, resulting in lower radiotracer uptake and image degradation. To 
this end patients are fasted for a minimum of four hours prior to scanning [140]. 
Hyperglycaemia may be treated with administration of 2-5 units of insulin, and the 
serum glucose level rechecked prior to 18F-FDG administration. There is some 
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disagreement over this, as insulin drives glucose transport into muscle, adipose tissue 
and myocardium, which may exaggerate physiological uptake [140]. 
Abstinence from caffeine, nicotine and alcohol in the 24 hours before the scan is 
recommended to minimise physiological myocardial uptake [140]. Some centres 
advocate a low carbohydrate/high protein/high fat diet on the preceding day to the same 
end [148]. 
To minimise physiological muscle uptake exercise is kept to a minimum on the day of 
scanning, and the patient instructed to rest following 18F-FDG administration. Patients 
are also kept warm to minimise physiological uptake within BAT [129]. 
The scan is obtained 50-70 minutes following intravenous injection of the radio-labelled 
tracer 18F-FDG. This allows sufficient time for trapping of the radiotracer within 
metabolically active tissue, whilst minimising the amount of residual radioactivity 
within the plasma and extracellular fluid [149]. 
2.4 Clinical applications of PET/CT 
Most tumour cells are highly metabolically active, exhibiting higher mitotic rates [150, 
151]. Over-expression of GLUT glucose transporters and hexokinase [151-153], and 
therefore higher rates of glucose metabolism than normal tissue making 18F-FDG 
PET/CT useful in the detection and staging of cancer and its metastases, and in the 
monitoring of treatment response [141]. The sensitivity and specificity of PET (without 
integrated CT) in cancer are approximately 84% and 88% respectively [154]. 18F-FDG 
is not specific and also accumulates in any metabolically active tissue including 
inflammation and infection. Consequently, 18F-FDG PET/CT has also been used 
successfully in the assessment of myocardial viability [155], Alzheimer disease [156], 
pyrexia of unknown origin [157], granulomatous and vasculitic diseases [158-160], and 
Crohn’s disease [161] to name but a few. Normal physiological 18F-FDG uptake occurs 
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within the brain, myocardium, liver, bowel and urinary tract [162], typified by Figure 
2-5. 
 
Figure 2-5: Maximum intensity 
projection (MIP) PET image 
performed on a 71-year old male 
showing physiological 18F-FDG 
uptake within brain, myocardium, 
liver, urinary tract and liver. 
  
 
 
 
 
 
Most tumours and their metastases manifest as areas of increased 18F-FDG uptake on 
PET (Figure 2-6). The degree of radiotracer uptake may be quantified and expressed in 
terms of the amount of radioactivity per unit volume. This ‘standardised uptake value’ 
(SUV), which is corrected for body weight and the injected dose of 18F-FDG (Equation 
2-2:), is a practical semi-quantitative index for 18F-FDG uptake [163] which may be 
used as a biomarker to assess treatment response [164, 165]. SUV is also useful in 
differentiating between malignant and benign tumours [163]. An SUV of 2.5 g/ml is 
typically taken as the threshold, above which uptake is considered suspicious for 
malignancy, although this threshold may not be applicable in all cases [166]. 
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Equation 2-2: Calculation of standardised uptake value. ‘ROI’ = region of interest, 
‘injected dose’ = decay-adjusted injected dose of radiotracer, ‘body weight’ is used as a 
surrogate for the volume of distribution of radiotracer. 
𝑆𝑈𝑉   𝑔 𝑚𝑙 = 𝑎𝑣𝑒𝑟𝑎𝑔𝑒  𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦  𝑖𝑛  𝑅𝑂𝐼   𝑀𝐵𝑞𝑙 𝑚𝑙𝑖𝑛𝑗𝑒𝑐𝑡𝑒𝑑  𝑑𝑜𝑠𝑒   𝑀𝐵𝑞 ×  𝑏𝑜𝑑𝑦  𝑤𝑒𝑖𝑔ℎ𝑡  (𝑔) 
Figure 2-6: MIP PET image (left) and coronal fused PET/CT image (right) of a 71-year old 
male, showing avid 18F-FDG uptake within a bronchogenic carcinoma within the right 
lung (red arrow). A metastatic deposit within a mediastinal lymph node (yellow arrow) 
evident on the MIP image is not evident on the fused PET/CT image. 
 
As a result of the correction for body weight, SUV measurements are semi-quantitative, 
but are subject to certain limitations. The SUV has a strong positive correlation with 
weight [167] as the SUV equation assumes that all the weight corresponds to glucose 
metabolising mass, when in fact this additional tissue is mostly adipose tissue which 
accumulates minimal 18F-FDG in the resting state [168]. Lean body mass (LBM) has 
been suggested as an alternative, but may be limited by the fact that LBM varies with 
age, which SUV calculations do not take into account [167]. 
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The delay between 18F-FDG administration and scanning is an important determinant of 
SUV. It takes 1-2 hours for 18F-FDG to become phosphorylated and trapped 
intracellularly, after which 18F-FDG uptake plateaus [169]. To scan too early would 
generate artificially low SUV measurements; conversely delayed scans will yield high 
SUVs. 
SUV measurements may be spuriously low in small lesions due to them being below the 
spatial resolution of the detectors resulting in ‘volume averaging’ or ‘partial volume’ 
effects [170, 171], but any lesion below 3 cm may be too small to measure accurately 
[137]. Furthermore, in areas of mis-registration between PET and CT images, for 
example in areas of respiratory motion, incorrect attenuation correction may cause SUV 
to vary by as much as 30% [172]. 
The high ionising radiation dose of PET/CT can be justified when performed for the 
diagnosis, staging and monitoring of cancer and its metastases. The utility of PET/CT in 
other situations is limited by its substantial effective radiation dose; a multicentre study 
of PET/CT doses in Germany reported an effective dose of 23-26 mSv for a 70 kg 
person [173], and the dose is similar in the UK [174]. The 2005 review of the Ionising 
Radiation Exposure of the UK Population [175] identified that the PET component 
contributes approximately 8 mSv, while the dose from the CT is dependent on the 
extent of the body scanned, but is in the order of 5 mSv for a CT thorax, 8.7 mSv for a 
CT abdomen, 4.9 mSv for a low dose CT of the abdomen and 16.6 mSv for a CT of the 
neck, chest and abdomen [176]. To put this into perspective the mean annual UK 
ionising radiation dose is approximately 2.7 mSv, of which 84% is derived from natural 
background radiation [175]. 
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2.5 Identification of BAT on 18F-FDG PET/CT 
2.5.1 Incidental discovery and prevalence of BAT on 18F-FDG PET and 
PET/CT 
In 1996, shortly after the commercial introduction of PET, Barrington et al. described 
avid symmetrical 18F-FDG uptake occurred within the neck, thorax and paravertebral 
regions [177], as demonstrated in Figure 2-7. Without the benefit of anatomical 
localisation afforded by concomitant CT this was interpreted as muscle uptake, as it 
disappeared following administration of diazepam (a benzodiazepine muscle relaxant) 
on repeat PET scanning. Other authors reported that diazepam had no effect on 18F-
FDG BAT uptake, but instead found that 
propranolol was more effective [178]. 
 
Figure 2-7: MIP PET performed in a 26-year 
old female showing physiological 18F-FDG 
uptake within the neck and supraclavicular 
fossae consistent with BAT. 
 
 
 
 
 
 
Although this novel pattern of 18F-FDG uptake was observed to be typically 
symmetrical in predictable locations, asymmetrical distributions were also reported in 
unusual locations [179, 180] which could mimic pathological uptake. Furthermore large 
quantities of BAT may also reduce the sensitivity of PET in assessing cancer by 
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decreasing the available pool of 18F-FDG [181]. Consequently PET protocols evolved to 
minimise this potential source of false positives (see section 2.3), including keeping 
subjects warm, high fat and low carbohydrate diets prior to fasting [182] and 
administering pharmacological agents to suppress BAT activity including propranolol 
[183]. 
With the commercial introduction of integrated co-registered PET/CT in 2001, it 
became possible to localise this uptake thereby reducing the likelihood of erroneous 
false positive diagnoses being made [184]. Hany et al. [131], Cohade et al. [185] and 
Yeung et al. [186] soon identified that this uptake occurred largely within areas of 
adipose tissue attenuation (Figure 2-8) on CT, and postulated that what later became 
known as ‘USA-fat’ (uptake in the supraclavicular area fat) may in fact represent BAT 
as the distribution of USA-fat on PET/CT was similar to that of BAT already described 
in post mortem human studies [37]. In 2007 Nedergaard et al. [101] analysed the 
radiological literature from a physiological perspective and concluded that there was 
overwhelming evidence that this this tissue did represent BAT. 
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Figure 2-8: (a) Maximum intensity projection PET, (b) fused coronal and (c) axial PET/CT 
images in a 17-year old male with a testicular germ cell tumour metastasis in the right 
lung showing the typical symmetrical pattern of 18F-FDG BAT uptake within the 
supraclavicular fossa and paravertebral regions. 
(a)  (b)  
(c)  
2.5.2 Evidence that 18F-FDG uptake within fat represents BAT 
Pathological studies had shown that BAT was prevalent in adult humans; a post-mortem 
study of 31 adults identified histological evidence of BAT in 26 (84%) [37]. 
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The first immunohistochemical proof that this avid 18F-FDG uptake did indeed 
represent BAT came in 2007, when Virtanen et al. [44] obtained tissue samples from 
areas of supraclavicular 18F-FDG BAT uptake in three adult human volunteers. The 
samples were subjected to immunohistochemical staining using the anti-UCP1 
antibody, which confirmed BAT. Further studies have demonstrated UCP1 in human 
tissue specimens taken from the neck [36, 38, 187], supraclavicular fossae [42-44, 105], 
mediastinum [188] and suprarenal [34] regions. In only four of these [44, 105, 187, 188] 
were the samples taken from areas of 18F-FDG BAT uptake on PET/CT, of which one 
was authored by our own team [188]. Lee et al. [105] performed immunohistochemical 
and quantitative polymerase chain reaction (PCR) analyses on samples of fat taken from 
the supraclavicular fossae and subcutaneous tissue in 17 patients with head and neck 
cancer: Three 18F-FDG BAT positive patients and 14 negative patients. All 17 subjects 
showed characteristic histological features of BAT within the supraclavicular fat and 
expressed the UCP1, PRDRM1, NDUFS3 (NADH dehydrogenase (ubiquinone) iron-
sulphur protein 3) and β3-adrenoceptor transcripts characteristic of BAT. UCP1 levels in 
subcutaneous fat on the other hand were barely detectable. Similar findings were 
reported by Lee et al. [187] and Van Marken Lichtenbelt et al. [43] who also identified 
strong UCP1 expression in samples of putative BAT but not in WAT. 
Zingaretti et al. [36] performed immunohistochemical analysis on fat samples from the 
neck of 35 patients undergoing surgery for thyroid diseases. Distinct islands of BAT 
were identified 10 patients (28.6%), on the basis of characteristic histological 
appearances and positive UCP1 staining. No correlation with PET/CT was performed 
however. 
These studies provide compelling evidence that areas of 18F-FDG uptake within fat do 
represent BAT based on UCP1 expression, while areas of non-18F-FDG avid fat (i.e. 
WAT) do not. As discussed in chapter 1, following the discovery of a separate 
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population of beige adipocytes, which are derived from a separate lineage, but also 
express UCP1 [60], the classical definition of BAT on the basis of UCP1 expression 
may be an oversimplification. Furthermore, the transcription factor PRDM16 which was 
previously associated with classical BAT [50], has also been identified in beige 
adipocytes. Nonetheless Nedergaard et al. [189] are of the opinion that BAT identified 
in humans most likely represents classical BAT. 
2.5.3 Prevalence of 18F-FDG BAT based on retrospective studies 
There is enormous variation in the reported prevalence of 18F-FDG BAT (summarised 
in Table 2-2), ranging from an overall prevalence of 1.1% in a large retrospective study 
of 6,005 PET/CT scans in South Korea [190], to 45% in a small French study analysing 
serial PET/CT scans in 33 women undergoing treatment for breast cancer [191]. A large 
retrospective study of 8,640 patients’ PET scans by Garcia et al. [192] reported a 
prevalence of 0.34%, but their inclusion criteria were extremely strict and all patients 
with proven or suspected head and neck cancer were excluded (as they did not have 
integrated PET/CT scanners to assist in anatomical localisation), as were those who had 
received treatment between scans (presumably for cancer). Therefore this value is 
undoubtedly a conservative estimate. 
18F-FDG BAT prevalence varies according to the cohort was being studied. Typically 
retrospective studies evaluating heterogeneous adult samples report 18F-FDG BAT 
prevalence below 10% [38, 127-136, 182, 186, 187, 190, 193-199]. A higher prevalence 
has been reported in certain homogenous groups, including women [191], young adults 
and children [200], and patients with phaeochromocytoma [201] all of whom are known 
to have a higher prevalence than average. 
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Table 2-2: Retrospective studies of BAT prevalence on PET/CT. 
Year Authors City No of BAT+ 
subjects 
No of 
subjects 
Prevalence 
2002 Hany et al. [131] Zurich, Switzerland 17 638 2.5% 
2003 Yeung et al. [186] New York, USA 20 863 2.3% 
2003 Cohade et al. [129] Baltimore USA 68 1,017 6.7% 
2004 Truong et al. [135] Houston, USA 15 845 1.8% 
2006 Rousseau et al. [191] Nantes, France (74) 33 (163a) 45% 
2007 Hadi et al. [201] New York, USA 16 83b 19.3% 
2007 Kim et al. [194] New York, USA 35 1,159 3.0% 
2008 Fang et al. [193] Qingdao, China 12 457 2.6% 
2008 Williams and Kolodny [182] Boston, USA  1972 5% 
2009 Au-Yong et al. [127] Nottingham, UK 167 3614 4.6% 
2009 Cypess et al. [38] Boston, USA 106 1,972 5.4% 
2009 Cheng et al. [128] Beijing, China 41 1,080 3.8% 
2010 Garcia et al. [202] Washington, DC, 
USA 
30c 8,640 0.34% 
2010 Jacene et al. [132] Baltimore, USA 56 908 6.2% 
2010 Lee et al. [187] Sydney, Australia 250 2,934 8.5%d 
2010 Park et al. [190] Seoul, South Korea 63 5115 1.1% 
2010 Pfannenberg et al. [199] Tübingen, Germany 110 3,604 3.1%e 
2010 Zukotynski et al. [200] Boston, USA 45 99 26.8%f 
2011 Akkas et al. [196] Ankara, Turkey 31 1032 3.0% 
2011 Pace et al. [134] Naples, Italy 73 848 8.6% 
2011 Ouellet et al. [133] Sherbrooke, 
Québec, Canada 
328 4842 6.8% 
2012 Cronin et al. [130] Boston, USA 298 6,867 4.3% 
                                                
a In this study each patient underwent 5 PET/CT scans, which should equate to 165 scans, although the 
paper only reports a total of 163 scans 
b Patients with suspected or proven phaeochromocytoma. Of those subsequently shown not to have 
phaeochromocytoma, 9.5% had evidence of 18F-FDG BAT 
c Based on strict exclusion criteria; all those with head and neck cancer, or who received treatment 
between scans were excluded 
d 145 patients were scanned more than once; 18F-FDG BAT prevalence increased to 65% in those who 
underwent more than 4 PET/CT scans 
e Comparison made against 198 age and sex matched controls 
f 18F-FDG BAT seen in 16/185 scans (8.6%) in the retrospective control group who were warmed to 24°C 
prior to scanning 
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2012 Huang et al. [197, 203] Kaohsiung, Taiwan 30 1,740 1.7% 
2012 Mei et al. [136] Hong Kong, China 66 1442 4.6% 
2013 Persichetti et al. [204] Rome, Italy 217 6454 3.4% 
2013 Perkins et al. [198] Pretoria, South 
Africa 
38 386 9.8% 
 
In these retrospective studies, analyses have either been confined to the first PET scan 
(to avoid clustering), or have only evaluated sequential scans for the purposes of 
identifying changes in the pattern or activity of 18F-FDG BAT. BAT is facultative and 
therefore only metabolically active when it is required as part of non-shivering 
thermogenesis [2], therefore inactive BAT will not be visible on PET. Furthermore 
BAT is highly dynamic and its activity may fluctuate over a matter of minutes [43], 
therefore any retrospective study is subject to the opportunistic nature of BAT detection. 
Essentially, the absence of evidence of BAT (in retrospective PET studies) cannot be 
taken as evidence of its absence, consequently it has even been suggested that 
prevalence data from these retrospective studies are so unreliable that they should be 
disregarded [189]. 
To address this limitation, some studies have evaluated the prevalence of 18F-FDG BAT 
based on serial scans. Lee et al. [187] reviewed the PET/CT scans of 145 patients 
scanned on multiple occasions and identified that the likelihood of detecting 18F-FDG 
BAT increased the more scans a patient underwent: 8% in those scanned twice, 18% in 
those scanned three times, 50% in those scanned four times, and plateauing at 65% for 
those undergoing more than 4 scans. In effect each additional PET/CT scan increased 
the likelihood of detecting 18F-FDG BAT by approximately 13%. This indicates that the 
true prevalence of BAT is far higher than most retrospective studies suggest. Similarly, 
Rousseau et al. [191], in their cohort study of 33 women with breast cancer, all of 
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whom underwent 5 PET/CT scans, found that 18F-FDG BAT prevalence increased from 
36.4% if only the first PET/CT scan was assessed, to 84.8% if all 5 scans were assessed. 
2.5.4 Dedicated studies to evaluate prevalence of BAT 
A potential limitation of retrospective studies is that been that they have been performed 
on patients with proven or suspected malignancy, which may be a confounder. There is 
controversy over whether BAT plays a role in cancer cachexia, with some post-mortem 
studies showing that BAT is more prevalent in patients with cancer cachexia (80%) than 
in age-matched controls [205] although it is not clear whether this association is 
clinically relevant. No convincing correlation between 18F-FDG BAT prevalence and 
neoplastic status has been demonstrated. Nonetheless these studies still rely on the 
opportunistic identification of 18F-FDG BAT. As described above (section 2.3) the 
scanning protocol has been devised to suppress physiological uptake (including within 
BAT), therefore even serial PET/CT imaging performed in ambient conditions is poorly 
reproducible, insensitive and may underestimate the true prevalence of BAT [187]. 
A small number of dedicated studies have explored the effect of temperature 
manipulation on BAT prevalence (Table 2-3), which have reported a BAT prevalence of 
between 15.3% and 100%. Skillen et al. [206] reported that following a change in 
scanning protocol in which patients were warmed with space blankets, the prevalence of 
18F-FDG BAT fell from 15.3% to 3.3%. The baseline prevalence of 15.3% is still rather 
low, reflecting the fact that patients were scanned at thermoneutrality (although the 
exact value is not reported) rather than being deliberately cooled, and is unlikely to have 
maximally stimulated 18F-FDG BAT. 
Few studies have sought to induce 18F-FDG BAT uptake on PET [42, 43, 113]. A small 
prospective study by Saito et al. [42] in Sapporo, Japan, reported a prevalence of 
approximately 33% in healthy volunteers exposed to cold (19°C) prior to PET scanning. 
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Of these, 8 underwent repeat scanning 2 weeks later following a period of warming 
(27°C), all of whom showed total abolition of 18F-FDG BAT uptake. In an extension to 
this study, Yoneshiro et al. [113] identified 18F-FDG BAT in 41.4% in a sample of 162 
healthy volunteers scanned prospectively (which included the 56 volunteers included in 
the study by Saito et al.) all of whom were exposed to cold (19°C) prior to PET 
scanning. 
Van Marken Lichtenbelt et al. [43] prospectively scanned 24 young health male 
volunteers using a standardised validated PET protocol in which subjects were exposed 
to cold (16°C) for 2 hours prior to scanning. 18F-FDG BAT was identified in 23/24 
(95.8%); the only subject to not demonstrate 18F-FDG BAT uptake had the highest BMI 
(38.7 kg/m2) and body fat percentage (41.8%). After an unspecified wash-out period, 
three volunteers were rescanned at thermoneutrality (22°C) all of whom showed no 
detectable 18F-FDG BAT uptake. 
Lee et al. [105] highlighted the extent to which PET/CT underestimates the true 
prevalence of BAT. They identified 18F-FDG BAT in 3/17 pre-operative PET/CT scans 
performed for staging of head and neck cancer (17.6%), but found 
immunohistochemical evidence of BAT in 100%. The proportion of UCP1-positive 
BAT cells was higher in those who were PET-positive (95-100%) than those who were 
PET-negative (3-28%). Similarly, Virtanen et al. [44], in a prospective study of 5 
healthy adult volunteers in Finland, reported 18F-FDG BAT in all subjects when 
exposed to cold (ambient temperature 17-19°C, whilst intermittently immersing the 
subjects’ feet in cold water for 5 minute periods) for 2 hours prior to scanning. Guided 
by the PET/CT biopsy specimens were obtained in 3 subjects, which showed the 
characteristic histological features of BAT, and stained for UCP1, whereas samples 
obtained from WAT did not. 
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Table 2-3: Dedicated prospective studies of BAT prevalence. 
Year Authors City No of BAT+ 
subjects 
No of 
subjects 
Intervention Prevalence 
2009 Virtanen et al. 
[44] 
Turku, 
Finland 
5 5 Cold (17-19°C) 100% 
2009 Saito et al. [42] Sapporo, 
Japan 
19 56 Cold (19°C) 33.9% 
2009 van Marken 
Lichtenbelt et al. 
[43] 
Maastricht, 
the 
Netherlands 
23 24 Cold (16°C) 95.8% 
2011 Lee et al. [105] Sydney, 
Australia 
3 17 UCP1 17.6%a 
2009 Zingaretti et al. 
[36] 
Ancona, Italy 10 35 UCP1 28.6% 
2012 Skillen et al. 
[206] 
Wagga 
Wagga, 
Australia 
23 
4 
150 
150 
Thermoneutrality 
Warming 
15.3%b 
3.3% 
2011 Yoneshiro et al. 
[113] 
Sapporo, 
Japan 
67 162 Cold (19°C) 41.4%c 
 
Despite the considerable variable in 18F-FDG BAT uptake on PET with its inherent 
limitations, PET/CT remains the standard against which other imaging modalities are 
compared. As described above, 18F-FDG BAT uptake on PET/CT is highly variable in 
terms of volume and activity, therefore whether its distribution on PET/CT reflects its 
true distribution is uncertain. In the next four chapters we shall explore both factors 
influencing 18F-FDG uptake, and how its pattern of distribution changes over time. 
                                                
a 100% expressed gene transcripts seen in BAT including UCP1 and PRDM16 
b Two groups: group A (n=150) was scanned using normal protocol at thermoneutrality; group B (n=150) 
following warming measures. Prevalence in group A = 15.3%, group B = 3.3%; overall prevalence 9.3%. 
c includes the 56 volunteers reported by Saito et al  
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2.6 Aims 
In chapters 3 and 4 we shall present work with the aim of determining the prevalence of 
18F-BAT non-invasively on PET/CT (i.e. 18F-FDG BAT) and assessing the correlation 
between various demographic, biological and environmental factors, upon the 
prevalence, volume and activity of 18F-FDG BAT. As studies of point prevalence 
underestimate the true prevalence of BAT in adult humans, we shall also evaluate the 
cumulative prevalence of 18F-FDG BAT on serial PET/CT scans. 
As discussed above, dedicated studies indicate that BAT is far more prevalent than 
analysis of ad hoc PET/CT scans would suggest. This calls into question the usefulness 
of PET/CT as a standard against which other imaging modalities can be compared. 
Therefore in chapters 5 and 6 we shall evaluate the reliability of 18F-FDG BAT uptake 
further by analysing the pattern and consistency of 18F-FDG BAT distribution on serial 
PET/CT scans to determine whether it occurs in a reproducible pattern, or in a more 
piecemeal fashion. This will enable the consistency of 18F-FDG BAT uptake on 
PET/CT to be tested. 
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Chapter 3: Predictors of 18F-FDG BAT prevalence on 
PET/CT 
3.1 Aims 
It is thought that multiple environmental and demographic variables (including 
temperature, gender and age) influence 18F-FDG BAT prevalence. In this chapter we 
shall determine the correlation between a variety of meteorological and biological 
variables on 18F-FDG BAT prevalence. 
3.2 Subjects and methods 
3.2.1 Subject selection 
The reports of 3,317 consecutive 18F-FDG PET/CT scans performed between June 2007 
and August 2012 at University Hospitals Coventry and Warwickshire NHS Trust 
(Coventry, UK; latitude 52.42°N, longitude 1.44°W) were searched using the keywords 
“brown adipose tissue” and “brown fat”, as normal practice at our institution is to 
comment on BAT if present. The vast majority of scans were performed for the 
purposes of cancer assessment. Twenty two scans were excluded from further analysis 
as they did not include all areas in which 18F-FDG BAT could occur (e.g. scans 
restricted to the head, neck and upper thorax), or were abandoned prematurely (Figure 
3-1). 
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Figure 3-1: Flow chart showing recruitment of the sample. 
 
3.2.2 Collection of data 
All eligible PET/CT scans performed between 1/6/2007 and 31/8/2012 which showed 
18F-FDG uptake consistent with BAT (henceforth referred to as 18F-FDG BAT) were 
retrospectively evaluated to confirm that 18F-FDG BAT was present, including cases 
where multiple PET/CT scans had been performed. 
Demographic data were collected including age, sex, height and weight. Body mass 
index (BMI) was calculated and categorised according to the World Health 
Organization classification [207], namely underweight (BMI <18.5 kg/m2), normal 
(18.5 – 24.99 kg/m2), overweight (25 – 30 kg/m2) and obese (≥ 30 kg/m2). 
Diabetic status was recorded inconsistently and may not therefore reflect the true 
prevalence. Furthermore binary categorisation into ‘diabetic’ and ‘not diabetic’ may not 
accurately reflect the quality of glycaemic control. Serum glucose levels following a 
period of fasting are, however, routinely checked and recorded prior to PET/CT 
examinations at our institution, which may better reflect the quality of glycaemic 
3,317 scans 
performed 
(2007-2012) 
2,263 patients 
with single scans 
107 patients with 
positive scans 
422 patients with multiple scans 
(n=1,032 scans) 
45 patients with positive scans 
(n=68 scans) 
15 patients with repeated 
uptake on multiple scans (n=38 
scans) 
22 excluded 
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control as well as capturing those who may be undiagnosed. We retrospectively 
assigned patients to one of three groups according to the World Health Organization 
2006 criteria [208], namely normoglycaemia (serum blood glucose ≤6.1mmol/l), 
impaired fasting glucose (6.1 - 6.9 mmol/l) and diabetes (≥7.0 mmol/l). 
Meteorological data (temperatures and sunlight data for the day of scanning, preceding 
day, three days, week and month) were obtained for the nearby Coundon weather 
station (latitude 52.42°N, longitude 01.53°W) from the Central Climate Unit, 
Meteorological Office and the website of Bablake Schoola (Coventry, UK; latitude 
52.41°N, longitude 1.52°W), both within the urban confines of Coventry, 5 miles (8 
km) and 4 miles (6.4 km) respectively from our institution. 
3.2.3 PET/CT protocol 
Scanning was performed on a combined GE Discovery STE PET/CT scanner (General 
Electric Medical Systems, Milwaukee, USA). In accordance with standard 
administration and acquisition protocol patients were fasted for 6 hours prior to 
scanning. After administration of 18F-FDG, patients sat for 60 minutes within the 
PET/CT suite, where ambient temperature was maintained at approximately 24°C. 
Prior to administration of 18F-FDG, serum glucose was checked, and 2 international 
units (IU) of insulin administered subcutaneously in cases of hyperglycaemia. Mean 
serum glucose was 5.7 mmol/l (standard deviation 1.6 mmol/l, range 1.0 – 26.8 
mmol/l). 18F-FDG was administered intravenously one hour prior to the scan (mean 
injected dose 362.1 MBq, standard deviation 33.2 MBq; range 103 – 505 MBq). 
Static emission data were obtained from the skull base to mid thigh with the arms 
elevated whenever possible. In cases of head and neck cancer a second set of emission 
data were obtained of the head and neck with the arms by the patients’ side. Emission 
                                                
a http://bws.users.netlink.co.uk/ 
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data were obtained for 3 minutes in each bed position (each covering 20 cm) with 3-
dimensional acquisition. PET images were reconstructed using a model-based iterative 
reconstruction algorithm. 
Unenhanced spiral CT scans were acquired from the skull base to the mid-thighs using 
3.3 mm slice thickness. All oncology patients with the exception of those being scanned 
for the purposes of head and neck cancer were given water-soluble iodinated contrast 
media (Gastrografin®, Bayer plc, Newbury, UK) for bowel opacification. Images were 
reconstructed using the filtered back-protection algorithm. 
3.2.4 Image analysis 
All PET/CT scans were initially reported by a consultant radiologist with expertise in 
nuclear imaginga as part of the patients’ routine clinical care using a Centricity PACS 
workstation (GE Healthcare, USA), and 18F-FDG BAT recorded in the report if present. 
For the purposes of this study each PET/CT scan was re-evaluated by second 
radiologistb using a GE ADW Advantage Workstation 4.3 (GE Healthcare, Milwaukee, 
USA) to confirm the presence of 18F-FDG BAT. 18F-FDG BAT was considered present 
when there was avid 18F-FDG uptake at a greater-than-background level (i.e. SUV > 1.0 
g/ml) in areas corresponding to the attenuation of adipose tissue on CT (i.e. an 
attenuation of between -100 and -10 Hounsfield units).  
3.2.5 Statistical analysis 
Statistical analyses were performed using SPSS version 21.0 (SPSS IBM Corp., New 
York, USA) and GraphPad Prism version 5.0 for Windows (GraphPad Software, San 
Diego, USA). Continuous data were initially tested for normality using the 
Kolmogorov-Smirnoff test. To assess differences between patients with and without 
                                                
a Dr Oludolapo Adesanya 
b Dr Terence Jones 
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18F-FDG BAT, Student’s t test or the Wilcoxon-Mann Whitney U test were performed 
for normally and non-normally distributed continuous variables respectively (e.g. age, 
temperature, BMI, serum glucose). The Chi-square test (or Fisher’s exact test if 
appropriate) was used for categorical data (e.g. gender). 
As the dependent variable is dichotomous (i.e. 18F-FDG BAT present or absent) 
binomial logistic regression was performed to identify the effect of variables on the 
prevalence of 18F-FDG BAT. Both univariate and multivariate analyses were employed, 
namely: univariate analysis to determine the effect of each variable in isolation, and 
multivariate to determine the effect when other variables are taken into account. Three 
techniques for multivariate binomial logistic regression were used in an attempt to 
address the problem of multicollinearity between variables: forced entry, forwards and 
backwards regressions. The forced entry technique, in which all variables are entered 
into the regression model, is the best known. Forwards regression seeks to construct a 
model that predicts the presence or absence of 18F-FDG BAT iteratively by 
incrementally adding single variables on the basis of likelihood, and continues until 
none of the remaining variables contribute significantly to the model. Conversely, 
backwards regression begins with a model containing all variables, and iteratively 
excludes those that contribute least to the model. The backwards method is generally 
preferred over forwards regression due to the potential for suppressor effects (i.e. when 
a predictor is only significant when another variable is held constant). Forward stepwise 
regression is more likely to erroneously exclude these predictors, thereby introducing a 
type II error (i.e. erroneously excluding a variable that is in fact significant). 
Multicollinearity was tested for using SPSS 21. Sex was defined as a categorical 
variable within the regression analysis. Missing values were substituted with means. A 
p-value <0.05 was considered to be statistically significant. 
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Logistic regression was performed on scan data (including where multiple scans were 
performed for the same patient). To address the potential risk of clustering, logistic 
regression was also performed for scan data for each patients’ first PET/CT scans 
(irrespective of whether it was positive or negative), and also for the scan showing the 
largest BAT volume. 
To compare the prevalence of 18F-FDG BAT between the first and second scans, 
McNemar’s test was performeda on the recommendation Dr Ric Crossman of the 
department of Statistics at Warwick Medical School. This is a variant of the Chi-
squared test for paired categorical data that takes into account the fact that the cells are 
not independent, and is appropriate when comparing the presence or absence of a 
dichotomous variable (i.e. the presence or absence of 18F-FDG BAT) in the same 
individual at two time points. 
3.3 Ethics 
Ethical approval had previously been obtained from the National Research Ethics 
Service of Birmingham East, North and Solihull Research Ethics Committee (NHS 
REC reference 11/H/1206/3) on 31 January 2011 for a study entitled ‘Investigation of 
metabolism in human participants’, as was NHS trust approval from the Research and 
Development office of University Hospitals Coventry and Warwickshire NHS Trust. 
                                                
a  VassarStats: Website for Statistical Computation, http://vassarstats.net/propcorr.html, accessed 10 
January 2014. 
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3.4 Results 
3.4.1 Demographic differences between 18F-FDG BAT positive and negative 
PET/CT scans 
Retrospective evaluation of 3,295 eligible PET/CT scans in 2,685 individuals (1,188 
women, 1,497 men; mean age 61, standard deviation 15 years; range 10 – 91 years) 
between June 2007 and August 2012 revealed 18F-FDG BAT in 175 scans (5.3%) in 152 
individuals (5.7%). 422 patients underwent multiple PET/CT scans (1,032 scans; mean 
scanning interval 9.1 ± 8.7 months), in whom 15 individuals (38 scans) showed 18F-
FDG BAT activity on more than one scan. 
A comparison of the demographic and environmental metrics for PET/CT scans with 
(n=175) and without 18F-FDG BAT uptake (n=3,120) is shown in Figure 3-1. 
3.4.1.1 Gender 
Although males comprised the greater proportion of the study group (55.8%), they only 
accounted for 26.3% of the 18F-FDG BAT positive scans (Table 3-1). There was a 
higher prevalence of 18F-FDG BAT on women’s scans (129/1,485; 8.7%) than for men 
(46/1,810; 2.5%), which was statistically significant (χ2 = 60.043; odds ratio 3.6, 95% 
CI 2.6 to 5.1 using the approximation of Woolf; p < 0.0001), and persisted with 
increasing age (Figure 3-2). Comparison of 18F-FDG BAT prevalence between the 
sexes using Chi-square (or Fisher’s exact test as appropriate) analysis for each age 
octile, showed that the difference was only significant between the 30-40 and 70-80 
year octiles (Figure 3-2 and Table 3-2). 
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Table 3-1: Demographic, clinical and meteorological profile for PET/CT scans with and 
without 18F-FDG BAT uptake. 
Characteristic No 18F-FDG PET 
uptake 
18F-FDG BAT 
uptake 
p-value 
Number of scans 3,120 175 - 
Sex; M:F ratio (% male) 1,356:1,764 (43.5%) 46:129 (26.3%) < 0.001 
Age (years) 62.0 ± 14.2 48.4 ± 19.6 < 0.001 
BMI (kg/m2) 26.6 ± 5.4 24.3 ± 4.5 < 0.001 
Fasting serum glucose (mmol/l) 5.7 ± 1.7 5.2 ± 0.8 < 0.001 
Dose of 18F-FDG administered (MBq) 362.3 ± 32.7 357.5 ± 41.2 0.374 
Daily temperature (°C) 
Min 
Mean 
Max 
 
6.1 ± 5.2 
10.0 ± 5.4 
14.2 ± 6.3 
 
4.3 ± 5.4 
8.0 ± 5.4 
11.8 ± 6.1 
 
<0.001 
< 0.001 
< 0.001 
Preceding day’s temperature (°C) 
Min 
Mean 
Max 
 
6.0 ± 5.3 
10.0 ± 5.5 
14.2 ± 6.5 
 
4.3 ± 5.3 
7.9 ± 5.4 
11.9 ± 6.1 
 
<0.001 
< 0.001 
< 0.001 
Preceding 3 days temperature (°C) 
Min 
Mean 
Max 
 
4.0 ± 5.3 
9.9 ± 5.3 
15.8 ± 6.4 
 
2.3 ± 5.3 
7.8 ± 5.2 
13.3 ± 6.0 
 
<0.001 
< 0.001 
< 0.001 
Preceding Weekly temperature (°C) 
Min 
Mean 
Max 
 
2.5 ± 5.1 
9.9 ± 5.1 
17.2 ± 6.2 
 
0.7 ± 4.9 
8.1 ± 4.8 
15.0 ± 5.7 
 
<0.001 
< 0.001 
< 0.001 
Mean monthly temp 10.5 ± 4.9 9.0 ± 4.6 0.472 
Hours of daylight (hours) 4.1 ± 2.8 3.6 ± 2.5 0.095 
Preceding day’s sunshine 4.1 ± 2.9 3.6 ± 2.4 0.051 
Mean monthly sunshine 4.0 ± 1.9 3.7 ± 1.9 0.016 
Total monthly sunshine 130.3 ± 50.1 119.0 ± 51.8 0.006 
Difference between mean temps (day 
of scan – preceding day) 
-0.0 ± 2.1 -0.1 ± 2.2 0.342 
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Figure 3-2: 18F-FDG prevalence decreases with age for both males and femalesa. 
 
Table 3-2: 18F-FDG BAT prevalence by age octile for males and females. 
Age octile 
(years) 
18F-FDG positive 
scans in females (%) 
18F-FDG positive 
scans in males (%) 
Odds ratio (95% confidence 
intervals) and p-value 
10-20 6/18 (33.3%) 6/21 (28.6%) 1.250 (0.320-4.855), p = 1.000 
20-30 19/59 (32.2%) 12/49 (24.5%) 1.465 (0.6260-3.427); p = 0.4017 
30-40 16/101 (15.8%) 4/84 (4.8%) 3.765 (1.207-11.744); p = 0.0175 
40-50 21/176 (11.9%) 0/144 (0.0%) 39.958 (2.397-666.15); p <0.0001 
50-60 23/282 (8.2%) 8/340 (2.4%) 3.685 (1.622-8.375); p = 0.0013 
60-70 24/436 (5.5%) 9/582 (1.5%) 3.709 (1.706-8.064); p = 0.0005 
70-80 18/326 (5.5%) 2/464 (0.4%) 13.500 (3.109 – 58.617); p <0.0001 
80-90 2/87 (2.3%) 4/123 (3.3%) 0.933 (0.1526 – 5.710); p = 1.000 
3.4.1.2 Age 
The age distribution of the sample is skewed towards older adults, with the greatest 
proportion of scans being performed in the 60-70 year age groups for both males and 
females (Figure 3-3). Individuals in whom scans showed 18F-FDG BAT uptake were on 
average younger (mean ± SD 48.4 ± 19.6 years) than those in whom scans were 
negative (62.0 ± 14.2 years; p < 0.001; Table 3-1 and Figure 3-4). 
                                                
a * = p-value <0.05, ** < 0.01, *** <0.001 
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Figure 3-3: Number of PET/CT scans performed according to age. 
 
 
Figure 3-4: Box and whisker plot 
with Tukey’s hingesa showing 
significant differences between the 
mean ages of those with and 
without 18F-FDG BAT (p < 0.001). 
 
 
3.4.1.3 BMI 
The prevalence of patients who were overweight or obese was slightly lower than the 
English average, with 783/1,463 females (53.5%) and 1,085/1,792 males (60.5%) 
having a BMI in ≥ 25 kg/m2 (Figure 3-5), compared the English average of 58% for 
females and 65% for males; 360/1,463 females (24.6%) and 348/1,792 males (19.4%) 
                                                
a The boxes demonstrate the 75th and 25th centiles, with the line in the centre indicating the mean. The 
whiskers represent the maximum and minimum values, while the dots represent outliers whose values are 
more than 1.5 times the interquartile range (the difference between the 25th and 75th quartile) above the 
75th centile 
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were obese (BMI ≥ 30 kg/m2), compared with the English average of 26% of women 
and 24% for men [209]. 
There was no significant difference in mean BMI between the females and males at 
baseline (26.5 kg/m2 and 26.4 kg/m2 respectively). No significant correlation between 
age and BMI was observed overall (r = 0.02, p = 0.28), nor between sexes (r = 0.05, p = 
0.06 for females; r = -0.02, p = 0.46 for males). 
Figure 3-5: Breakdown of BMI categories by sex. 
 
18F-FDG BAT was observed in all BMI categories. There is a weak positive correlation 
between age and BMI for those scans demonstrating 18F-FDG BAT (r = 0.22, p = 
0.0045), but not for those without evidence of 18F-FDG BAT (r = -0.001, p = 0.59; 
Figure 3-6). 
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Figure 3-6: Scatterplot of age against BMI, showing no significant correlation. The dotted 
line at 25 kg/m2 indicates the upper limit of the ‘ideal’ BMI. 
 
 
The mean BMI of those who exhibited 18F-FDG BAT was slightly lower (24.3 ± 4.5 
kg/m2) than those who did not (26.6 ± 5.4 kg/m2), which was statistically significant (p 
< 0.001; Figure 3-7). In males the highest prevalence of 18F-FDG BAT occurred in 
those who were underweight (7.3%) while in females the highest prevalence was in 
those with an ideal BMI (11.0%). 18F-FDG BAT uptake was evident in all BMI 
categories, although for both males and females, the prevalence progressively decreased 
in those who were overweight and obese (Figure 3-8 andTable 3-3), although the trend 
was most marked in males, in whom 18F-FDG BAT prevalence fell to 0.9% in those 
who were either overweight or obese. The gender difference in 18F-FDG BAT 
prevalence was significant for all BMI categories except for those who were 
underweight.  
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Figure 3-7: Mean BMI for 18F-FDG BAT negative and positive scans. Lines at 25 and 30 
kg/m2 indicate the boundaries between ideal, overweight and obese BMI values. 
 
Figure 3-8: Prevalence of 18F-FDG BAT according to BMI and gendera. 
 
                                                
a * = p-value <0.05, ** < 0.01, *** <0.001 
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Table 3-3: Frequency of 18F-FDG BAT positive scans according to BMI categorya. 
BMI (kg/m2) 18F-FDG 
positive scans 
in females (%) 
18F-FDG positive 
scans in males 
(%) 
OR (95% CI) and significance 
Underweight (<18.5) 6/69 (8.7%) 4/55 (7.3%) 1.21 (9.32-4.54); p = 1.000 
Ideal (18.5-24.99) 67/611 (11.0%) 43/652 (6.7%) 1.74 (1.17-2.60), p = 0.0069 
Overweight (25-29.99) 42/423 (10.0%) 7/737 (0.9%) 10.92 (4.86-24.54); p <0.0001 
Obese (≥30) 13/360 (3.6%) 3/348 (0.9%) 4.31 (1.22-15.26), p = 0.0202 
BMI data not recorded 1/22 (4.5%) 0/18 (0%) - 
3.4.1.4 Fasting glycaemic status and injected 18F-FDG dose 
Mean fasting serum glucose was lower in individuals showing 18F-FDG PET (5.3 ± 0.8 
mmol/l) than those who did not (5.7 ± 1.7 mmol/l), which was also statistically 
significant (p < 0.0001). 
There was a higher prevalence of 18F-FDG BAT in normoglycaemic subjects (fasting 
serum glucose ≤ 5.5 mmol/L; 6.5%), becoming progressively smaller in those with 
impaired fasting glucose (‘IFG’; 5.6 – 6.9 mmol/L; 4.4%) or diabetes mellitus (≥ 7.0 
mmol/L; 1.9%). This trend was statistically significant (p = 0.0002). Although males 
showed a consistently lower prevalence for all glycaemic categories (Figure 3-9), the 
difference between sexes did not quite reach statistical significance (p = 0.88). 
There was no significant difference in the dose of 18F-FDG radiopharmaceutical 
administered between individuals with (357.5 ± 41.2 MBq) and without 18F-FDG BAT 
uptake (362.3 ± 32.7 MBq) on PET/CT. 
                                                
a BMI data not available for 22 females and 18 males 
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Figure 3-9: Prevalence of 18F-FDG BAT with glycaemic status according to sex. 
 
3.4.1.5 Environmental variables 
A strong inverse correlation was identified between mean monthly temperature and the 
prevalence of 18F-FDG BAT (r = -0.74; Figure 3-10 and Table 3-4), although there was 
no statistically significant difference in the mean monthly temperature between 18F-
FDG BAT positive and negative scans (Table 3-1). The probability of detecting 18F-
FDG BAT on PET/CT was highest in February, and lowest in July (Table 3-4 and 
Figure 3-10). 
The mean daily temperature was slightly lower in 18F-FDG positive scans (8.0 ± 5.4°C) 
than negative scans (10.0 ± 5.4°C), which was statistically significant (p < 0.0001). The 
same pattern was seen for the remaining temperature metrics (Table 3-1). 
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Table 3-4: Mean monthly temperature and 18F-FDG BAT prevalence. 
Month Mean monthly temperature (°C) Number of 18F-FDG BAT positive scans 
(%) 
January 1.2 16 / 294 (5.4%) 
February 1.5 30 / 279 (10.8%) 
March 3.0 18 / 291 (6.2%) 
April 4.9 11/265 (4.2%) 
May 7.1 16/284 (5.6%) 
June 10.6 11/297 (3.7%) 
July 12.2 5/309 (1.6%) 
August 12.4 11/297 (3.7%) 
September 10.2 10/239 (4.2%) 
October 7.2 14/227 (6.2%) 
November 4.6 17/272 (6.3%) 
December 0.4 16/241 (6.6%) 
 
Figure 3-10: Mean monthly temperature and 18F-FDG BAT prevalence. 
 
 
There is a significant negative correlation (r = -0.89, p = 0.001) between the time when 
the scan was acquired, and 18F-FDG BAT prevalence (Table 3-5 and Figure 3-11); the 
highest prevalence being 7.0% at 09:00, and the lowest prevalence of 3.2% at 14:00. 
18F-FDG BAT prevalence (%) 
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Only 6 scans were performed after 17:00, all of which were negative – a potentially 
aberrant result that may skew the correlation. Nonetheless, even if these data are 
excluded, a significant correlation persists (r = -0.85, p = 0.006). Chi-squared test for 
trend showed this trend to be significant (p = 0.015, χ2 = 5.95). 
Table 3-5: Variation in 18F-FDG BAT prevalence with time of day. 
Time of day Number of 18F-FDG 
BAT positive scans 
Total number of scans % of 18F-FDG BAT 
positive scans 
08:00 12 175 6.9% 
09:00 38 542 7.0% 
10:00 18 302 6.0% 
11:00 29 562 5.2% 
12:00 24 438 5.5% 
13:00 30 632 4.7% 
14:00 9 284 3.2% 
15:00 11 245 4.5% 
16:00 4 83 4.8% 
17:00 0 6 0% 
 
Figure 3-11: Variation in 18F-FDG BAT prevalence with time of day. 
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3.4.2 Binomial logistic regression 
3.4.2.1 Univariate regression analysis of 18F-FDG BAT prevalence 
Univariate analysis revealed that lower age, female sex, lower BMI and lean body mass, 
basal metabolic rate, and lower fasting serum glucose level were all predictive of higher 
18F-FDG BAT prevalence (Table 3-6). Lower temperature (be it on the day of scanning, 
preceding day, preceding 3 days, preceding month and mean monthly temperature), 
time of day (earlier), shorter duration of sunlight (on the day of scanning, preceding 
day, and total monthly sunlight) were also predictive of higher 18F-FDG BAT 
prevalence. 
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Table 3-6: Univariate binomial logistic regression performed on all PET/CT scans 
(n=3,295). 
Characteristic B (SE) P-value 95% CI for odds ratio 
Odds ratio Lower Upper 
Age -0.047 (0.005) <0.001 0.954 0.944 0.964 
Sex (M compared to F) -1.254 (0.185) <0.001 0.285 0.199 0.410 
BMI (kg/m2) -0.080 (0.017) <0.001 0.923 0.893 0.954 
Lean body mass (kg) -0.073 (0.009) <0.001 0.930 0.913 0.946 
Basal metabolic rate -0.001 (0.000) <0.001 0.999 0.998 0.999 
Fasting serum glucose (mmol/l) -0.308 (0.078) <0.001 0.735 0.631 0.856 
Injected 18F-FDG dose (MBq) -0.004 (0.002) 0.062 0.996 0.992 1.000 
Time of scan 0.000 (0.000) 0.019 1.000 1.000 1.000 
Temperature on scan date (°C) 
Minimum 
Mean 
Maximum 
 
-0.064 (0.015) 
-0.064 (0.014) 
-0.059 (0.012) 
 
<0.001 
<0.001 
<0.001 
 
0.938 
0.938 
0.942 
 
0.912 
0.913 
0.920 
 
0.965 
0.964 
0.965 
Temperature on preceding day 
(°C) 
Minimum 
Mean 
Maximum 
 
-0.061 (0.014) 
-0.067 (0.014) 
-0.055 (0.012) 
 
<0.001 
<0.001 
<0.001 
 
0.941 
0.935 
0.946 
 
0.915 
0.910 
0.924 
 
0.968 
0.961 
0.969 
Preceding 3 days’ temperature (°C) 
Minimum 
Mean 
Maximum 
 
-0.059 (0.014) 
-0.072 (0.014) 
-0.058 (0.012) 
 
<0.001 
<0.001 
<0.001 
 
0.941 
0.930 
0.943 
 
0.917 
0.905 
0.921 
 
0.970 
0.957 
0.966 
Preceding week’s temperature (°C) 
Minimum 
Mean 
Maximum 
 
-0.066 (0.015) 
-0.069 (0.015) 
-0.057 (0.013) 
 
<0.001 
<0.001 
<0.001 
 
0.936 
0.933 
0.945 
 
0.909 
0.906 
0.922 
 
0.964 
0.961 
0.969 
Mean monthly temperature (°C) -0.061 (0.016) <0.001 0.941 0.912 0.970 
Hours of sunlight on scan date -0.057 (0.029) 0.05 0.944 0.892 1.000 
Total monthly hours of sunlight -0.004 (0.002) 0.005 0.996 0.992 0.999 
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3.4.2.2 Multivariate regression analysis of 18F-FDG BAT prevalence 
Multivariate binomial logistic regression, using the three approaches described in 
section 3.2.5, was performed on those variables which appeared a priori plausible from 
the univariate analysis.  
Multivariate analysis using the forced entry method, after adjustment for other 
variables, revealed that lower age, female sex, lower BMI, time of day (earlier), and 
lower mean temperature in the preceding 3 days remained as significant predictors of 
increased 18F-FDG BAT prevalence (Table 3-7). In effect the probability of detecting 
18F-FDG BAT on PET/CT increases as these variables decrease. The impact of time of 
day on 18F-FDG BAT prevalence appears imperceptibly small (B coefficient = 0.000), 
although this is due to the units of measurement being small (seconds). If this had been 
expressed in hours the effect would be greater. 
Higher minimum temperature in the preceding 3 days was also shown to be an 
independent predictor of 18F-FDG BAT prevalence, i.e. the higher the minimum 
temperature in the 3 days prior to scanning, the greater the odds of detecting 18F-FDG 
BAT on PET/CT. This regression model correctly predicted 18F-FDG BAT status in 
94.7% of cases. It is noteworthy that the prevalence of 18F-FDG BAT was 5.3%; this 
model correctly predicted all negative scans, but not the positive scans. 
Fasting serum glucose (lower), maximum (lower) temperature on the day of scanning, 
and minimum (lower) temperature in the preceding week approached statistical 
significance but in all cases the odds ratio 95% confidence intervals cross 1, and 
therefore the direction of effect cannot be determined. 
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Table 3-7: Binomial multivariate logistic regression (forced entry technique) performed 
on all scans (n=3,295) showing determinants of 18F-FDG BAT. 
Characteristic B (SE) P-value 95% CI for odds ratio 
Odds ratio Lower Upper 
Constant 4.891 (0.933)     
Age -0.046 (0.005) < 0.001 0.955 0.946 0.965 
Sex (M compared to F) -1.267 (0.1854 <0.001 0.282 0.196 0.404 
BMI (kg/m2) -0.078 (0.016) <0.001 0.925 0.896 0.956 
Fasting serum glucose (mmol/l) -0.158 (0.082) 0.054 0.854 0.727 1.002 
Time of scan 0.000 (0.000) 0.034 1.000 1.000 1.000 
Temperature on scan date (°C) 
Minimum 
Mean 
Maximum 
 
0.017 (0.077) 
0.071 (0.064) 
-0.110 (0.060) 
 
0.826 
0.270 
0.066 
 
1.017 
1.073 
0.895 
 
0.874 
0.947 
0.796 
 
1.183 
1.217 
1.007 
Temperature on preceding day (°C) 
Minimum 
Mean 
Maximum 
 
0.061 (0.050) 
0.009 (0.159) 
0.095 (0.088) 
 
0.228 
0.954 
0.283 
 
1.063 
1.009 
1.099 
 
0.963 
0.739 
0.925 
 
1.173 
1.379 
1.306 
Preceding 3 days’ temperature (°C) 
Minimum 
Mean 
Maximum 
 
0.110 (0.056) 
-0.367 (0.159) 
0.001 (0.082) 
 
0.048 
0.021 
0.989 
 
1.116 
0.693 
1.001 
 
1.001 
0.507 
0.852 
 
1.245 
0.946 
1.176 
Preceding week’s temperature (°C) 
Minimum 
Mean 
Maximum 
 
-0.103 (0.054) 
0.118 (0.121) 
-0.019 (0.065) 
 
0.055 
0.328 
0.787 
 
0.902 
1.125 
0.767 
 
0.812 
0.888 
0.981 
 
1.002 
1.427 
1.115 
Mean monthly temperature (°C) 0.049 (0.048) 0.487 1.032 0.945 1.126 
Hours of sunlight on scan date 0.031 (0.045) 0.574 1.043 0.900 1.209 
Total monthly hours of sunlight 0.000 (0.003) 0.926 1.000 0.995 1.005 
R2 goodness of fit = 0.072 (Cox and Snell), 0.212 (Nagelkerke) 
 
Both methods of stepwise multivariate regression also revealed that age, sex, BMI and 
time of day remained independent predictors of 18F-FDG BAT prevalence (Table 3-8). 
There was some discordance between the two techniques for meteorological variables 
however: forward stepwise regression revealed that the preceding day’s mean 
temperature was a significant predictor, while backwards stepwise regression identified 
that mean temperature in the preceding 3 days was a significant predictor. 
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Table 3-8: Stepwise forwards and backwards binomial logistic regression for all scans 
(n=3,295) showing significant predictors of 18F-FDG BAT for each regression model. 
Variable Forward stepwise technique Backward stepwise technique 
B (SE) P-value OR (95% CI) B (SE) P-value OR (95% CI) 
Constant 3.895 
(0.677) 
- - 4.726 
(0.808) 
- - 
Age (years) -0.048 
(0.005) 
<0.001 0.953 
(0.945-0.962) 
-0.045 
(0.005) 
<0.001 0.956 
(0.947-0.965) 
Sex (M) -1.236 
(0.182) 
<0.001 0.291 
(0.203-0.415) 
-1.230 
(0.182) 
<0.001 0.292 
(0.205-0.417) 
BMI (kg/m2) -0.077 
(0.016) 
<0.001 0.925 
(0.896-0.956) 
-0.077 
(0.016) 
<0.001 0.926 
(0.897-0.956) 
Glucose (mmol/l) - - - -0.154 
(0.080) 
0.056 0.857 
(0.732-1.004) 
Time of scanning 
(hh:mm:ss) 
0.000 
(0.000) 
0.054 1.000 
(1.000-1.000) 
0.000 
(0.000) 
0.028 1.000 
(1.000-1.000) 
Preceding days’ 
mean temp (°C) 
-0.081 
(0.015) 
<0.001 0.922 
(0.895-0.950) 
- - - 
Preceding 3 days 
mean temp (°C) 
- - - -0.083 
(0.015) 
<0.001 0.920 
(0.893-0.948) 
Goodness-of-fit tests for forward regression: 0.067 (Cox and Snell), 0.196 (Nagelkerke R2); Backwards 
regression: 0.068 (Cox and Snell R2), 0.200 (Nagelkerke R2) 
 
3.4.3 Regression analysis of 18F-FDG prevalence on first PET/CT scans 
When analysis is restricted to the first scans only, 149/2,685 of patients (5.5%) showed 
evidence of 18F-FDG BAT uptake. 
The above findings were largely mirrored when the logistic regression was confined to 
patients’ initial scans. With the exception of the injected dose of 18F-FDG, all variables 
were significant predictors of 18F-FDG BAT prevalence on univariate logistic 
regression analysis (Appendix A, supplementary table 1). Multivariate logistic 
regression analysis revealed lower age, female sex, lower BMI, and earlier time of day 
to be significant predictors of 18F-FDG BAT prevalence (Appendix A, supplementary 
table 2). The impact of lower serum glucose and lower mean temperature in the 
preceding 3 days upon 18F-FDG BAT prevalence approached statistical significance. 
This model correctly predicted 18F-FDG BAT status in 94.4% of cases. 
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3.4.4 Multicollinearity testing 
Multicollinearity is a problem in multiple regression in which variables are highly 
correlated with each other, making it difficult to separate out the effects of individual 
variables and potentially introducing bias into the regression model [210]. 
Multicollinearity is most likely to be an issue with the temperature data. This is apparent 
when the pattern of mean, minimum and maximum temperature fluctuation throughout 
the study period are compared (Figure 3-12). Furthermore temperature is closely 
mirrored by total monthly sunshine. Collinearity calculations confirm this to be the case 
(Table 3-9). The variance inflation factor (VIF) is a measure of how much each 
coefficient’s variance is affected by multicollinearity - a value >1 suggests that 
multicollinearity may be biasing the regression model, while values >10 indicates a 
significant issue [210]. High VIF values were detected for all temperature data implying 
a strong linear relationship between some of these variables. 
Figure 3-12: Seasonal variation in monthly temperature, and mean monthly sunshine. 
 
 
0"
50"
100"
150"
200"
250"
300"
0"
5"
10"
15"
20"
25"
Ju
n$
07
'
Se
p$
07
'
De
c$
07
'
M
ar
$0
8'
Ju
n$
08
'
Se
p$
08
'
De
c$
08
'
M
ar
$0
9'
Ju
n$
09
'
Se
p$
09
'
De
c$
09
'
M
ar
$1
0'
Ju
n$
10
'
Se
p$
10
'
De
c$
10
'
M
ar
$1
1'
Ju
n$
11
'
Se
p$
11
'
De
c$
11
'
M
ar
$1
2'
Ju
n$
12
'
Se
p$
12
'
Mean'minimum'temperature'(°C)' Mean'temperature'(°C)'
Mean'maximum'temperature'(°C)' Total'monthly'sunshine'(hours)'
  87 
The variables most affected by multicollinearity were identified by calculating the 
Spearman’s rho correlation coefficient for all combinations of variable (Supplementary 
table 3, Appendix A).  
The most highly correlated variables (i.e. those with a correlation coefficient >0.9) were 
removed incrementally until all VIF values fell within acceptable limits (Table 3-9). 
Multivariate binomial logistic regression was repeated on the remaining variables which 
identified age, sex, BMI, and minimum temperature on the preceding day to be 
significant predictors of the presence of 18F-FDG BAT occurrence (Table 3-10). 
Table 3-9: Multicollinearity calculations for predictors of 18F-FDG BAT prevalence. 
Variable VIF VIF (following removal of covariates) 
Age (years) 1.045 1.041 
Sex 1.016 0.010 
BMI (kg/m2) 1.011 1.008 
Fasting serum glucose (mmol/l) 1.059 1.055 
Time of scan (hh:mm:ss) 1.038 1.022 
Temperature on scan date (°C) 
Minimum 
Mean 
Maximum 
 
21.126 
18.679 
20.708 
 
- 
- 
- 
Temperature on preceding day (°C) 
Minimum 
Mean 
Maximum 
 
10.026 
107.486 
43.906 
 
1.222 
- 
- 
Preceding 3 days’ temperature (°C) 
Minimum 
Mean 
Maximum 
 
12.807 
103.850 
42.542 
 
- 
- 
- 
Preceding week’s temperature (°C) 
Minimum 
Mean 
Maximum 
 
11.540 
55.765 
24.699 
 
- 
- 
- 
Mean monthly temperature (°C) 8.222 - 
Hours of sunlight on scan date (h) 2.037 1.456 
Total monthly hours of sunlight (h) 2.558 1.708 
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Table 3-10: Multivariate binomial logistic regression of predictors of 18F-FDG BAT 
prevalence following removal of covariates. 
Characteristic B (SE) P-value 95% CI for odds ratio 
Odds ratio Lower Upper 
Constant 3.897 (0.813)     
Age (years) -0.045 (0.005) <0.001 0.956 0.947 0.965 
Sex -1.214 (0.182) <0.001 0.297 0.208 0.424 
BMI (kg/m2) -0.075 (0.016) <0.001 0.928 0.898 0.958 
Fasting serum glucose (mmol/l) -0.147 (0.080) 0.066 0.863 0.737 1.010 
Time of day (hh:mm:ss) 0.000 (0.000) <0.001 1.000 1.000 1.000 
Min temp on preceding day (°C) -0.059 (0.017) 0.001 0.943 0.912 0.975 
Hours of sunlight on scan date (h) -0.013 (0.036) 0.725 0.987 0.919 1.060 
Total monthly hours of sunlight (h) -0.002 (0.002)  0.304 0.998 0.994 1.002 
Goodness-of-fit tests for forward regression: 0.066 (Cox and Snell), 0.194 (Nagelkerke R2) 
 
Time of day was a significant predictor of 18F-FDG BAT in both the forced entry and 
backwards regression models (Table 3-10 and Table 3-11), and approached statistical 
significance (p=0.056) in the forwards regression model (Table 3-11). 
Table 3-11: Stepwise forwards and backwards binomial logistic regression for all scans 
(n=3,295) following removal of covariates, showing significant predictors of 18F-FDG BAT 
prevalence for each regression model. 
Variable Forward stepwise technique Backward stepwise technique 
B (SE) P-value OR (95% CI) B (SE) P-value OR (95% CI) 
Constant 2.847 
(0.659) 
  3.606 
(0.785) 
  
Age (years) -0.047 
(0.005) 
<0.001 0.954 (0.945-
0.963) 
-0.045 
(0.005) 
<0.001 0.956 (0.947-
0.965) 
Sex (M) -1.215 
(0.181) 
<0.001 0.297 (0.208-
0.423) 
-1.209 
(0.181) 
<0.001 0.299 (0.209-
0.426) 
BMI -0.076 
(0.016) 
<0.001 0.927 (0.898-
0.957) 
-0.072 
(0.867) 
<0.001 0.928 (0.899-
0.958) 
Glucose - - - -0.143 
(0.079) 
0.072 0.867 (0.742-
1.013) 
Time of day 0.000 
(0.000) 
0.056 1.000 (1.000-
1.000) 
0.000 
(0.000) 
0.031 1.000 (1.000-
1.000) 
Preceding day’s 
min temp 
-0.067 
(0.015) 
<0.001 0.935 (0.908-
0.963) 
-0.069 
(0.015) 
<0.001 0.934 (0.906-
0.962) 
Goodness-of-fit tests for forward regression: 0.064 (Cox and Snell), 0.189 (Nagelkerke R2); Backwards 
regression: 0.068 (Cox and Snell R2), 0.200 (Nagelkerke R2) 
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3.4.5 Comparison of differences between 18F-FDG BAT prevalence on first 
and second PET/CT scans 
McNemar’s test with Yates’ continuity correction assesses the significance of the 
difference between two correlated proportions, as in this case where 22/422 (5.2%) of 
patients with multiple scans showed 18F-FDG BAT uptake on their first scan, while 
26/422 (6.2%) showed it on the second (Table 3-12), which were not significantly 
different (p=0.596; χ2=0.281, 1 degree of freedom, odds ratio 0.778, 95% CI 0.358 to 
1.655). 
Table 3-12: 2x2 contingency table showing concordance in 18F-FDG BAT uptake between 
first and second PET/CT scans. 
  Second scan 
Total 
  18F-FDG BAT positive 18F-FDG negative 
Fi
rs
t 
sc
an
 18F-FDG BAT positive 8 14 22 
18F-FDG BAT negative 18 382 400 
 Total 26 396 422 
 
Of the 22 patients who showed 18F-FDG BAT uptake on their first scan, only 8 (36.4%) 
also showed it on their second scan. Conversely 18 patients who showed no evidence of 
18F-FDG BAT on their baseline PET/CT, had uptake on their second PET/CT. 
Therefore the presence or absence of 18F-FDG BAT on baseline PET/CT is a poor 
predictor of uptake on second (or subsequent) scans, and therefore one cannot assume 
that a patient is genuinely BAT negative on the basis of an initial negative scan. 
3.4.6 Sensitivity and specificity of PET/CT in detecting 18F-FDG BAT 
Of the 422 patients with multiple PET/CT scans, 45 showed 18F-FDG BAT uptake on at 
least one scan, but only 22 showed it on their initial scan (Table 3-13). This equates to a 
sensitivity of 48.9%, specificity of 100%, positive predictive value of 100% and 
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negative predictive value of 94.3%. Although on the face of it these values are 
reassuring, almost half of those patients with 18F-FDG BAT would be missed if analysis 
was confined to the first scan. 
Table 3-13: Contingency table showing proportion of patients with 18F-FDG BAT activity 
correctly identified on their first PET/CT. 
  Overall BAT status 
Total 
  18F-FDG BAT positive 18F-FDG BAT negative 
Fi
rs
t 
sc
an
 
18F-FDG BAT positive 22 0 22 
18F-FDG BAT 
negative 
23 377 400 
 Total 45 373 422 
3.4.7 Cumulative prevalence of 18F-FDG BAT on serial PET/CT scans 
The impact of repeated scanning on the likelihood of detecting 18F-FDG BAT was 
assessed by calculating the cumulative prevalence of 18F-FDG BAT on serial scans, in 
similar manner to that described by Lee et al. [187]. 
Four hundred and twenty two patients had more than one PET/CT scan. There was a 
trend towards higher 18F-FDG BAT prevalence with greater number of scans, viz. 4.7% 
in those scanned once, 7.8% in those scanned twice, 15.1% when scanned three times, 
20.8% four, 25.0% five, and 33.3% in those scanned six times (Table 3-14 and Figure 
3-13). Exceptionally five patients were scanned more than 6 times, but these were 
considered outliers; the patient who underwent 10 scans was a child (14.5 years of age 
at the first scan), as was the only patient who showed 18F-FDG BAT uptake after 6 
scans (16.9 years at first scan), both of whom would be expected to have a higher 
prevalence. For those scanned two, three, four, five and six times, the likelihood of 
detecting 18F-FDG BAT within an individual increased by 3.1%, 7.3%, 5.7%, 4.2% and 
8.3% respectively. This equates to a mean probability of a patient being 18F-FDG BAT 
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positive increasing by 5.8% with each additional scan (at least as far as 6 scans, when 
the prevalence plateaus at approximately 30%). These conclusions should be treated 
with caution, however, due to the comparatively small numbers of patients who showed 
18F-FDG BAT activity on multiple scans. 
Table 3-14: Cumulative prevalence of 18F-FDG BAT on serial PET/CT scans. 
Number of 
scans 
performed 
Number of patients Number of 
individuals with 
positive scans (%) 
Incremental 
change in 
prevalence 
Number of 
positive scans (%) 
1 2,263 107/2,263 (4.7%)  107/2,263 (4.7%) 
2 309 24/309 (7.8%) 3.1% 29/618 (4.7%) 
3 73 11/73 (15.1%) 7.3% 13/219 (5.9%) 
4 24 5/24 (20.8%) 5.7% 12/96 (12.5%) 
5 8 2/8 (25.0%) 4.2% 5/40 12.5%) 
6 3 1/3 (33.3%) 8.3% 3/18 (16.7%) 
7 1 0/1 (0%) - 0/7 (0%) 
8 3 1/3 (33.3%) - 1/24 (4.2%) 
9 0 - - - 
10 1 1/1 (100%) - 5/10 (50.0%) 
Figure 3-13: Cumulative prevalence of 18F-FDG BAT with increasing numbers of scans. 
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3.5 Summary 
In this chapter we sought to identify meteorological and demographic factors which 
were predictors of higher 18F-FDG BAT prevalence. The overall prevalence was 5.3%, 
with female gender, younger age, lower BMI, lower serum glucose, earlier time of day 
and lower temperature being predictive of higher 18F-FDG BAT prevalence. We 
identified that the likelihood of a PET/CT showing 18F-FDG BAT increased by 
approximately 5.8% for each additional scan, plateauing at a prevalence of 
approximately 30%. 
Multivariate analysis identified younger age, female sex, lower BMI and earlier time of 
day as significant predictors or BAT occurrence. We also identified that lower 
temperatures were also predictive of 18F-FDG BAT occurrence, although it was not 
clear whether it was the temperature on the preceding day or preceding 3 days which 
was most important as these were highly correlated. 
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Chapter 4: Predictors of 18F-FDG BAT volume and 
activity on PET/CT 
4.1 Aims 
In the preceding chapter we identified multiple environmental and demographic factors 
which are associated with higher 18F-FDG BAT prevalence. In this chapter we shall 
determine whether these variables correlate with 18F-FDG BAT volume and metabolic 
activity. 
4.2 Subjects and methods 
4.2.1 Subject selection 
All 3,295 eligible PET/CT scans of the 2,685 patients introduced in Chapter 3 between 
June 2007 and August 2012 were included.  
4.2.2 Data collection 
As described in section 3.2.2, the biological and meteorological metrics which appeared 
a priori plausible were recorded. 
4.2.3 Image analysis 
All eligible PET/CT scans (n=3,295) were reviewed to identify those with evidence of 
18F-FDG BAT uptake (n=175). Commercially available image fusion software (Mirada 
XD 3.4, Mirada Medical Ltd, Oxford, UK) was used to semi-automatically define 
isocontours around putative 18F-FDG BAT depots on axial PET/CT scans (Figure 4-1), 
with a threshold set at an SUV of 2.5 g/ml using a similar technique to that described by 
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Huang et al. [203] and van Marken Lichtenbelt et al. [43]. We found that this threshold 
provided the best compromise between capturing the extent of 18F-FDG uptake within 
BAT, whilst minimising artefactual ‘bleeding’ of signal into adjacent tissues. From this 
the volume (Figure 4-2) and SUVmax (i.e. the maximum SUV measurement within a 
region of interest) were calculated for each depot. 
Figure 4-1: Semi-automatic selection of 18F-FDG regions of interest by defining an 
isocontour set at SUV of 2.5 g/ml (a). Isocontours set at 2.0g/ml overestimate the extent 
of 18F-FDG BAT uptake (b). 
(a)   
(b)  
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Figure 4-2: Coronal PET MIP image, showing isocontours around BAT from which 
volumes were derived. 
 
4.2.4 Statistical analysis 
Normality testing using both the Kolmogorov-Smirnov (KS) and Shipiro-Wilk (SW) 
tests indicated that both 18F-FDG BAT volume and SUVmax followed a non-normal 
distribution (KS statistic = 0.501, SW statistic = 0.120, p<0.001 for volume; KS = 
0.529, SW = 0.213, p<0.001 for SUVmax). Both volume and SUVmax were heavily 
skewed due to there being 3,120/3,295 scans with no 18F-FDG BAT uptake (Figure 
4-3). 
Figure 4-3: Frequency histogram showing distribution of 18F-FDG BAT volumes. 
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Following logarithmic transformation, log10[18F-FDG BAT volume] followed a normal 
distribution using the Kolmogorov-Smirnov test (KS statistic = 0.099, p = 0.200) 
whereas the Shapiro-Wilk was borderline (SW statistic = 0.984, p=0.048) – likely due 
to some outliers with particularly high BAT volumes (Figure 4-4). Logarithmic 
transformation of SUVmax did not result in a normal distribution (KS statistic = 0.099, 
p<0.001; SW statistic = 0.9871, p=0.001). As logarithmic transformation excluded all 
18F-FDG BAT negative scans, transformation was not considered appropriate. Therefore 
linear regression was performed on the raw volume and SUVmax data. As conventional 
linear regression is not appropriate on these non-normally distributed data, non-
parametric univariate and multivariate linear regression (Tobit analysis [211]) was 
performed on variables that seemed a priori plausible or which were found to be 
significant determinants of 18F-FDG BAT prevalence. 
Figure 4-4: Normal Q-Q plot showing almost normal distribution of log10[18F-FDG BAT 
volume] except for those at the extremes. 
 
 
For PET/CT scans with evidence of 18F-FDG BAT the association between both 18F-
FDG BAT volume and SUVmax, and variables was tested using Spearman correlation. 
Differences between 18F-FDG BAT volume and SUVmax between groups (i.e. between 
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sexes, BMI categories, fasting glucose status) were tested using the Wilcoxon-Mann 
Whitney or Kruskal-Wallis tests as appropriate. Missing values were replaced with 
mean or median values as appropriate. 
Statistical analyses were performed using SPSS version 21.0 (SPSS IBM Corp., New 
York, USA) and GraphPad Prism version 5.0 for Windows (GraphPad Software, San 
Diego, USA). Tobit analyses were performed in R (R Foundation for Statistical 
Computing, Vienna, Austria). 
4.3 Results 
A strong positive correlation between 18F-FDG BAT volume and SUVmax was 
observed (r = 0.870, p<0.0001; Figure 4-5) indicating that larger BAT volumes were 
associated with greater metabolic activity. The frequency distribution of 18F-FDG BAT 
volume data was skewed, with the overwhelming majority of scans showing no 
evidence of BAT activity (Figure 4-3). 
Figure 4-5: Scatterplot of 18F-FDG BAT volume against SUVmax. 
 
  98 
4.3.1 Factors associated with 18F-FDG BAT volume 
4.3.1.1 Sex 
Females tended to have a higher mean 18F-FDG BAT volume (6.79 ± 37.85ml) than 
males (volume = 1.39 ± 15.80ml), which was statistically significant (p <0.0001). 
However, when analysis is restricted to those PET scans showing 18F-FDG BAT uptake 
(n=175) to account for the significant difference in BAT prevalence between sexes (see 
section 3.4.1.1), no significant difference in mean volume was observed between the 
sexes (p = 0.29; Figure 4-6). 
Figure 4-6: Box and whisker plot showing no significant differences between mean 18F-
FDG BAT volume between sexes. 
 
4.3.1.2 Age 
When analysis was confined to 18F-FDG BAT positive scans, there was a moderate 
inverse correlation between age and 18F-FDG BAT volume (r = -0.308; Table 4-1) for 
both females (r = -0.308, p=0.0007) and males (r = -0.34, p = 0.0194; Figure 4-7). The 
difference between sexes approached statistical significance (p = 0.077). 
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Table 4-1: Spearman’s correlations with 18F-FDG BAT volume and SUVmax  
(** = p<0.01, * = p<0.05). 
 All PET/CT scans 
(n = 3,295) 
Positive PET/CT scans 
(n = 175) 
Variable Volume 
(ml) 
SUVmax (g/ml) Volume 
(ml) 
SUVmax 
(g/ml) 
Sex -0.136** -0.136** -0.080 -0.056 
Age (years) -0.160** -0.159** -0.308** -0.239** 
BMI (kg/m2) -0.106** -0.106** -0.016 0.028 
Fasting serum glucose (mmol/l) -0.071** -0.071** -0.002 -0.024 
Injected 18F-FDG dose (MBq) -0.015 -0.015 -0.096 -0.095 
Time of scan (hh:mm:ss) -0.044* -0.044* -0.142 -0.092 
Temperature on scan date (°C) 
- Minimum 
- Mean 
- Maximum 
 
-0.072** 
-0.075** 
-0.079** 
 
-0.072** 
-0.076** 
-0.079** 
 
0.134 
0.137 
0.132 
 
0.107 
0.092 
0.068 
Temperature on preceding day (°C) 
- Minimum 
- Mean 
- Maximum 
 
-0.072** 
-0.080** 
-0.078** 
 
-0.072** 
-0.080** 
-0.078** 
 
0.248**  
0.149** 
0.145 
 
0.211** 
0.114 
0.112 
Preceding 3 days’ temperature (°C) 
- Minimum 
- Mean 
- Maximum 
 
-0.069** 
-0.085** 
-0.084** 
 
-0.069** 
-0.085** 
-0.084** 
 
0.179* 
0.186* 
0.171* 
 
0.138 
0.149* 
0.138 
Preceding week’s temperature (°C) 
- Minimum 
- Mean 
- Maximum 
 
-0.076** 
-0.081** 
-0.080** 
 
-0.076** 
-0.081** 
-0.080** 
 
0.126 
0.185* 
0.158* 
 
0.121 
0.144 
0.114 
Mean monthly temperature (°C) -0.066** -0.066** 0.136 0.111 
Hours of sunlight on scan date (h) -0.030 -0.030 0.094 0.070 
Total monthly hours of sunlight (h) -0.046** -0.047** 0.034 -0.021 
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Figure 4-7: Scatterplot showing inverse correlation between age and 18F-FDG BAT 
volume for both genders. 
 
4.3.1.3 BMI 
There was a weak inverse correlation between BMI and 18F-FDG BAT volume (r = -
0.106) which disappeared when analysis was confined to positive scans (r = -0.016; 
Table 4-1). Analysis of all 3,295 PET/CT scans according to BMI category showed that 
overweight and obese patients had a significantly lower mean 18F-FDG BAT volume 
(2.95 ± 1.69ml and 1.75 ± 2.55ml respectively) than individuals with an ideal BMI 
(5.96 ± 34.36ml) which was statistically significant (p<0.05). Underweight patients also 
showed a lower volume (2.89 ± 14.58ml) but this was not statistically significant. 
However, when analysis is restricted to those 18F-FDG BAT positive PET/CT scans (to 
account for the significant difference in 18F-FDG BAT prevalence between BMI 
categories, highlighted in Figure 3-8), no statistically significant difference in volume 
was observed between BMI categories (p=0.41; Figure 4-8). Males tended to have a 
lower mean volume of 18F-FDG BAT than females across all BMI categories (Figure 
4-9), and became more pronounced for higher BMIs, although the differences between 
sexes were not statistically significant (Table 4-2). Nonetheless, the trend was towards 
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diminishing BAT volumes with increasing BMI in males, with little corresponding 
change in BAT volume in females across BMI categories. 
Figure 4-8: Box and whisker plot (with Tukey’s hinges) showing no significant difference 
in 18F-FDG BAT volume between BMI categories. 
 
Figure 4-9: Scatterplot of 18F-FDG BAT volume against BMI category (according to 
gender). 
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Table 4-2: Mean 18F-FDG BAT volume for each BMI category according to sex. 
BMI (kg/m2) 18F-FDG BAT volume (ml) 
in females (mean ± SD) 
18F-FDG BAT volume (ml) 
in males (mean ± SD) 
Significance 
Underweight (<18.5) 42.5 (49.7) 30.6 (29.1) 0.76 
Ideal (18.5-24.99) 81.0 (109.4) 68.6 (96.5) 0.84 
Overweight (25-29.99) 77.9 (93.3) 24.0 (28.7) 0.20 
Obese (≥30) 89.8 (140.9) 10.4 (7.9) 0.08 
4.3.1.4 Fasting serum glucose and injected 18F-FDG dose 
No clinically significant correlation between 18F-FDG BAT volume and both fasting 
serum glucose and injected 18F-FDG dose (Table 4-1) was found. Females were found 
to have a higher mean 18F-FDG BAT volume for each glycaemic group although testing 
with 2-way ANOVA showed this not to be statistically significant (Figure 4-10). 
Figure 4-10: Mean 18F-FDG BAT volumes according to glycaemic groups. 
 
4.3.1.5 Environmental variables 
A weak positive correlation was also identified between 18F-FDG BAT volume (on 
positive PET/CT scans) for all temperature metrics as well as time of day (Table 4-1 
and Table 4-3). The most pronounced correlation was with the preceding day’s 
minimum temperature (r = 0.248). However, when analysed according to sex, no 
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significant correlation between mean temperature and volume was seen (with the 
possible exception of males in whom there was a significant positive correlation 
between volume and mean temperature on the day of scanning; r = 0.334; Table 4-3). 
Women tended to have a more blunted response to temperature change than men 
(Figure 4-11), nonetheless, there was no significant difference between the sexes in 
terms of correlation between temperature and volume. 
Figure 4-11: Scatterplot showing a weak positive correlation between mean temperature 
on the day of scanning and 18F-FDG BAT volume. 
 
 
It is noteworthy that although there was an overall rather counter-intuitive positive 
correlation between volume and temperature (i.e. higher temperatures were associated 
with higher 18F-FDG BAT volumes), the largest volumes occurred between 
approximately 0 and 10ºC (a pattern repeated for all temperature metrics) which is by 
no means warm. Above 10ºC there was a trend towards lower volumes (Figure 4-11) for 
all temperature metrics. Furthermore, there was also a consistent trend towards lower 
18F-FDG BAT volumes for very low temperatures (i.e. below 5ºC or so). 
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There was also a weak positive correlation between 18F-FDG BAT volume and duration 
of sunlight on the day preceding scanning (r = 0.154, p = 0.043), but not on the day of 
scanning (r = 0.094), nor mean monthly sunlight duration (r = 0.018). Although 
prevalence of 18F-FDG BAT showed a prominent seasonal variation (Figure 3-10), 
volume did not (p = 0.6696; Figure 4-12). 
Table 4-3: Correlations between 18F-FDG BAT volume and temperature by sex. 
Time period 
(mean) 
Overall 
Spearman’s r 
correlation 
Spearman’s r for 
females (p-value) 
Spearman’s r for 
males (p-value) 
P value of 
difference 
between sexes 
Day of scanning 0.137 (p=0.072) 0.061 (0.492) 0.334 (0.023) 0.167 
Preceding day 0.149 (p=0.050) 0.106 (0.230) 0.219 (0.143) 0.180 
Preceding 3 days 0.186 (p=0.014) 0.165 (0.061) 0.242 (0.105) 0.196 
Preceding week 0.185 (p=0.014) 0.153 (0.085) 0.266 (0.074) 0.192 
Month 0.136 (p=0.074) 0.099 (0.264) 0.228 (0.127) 0.173 
 
Figure 4-12: Mean 18F-FDG BAT volume by month. 
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Subgroup analysis of the 15 subjects with multiple 18F-FDG BAT positive scans 
showed that index scans (i.e. the PET/CT with the highest 18F-FDG BAT volume) 
occurred throughout the year. The bubble plot at Figure 4-13, in which the size of each 
bubble is proportional to 18F-FDG BAT volume, illustrates this pattern. Six out of 
fifteen subjects (40%) showed highest volumes in the winter (subjects A, C, F, J, L and 
M), followed by Autumn (B, E, K and O) and Spring (D, G, H and N) - 26.7% each. 
One subject (6.7%) showed their highest volume in the Summer (I). 
Three subjects (B, D and L) underwent multiple PET/CT scans within the same 
calendar month (albeit in different years) which yielded different 18F-FDG BAT 
volumes; subjects B and D both had negative scans in the same calendar month as their 
scans with the greatest 18F-FDG BAT volume (94.3ml in September and 324.8ml in 
March respectively) and subject L had two scans with 111 ml and 20 ml in February. 
Patient B underwent 10 scans (of which 5 were positive), which showed considerable 
monthly variation with approximately 70ml in the Spring, subsiding in the early 
Summer, then fluctuating throughout the Autumn and Winter. This highlights that 
volumes vary considerably within the same individual within a short period. 
From this we were able to determine, for each season, the likelihood of a particular 
PET/CT scan being the index scan (Table 4-4). It is clear that, for those 15 subjects with 
multiple positive PET/CT scans, the likelihood of a particular scan being the index scan 
is six times higher in the Winter than the Summer. 
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Figure 4-13: Bubble plot showing monthly variation in 18F-FDG BAT volume for 15 
subjects with multiple positive scans. A: index scans (highest volume PET/CT scans for 
each subject); B: All scans (including subordinate and negative scans). 
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Table 4-4: Likelihood of an index scan being performed according to season. 
 
 
4.3.2 Factors associated with 18F-FDG BAT activity (SUVmax) 
4.3.2.1 Sex 
18F-FDG BAT within females had a higher mean SUVmax (7.36 ± 4.12 g/ml) than in 
males (7.00 ± 3.82 g/ml) when analysis is restricted to the 175 18F-FDG BAT positive 
PET scans, although this was not statistically significant (p = 0.46; Figure 4-14). 
Figure 4-14: Box and whisker plot showing no significant differences between mean 18F-
FDG BAT SUVmax between sexes (n=175). 
 
4.3.2.2 Age 
Overall, there is a mild inverse correlation between age and SUVmax (r = -0.16, p < 
0.001). This correlation is more pronounced when analysis is confined to positive scans 
Season Number of index 
scans performed 
Total number of 
scans performed 
% of index scans 
Winter 6 13 46.2% 
Spring 4 16 25.0% 
Summer 1 13 7.7% 
Autumn 4 15 27.7% 
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only (r = -0.239, p = 0.0015). This inverse correlation between age and SUVmax is 
evident for both females (r = -0.211, 95% CI -0.375 to -0.033, p = 0.0171) and males (r 
= 0.288, 95% CI -0.540 to 0.011, p = 0.0519; Figure 4-15), and do not differ 
significantly (p=0.988). 
Figure 4-15: Scatterplot showing inverse correlation between age and 18F-FDG BAT 
SUVmax for both sexes (n=175). 
 
4.3.2.3 BMI 
Although correlations between both BMI and fasting serum glucose, and SUVmax were 
observed when all scans were analysed (Table 4-1), no such correlation was present 
when analysis was confined to positive scans. 
Similarly, although analysis of SUVmax across BMI categories for all scans showed a 
significantly lower SUVmax in overweight (p < 0.05) or obese patients (p < 0.05) 
compared with those with a normal BMI, no significant difference in mean SUVmax 
was identified between BMI categories when analysis was confined to the 175 positive 
scans (p = 0.73). 
  109 
As with volume, there was a trend towards lower SUVmax in men for higher BMI 
categories (Figure 4-16), albeit not significant (p for interaction = 0.3075, using 2 way 
ANOVA). 
Figure 4-16: Scatterplot of mean 18F-FDG BAT SUVmax against BMI category (by gender). 
 
4.3.2.4 Fasting serum glucose and injected 18F-FDG dose 
As with volume, there was no significant correlation between SUVmax and both fasting 
serum glucose and injected 18F-FDG dose (Table 4-1). No significant difference in 
mean SUVmax was observed between males and females in normoglycaemia or 
impaired fasting glucose. For those with a fasting serum glucose in the diabetes mellitus 
range, a significant difference did emerge (Figure 4-17). 
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Figure 4-17: Mean SUVmax against fasting glycaemic status (by gender). 
 
4.3.2.5 Environmental variables 
The pattern of correlation between SUVmax and temperature on positive scans mirrored 
that of volume (section 4.3.1.5), with a somewhat counterintuitive weak positive 
correlation for 18F-FDG BAT positive scans (Table 4-1), which was most significant for 
the preceding day’s minimum temperature (r = 0.211). 
As with volume, the correlation between SUVmax and temperature was stronger in 
males than in females (e.g. for mean temperature on the day of scanning, r = 0.334 for 
males, r = 0.061 for females; Figure 4-18), although they did not differ significantly. 
Table 4-5: Correlations between 18F-FDG BAT SUVmax and mean temperature by gender. 
Time period 
(mean) 
Overall 
Spearman’s r 
correlation 
Spearman’s r for 
females (p-value) 
Spearman’s r 
for males (p-
value) 
P value of 
difference between 
sexes 
Day of scanning 0.092 (p = 0.228) 0.061 (0.492) 0.334 (0.023) 0.167 
Preceding day 0.114 (p = 0.136) 0.023 (0.798) -0.117 (0.441) 0.740 
Preceding 3 days 0.149 (p = 0.050) 0.135 (0.130) 0.192 (0.200) 0.660 
Preceding week 0.144 (p = 0.058) 0.116 (0.192) 0.215 (0.151) 0.625 
Month 0.111 (p = 0.145) 0.064 (0.472) 0.255 (0.087) 0.409 
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Figure 4-18: Scatterplot showing of mean temperature on the day of scanning against 
18F-FDG BAT activity (SUVmax) according to gender. 
 
 
No significant correlation between mean SUVmax and time of day was observed for 
positive scans (p = 0.812; Figure 4-19). 
Figure 4-19: Mean 18F-FDG BAT SUVmax according to time of day. 
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4.3.3 Linear regression analysis 
As discussed above (section 4.2.4), 18F-FDG BAT volume and SUVmax were not 
normally distributed. Despite logarithmic transformation, SUVmax failed normality 
testing, and the distribution of 18F-FDG BAT volume data was borderline. Therefore the 
non-parametric Tobit regression model was used which is specifically designed for 
skewed data with a large percentage of values at the lower or upper limit [211]. 
4.3.3.1 Regression analysis of 18F-FDG BAT mass 
Stepwise multivariate Tobit analyses of the non-transformed mass dataa from all scans 
(n=3,295) returned a model which showed age, sex, BMI, time of day, and maximum 
temperature on the day of scanning to be significant predictors of 18F-FDG BAT mass 
(Table 4-6). Maximum temperature on the preceding day was also identified as a 
significant predictor of mass, although unlike the other variables, this has a positive 
coefficient of 28.7, indicating a positive relationship (i.e. that higher maximum 
temperatures are associated with a higher 18F-FDG BAT mass). 
                                                
a Mass was derived from volume by applying a multiplication factor of 0.92. Consequently there is a 
linear relationship between BAT mass and volume. 
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Table 4-6: Predictors of 18F-FDG BAT mass on Tobit model univariate and multivariate 
regression analyses. 
Variable (n = 3,295) 
Univariate Multivariate 
Coefficient P-value Coefficient P-value 
  
Age -4.64 <0.001 -4.13 <0.001 
Sex (M compared to F) -121 <0.001 -105 <0.001 
BMI (kg/m2) -7.95 <0.001 -6.96 <0.001 
Fasting serum glucose (mmol/l) -24.3 <0.001 - - 
Time of scan -0.19 <0.001 -0.215 <0.001 
Temperature on scan date (°C) 
Minimum 
Mean 
Maximum 
 
-5.33 
-5.53 
-5.23 
 
<0.001 
<0.001 
<0.001 
 
- 
- 
-34.8 
 
- 
- 
0.005 
Temperature on preceding day (°C) 
Maximum 
 
-5.03 
 
<0.001 
 
28.7 
 
0.020 
Preceding week’s temperature (°C) 
Mean 
 
-6.10 
 
<0.001 
-  
- 
Mean monthly temperature (°C) -4.96 0.001 - - 
Hours of sunlight on scan date -6.10 -0.030 - - 
Total monthly hours of sunlight -12.6 0.009 - - 
 
As identified in section 4.2.4, log10[18F-FDG BAT volume] passed normality testing 
using the Shapiro-Wilks test, therefore conventional parametric linear regression could 
reasonably be performed. Multivariate regression returned a model in which only age (p 
< 0.001) and minimum temperature on the preceding day (p = 0.014) were significant 
predictors of 18F-FDG BAT volume (Table 4-7). 
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Table 4-7: Predictors of log10[18F-FDG BAT volume] on parametric univariate and 
multivariate linear regression. 
Variable (n=175) 
Univariate Multivariate 
B (SE) P-value B (SE) P-value 
  
Age -0.010 (0.002) <0.001 -0.011 (0.003) <0.001 
Sex (M compared to F) -0.104 (0.115) 0.365 -0.127 (0.116) 0.272 
BMI (kg/m2) -0.001 (0.011) 0.931 0.009 (0.012) 0.423 
Fasting serum glucose (mmol/l) 0.027 (0.060) 0.657 0.109 (0.065) 0.093 
Injected 18F-FDG dose (MBq) -0.002 (0.001) 0.081 -0.002 (0.001) 0.226 
Time of scan -1.2 x 10-5 (0.000) 0.073 -6.2 x 10-6 (0.000) 0.373 
Temperature on scan date (°C) 
Minimum 
Mean 
Maximum 
 
0.016 (0.009) 
0.016 (0.009) 
0.014 (0.008) 
 
0.089 
0.096 
0.101 
 
-0.022 (0.047) 
0.028 (0.037) 
-0.037 (0.037) 
 
0.645 
0.461 
0.324 
Temperature on preceding day (°C) 
Minimum 
Mean 
Maximum 
 
0.029 (0.009) 
0.018 (0.009) 
0.015 (0.008) 
 
0.003 
0.062 
0.066 
 
0.078 (0.032) 
0.027 (0.102) 
-0.016 (0.056) 
 
0.014 
0.793 
0.772 
Preceding 3 days’ temperature (°C) 
Minimum 
Mean 
Maximum 
 
0.019 (0.010) 
0.023 (0.010) 
0.017 (0.008) 
 
0.052 
0.021 
0.045 
 
-0.051 (0.036) 
0.035 (0.104) 
-0.057 (0.055) 
 
0.153 
0.735 
0.303 
Preceding week’s temperature (°C) 
Minimum 
Mean 
Maximum 
 
0.015 (0.010) 
0.023 (0.010) 
0.019 (0.009) 
 
0.149 
0.026 
0.029 
 
-0.039 (0.031) 
0.096 (0.075) 
0.005 (0.043) 
 
0.214 
0.206 
0.906 
Mean monthly temperature (°C) 0.016 (0.011) 0.147 -0.014 (0.029) 0.627 
Hours of sunlight on scan date 0.016 (0.020) 0.427 0.047 (0.049) 0.342 
Total monthly hours of sunlight 0.000 (0.001) 0.689 0.001 (0.002) 0.516 
4.3.3.2 Regression analysis of 18F-FDG BAT activity (SUVmax) 
Tobit regression analysis identified age, sex, BMI, time of day, maximum temperature 
on the day of scanning and on the preceding day to be significant predictors of 18F-FDG 
BAT activity. Although conventional parametric linear regression could not be used on 
the non-normally distributed SUVmax data, given the high correlation between 18F-
FDG BAT and volume, it is likely that similar variables predict 18F-FDG BAT activity 
as do volume. 
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Table 4-8: Predictors of 18F-FDG BAT activity (SUVmax) on Tobit model univariate and 
multivariate regression analysis. 
Variable (n = 3,295) 
Univariate Multivariate 
Coefficient P-value Coefficient P-value 
  
Age -0.378 <0.001 -0.334 <0.001 
Sex (M compared to F) -10.1 <0.001 -8.93 <0.001 
BMI (kg/m2) -2.11 <0.001 -0.612 <0.001 
Fasting serum glucose (mmol/l) -0.679 <0.001 -0.803 0.121 
Time of scan -0.015 0.002 -0.017 <0.001 
Temperature on scan date (°C) 
Minimum 
Mean 
Maximum 
 
-0.453 
-0.474 
-0.451 
 
<0.001 
<0.001 
<0.001 
 
- 
- 
-2.88 
 
- 
- 
0.006 
Temperature on preceding day (°C) 
Maximum 
 
-0.436 
 
<0.001 
 
2.34 
 
0.025 
Preceding week’s temperature (°C) 
Mean 
 
-0.528 
 
<0.001 
 
- 
 
- 
Mean monthly temperature (°C) -0.426 <0.001 - - 
Hours of sunlight on scan date -0.544 0.021 - - 
Total monthly hours of sunlight -0.544 0.021 - - 
4.4 Summary 
In this chapter we sought to identify which meteorological and demographic factors 
correlated with 18F-FDG BAT volume and activity (SUVmax). When data from all 
3,295 PET/CT scans is analysed (i.e. for both 18F-FDG BAT positive and negative 
scans), those factors predicative of higher prevalence appear to correlate most highly 
with 18F-FDG BAT volume and activity. Non-parametric multivariate linear regression 
(Tobit) analysis returned a model in which age, sex, BMI, time of day, maximum 
temperature on the day of scanning and on the preceding day to be significant predictors 
of both 18F-FDG BAT volume and activity. 
A different picture emerges if analysis is confined to scan data from 18F-FDG BAT 
positive scans; multivariate regression analysis returned a model in which only age and 
minimum temperature on the preceding day are significant predictor of BAT volume. 
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Chapter 5: Occurrence of 18F-FDG BAT uptake within 
anatomical compartments on serial PET/CT scans 
5.1 Aims 
In the preceding studies, we found that the prevalence, volume and activity of 18F-FDG 
varies within a population and within individuals. In this study, we aim to determine 
whether 18F-FDG BAT, regardless of its propensity to vary in volume and activity over 
time, occurs in consistent locations within individuals, or whether it occurs in a much 
more haphazard fashion. 
5.2 Subjects and methods 
All PET/CT scans which showed evidence of 18F-FDG BAT activity in Chapter 3 were 
reviewed (175 scans in 152 patients) to determine whether 18F-FDG BAT uptake 
occurred within each of four anatomical compartments: neck/supraclavicular fossae, 
mediastinum, paravertebral and peri-renal regions. 18F-FDG BAT was considered 
present if it met the criteria outlined in section 3.2.4. 
5.2.1 Image analysis 
The presence or absence of uptake within these regions over time was plotted in a 
matrix to illustrate the pattern of activity over time for each patient. From the 18F-FDG 
BAT volumes calculated in section 4.2.3 above, the scans with the largest volume of 
18F-FDG BAT were identified for each patient (the ‘index scan’), against which the 
patient’s other 18F-FDG BAT positive PET/CT scans (the ‘subordinate scans’) were 
compared. Negative scans were excluded. 
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5.2.2 Statistical analysis 
For each 18F-FDG BAT positive PET/CT scan, the presence or absence of BAT within 
each of four anatomical compartments was recorded (i.e. cervical/supraclavicular 
fossae, paravertebral, mediastinal and peri-renal compartments), as was the pattern of 
distribution along the lines described by Ouellet et al. [133]. 
Further analysis was performed on the subgroup of patients with 18F-FDG BAT uptake 
on sequential PET/CT Scans (n=15). The degree of concordance of 18F-FDG BAT 
distribution across each patient’s sequential positive scans was measured using pairwise 
percent agreement, Fleiss’ kappa and Krippendorff’s alphaa using the online calculator 
ReCal3 (“Reliability Calculator for 3 or more coders”)b [212]. Although both tests are 
typically employed to measure the level of agreement among raters, this situation is 
similar in that we are faced with multiple ‘raters’ (i.e. multiple PET/CT scans over time) 
measuring multiple ‘subjects’ (i.e. the anatomical compartments). Unlike Cohen’s 
kappa which is limited to two raters, Fleiss’ kappa can be used to measure the 
agreement between any number of raters, and takes into account the level of agreement 
that would be expected by chance – which is of particular importance when the number 
of categories being measured is small, as in this study, where the likelihood of 
agreement by chance is high. Furthermore both tests may be used with nominal and 
ordinal data. 
To determine whether there was a difference between mean 18F-FDG BAT volume and 
the number of positive anatomical compartments, the Kruskal-Wallis test (a non-
parametric variant of one-way ANOVA that compares the means of three or more 
unmatched groups) with Dunn’s post tests was performed using GraphPad Prism 5.0 for 
Windows (GraphPad Software, San Diego, California, USA). 
                                                
a Where α = 1 indicates perfect agreement, α = 0 indicates the absence of agreement, and α < 0 indicates 
systematic disagreements greater than that expected by chance. 
b http://dfreelon.org/utils/recalfront/recal3/ 
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5.3 Results 
5.3.1 Patterns of 18F-FDG BAT uptake 
Various patterns of 18F-FDG BAT distribution were identified; 18F-FDG BAT was most 
prevalent within the cervical/supraclavicular fossae (‘SCF’), and was present in 162/175 
(92.6%) of scans (Table 5-1), followed by the paravertebral compartment in 143/175 
(81.7%). In no case was 18F-FDG BAT confined exclusively to the peri-renal 
compartment. 
In only 25/175 scans (14.3%) was 18F-FDG BAT confined to a single compartment 
(patterns 1, 5, 13 and 14). The commonest pattern was of uptake within the 
cervical/SCF, paravertebral and mediastinal compartments (pattern 3), occurring in 
37.7%. 
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Table 5-1: Distribution patterns of 18F-FDG BAT on serial PET/CT scans. 
Pattern 
(n=175) 
Anatomical compartment 
Number of 
scans  
Cervical / SCF Paravertebra
l 
Mediastinal Peri-renal 
1 + - - - 20 (11.4%) 
2 + + - - 34 (19.4%) 
3 + + + - 66 (37.7%) 
4 + + + + 29 (17.6%) 
5 - + - - 4 (2.3%) 
6 + - + - 10 (5.7%) 
7 + - - + 0 (0.0%) 
8 + + - + 2 (1.1%) 
9 - + + + 0 (0.0%) 
10 - + - + 3 (1.7%) 
11 + - + + 1 (0.6%) 
12 - + + - 5 (2.9%) 
13 - - + - 1 (0.6%) 
14 - - - + 0 (0.0%) 
Number of scans  162 (92.6%) 143 (81.7%) 112 (64.0%) 35 (20.0%)  
 
5.3.2 18F-FDG BAT distribution patterns on serial 18F-FDG BAT positive 
scans 
The demographics of the subgroup consisting of 15 patients with 18F-FDG BAT uptake 
on serial PET/CT scans are shown in Table 5-2; four were males (mean age 37.3 years) 
and 11 females (mean age 40.1 years). All underwent PET/CT scans as part of their 
routine workup for cancer. Table 5-3 shows the number of anatomical compartments 
containing 18F-FDG BAT for both index scans (denoted by *) and subordinate scans. In 
only one aberrant case did the subordinate scan show 18F-FDG BAT uptake within more 
anatomical compartments than the index scan (patient H). There was little difference in 
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the 18F-FDG BAT volumes between the two scans (43.6 ml and 43.5 ml) and this could 
be attributed to measurement error. 
Table 5-2: Patient demographics of individuals with multiple positive PET/CT scans. 
Subject Age at first scan (years) Sex Diagnosis 
A 57 Male Squamous cell carcinoma of the lung 
B 14 Male Hodgkin’s lymphoma 
C 20 Female Hodgkin’s lymphoma 
D 52 Female Malignant melanoma 
E 29 Female Hodgkin’s lymphoma 
F 20 Male Hodgkin’s lymphoma 
G 85 Female Bronchogenic cancer 
H 58 Male Gastro-intestinal stromal tumour 
I 22 Female Hodgkin’s lymphoma 
J 17 Female Hodgkin’s lymphoma 
K 37 Female Breast cancer 
L 43 Female Oesophageal cancer 
M 25 Female Hodgkin’s lymphoma 
N 36 Female Cervical cancer 
O 75 Female Bowel cancer 
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Table 5-3: Anatomical compartments showing 18F-FDG BAT on serial PET/CT scans. 
Subject Scan date (* = index scan) 
18F-FDG 
volume 
(ml) 
Anatomical compartment 
Cervical 
/ SCF Paravertebral Mediastinal 
Peri-
renal 
A January 2009* 31.8* 1 1 1 0 
 November 2011 30.8 1 1 1 0 
B March 2009 70.7 1 1 1 0 
 September 2009* 94.3* 1 1 1 0 
 November 2009 72.9 1 1 1 0 
 January 2010 24.0 1 1 0 0 
 December 2010 18.6 1 1 1 0 
C November 2009 2.0 1 1 0 0 
 December 2009* 49.4* 1 1 0 0 
D November 2010 217.4 1 1 1 0 
 March 2011* 324.8* 1 1 1 0 
E September 2010* 47.9* 1 1 0 0 
 March 2011 9.1 1 1 0 0 
F January 2011* 84.0* 1 1 1 0 
 June 2011 33.9 1 1 1 0 
 September 2011 44.3 1 1 1 0 
 February 2012 32.7 1 1 1 0 
G April 2012* 20.1* 0 1 0 1 
 October 2012 2.5 0 1 0 1 
H April 2008* 43.6* 1 1 0 1 
 May 2011 43.5 1 1 1 1 
I February 2011 35.8 1 1 1 0 
 August 2011* 258.9* 1 1 1 1 
 March 2012 29.5 1 1 1 0 
J February 2011* 409.7* 1 1 1 1 
 April 2011 25.8 1 1 1 0 
 July 2011 53.8 1 1 1 0 
K November 2011* 73.3* 1 1 1 0 
 February 2012 10.9 1 1 1 0 
L February 2008* 111.1* 1 1 1 1 
 February 2012 20.0 1 0 1 0 
M June 2009 8.0 1 0 0 0 
 February 2010* 37.0* 1 0 0 0 
 March 2009 1.7 1 0 0 0 
N August 2009 23.2 1 1 1 1 
 March 2009* 61.7* 1 1 1 1 
O May 2011 0.9 0 1 1 0 
 Sep 2009* 18.9* 1 1 1 0 
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Furthermore both scans were performed in the Spring, approximately three years apart. 
In the remaining 14 cases, the index scan showed uptake within at least as many 
anatomical compartments as the subordinate scans (Figure 5-1). In those cases where 
the index scan showed a much greater 18F-FDG BAT volume than the subordinate scans 
(subjects I, J, L and possibly O), 18F-FDG BAT was present in more compartments on 
the index scan than the subordinate scans. 
Figure 5-1: Bar chart showing the number of anatomical depots on serial scans for 15 
patients (orange = index scan, blue = subordinate scan). 
 
Table 5-4 shows the inter-rater reliability calculations for the 15 subjects with multiple 
18F-FDG BAT positive scans. Nine subjects (60%) showed 18F-FDG BAT uptake within 
the same anatomical compartments on serial scans (100% pairwise agreement, Fleiss’ κ 
= 1, Krippendorff’s alpha = 1), greater than that expected by chance. Most prominent 
among these was patient F who showed 100% concordance in 18F-FDG BAT 
distribution across four scans performed over a 13 month period. Also worthy of note is 
subject B who underwent five 18F-FDG BAT positive scans, which showed a high level 
of concordance in terms of 18F-FDG BAT distribution (mean pairwise agreement 90%, 
Fleiss’ κ = 0.762, Krippendorff’s α= 0.774) - higher than that expected by chance. Four 
subjects (I, J, L and O) showed a lower inter-rater agreement; three disagreed on a 
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single anatomical compartment only, resulting in a Fleiss’ κ statistic of 0.4 - 0.467 
indicating fair-to-moderate agreement according to the criteria of Landis and Koch 
[213] shown in Table 5-5. Patient L is noteworthy insofar as there is discordance 
between two anatomical depots on two PET/CT scans (performed 4 years apart, both in 
February) resulting in poor agreement (Fleiss’ κ = -0.333). 
The inter-observer reliability for subject H’s scans are lower than would be expected by 
chance. This subject only had two positive scans, and there is doubt as to whether the 
index scan has been correctly identified as both have similar 18F-FDG BAT volumes 
(vide supra, page 119). 
Table 5-4: Inter-rater reliability calculations for serial 18F-FDG BAT positive PET/CT 
scans. 
Patient Average pairwise 
agreement (%) 
Fleiss' 
k 
Fleiss (observed 
agreement) 
Fleiss 
(expected 
agreement) 
Krippendorff's 
α  
A 100 1 1 0.625 1 
B 90 0.762 0.9 0.58 0.774 
C 100 1 1 0.5 1 
D 100 1 1 0.625 1 
E 100 1 1 0.5 1 
F 100 1 1 0.625 1 
G 100 1 1 0.5 1 
H 75 -0.143 0.75 0.781 0 
I 83.3 0.4 0.833 0.722 0.45 
J 83.333 0.4 0.833 0.722 0.45 
K 100 1 1 0.625 1 
L 50 -0.333 0.5 0.625 -0.167 
M 100 1 1 0.625 1 
N 100 Undefined due to invariant values 1 
O 75 0.467 0.75 0.531 0.533 
 
 
  124 
Table 5-5: Landis and Koch's criteria for interpreting kappa statistics [213]. 
κ  Interpretation 
< 0 Poor agreement 
0.01 – 0.20 Slight agreement 
0.21 – 0.40 Fair agreement 
0.41 – 0.60 Moderate agreement 
0.61 – 0.80 Substantial agreement 
0.81 – 1.00 Almost perfect 
agreement 
 
Unsurprisingly, there was a moderately strong positive correlation between the number 
of anatomical compartments showing 18F-FDG BAT activity and the corresponding 
BAT volume in those patients with 18F-FDG BAT positive scans (r = 0.72, 95% CI 0.63 
– 0.78, p <0.0001), and the subgroup of 15 patients with multiple scans (r = 0.57, 95% 
CI 0.31 – 0.76, p <0.001). Although on the face of it this would seem obvious, the mean 
18F-FDG BAT volume increases in a super-linear fashion as the number of involved 
anatomical compartments increases, i.e. mean volume in 1 compartment = 9.3 ± 11.7ml; 
2 compartments = 20.39 ± 19.36ml; 3 compartments = 77.67 ± 74.5ml and 4 
compartments = 205.0 ±145.2ml (Figure 5-2). 
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Figure 5-2: Box and whisker plot showing super-linear relationship between the number 
of compartments showing 18F-FDG BAT uptake and mean BAT volume. 
 
5.4 Summary 
In this chapter we analysed the patterns of 18F-FDG BAT on serial PET/CT scans in 15 
patients with the aim of determining the consistency of BAT uptake across multiple 
scans. 
After identifying each patient’s ‘index’ scan (i.e. the PET/CT scan with the largest 
volume of 18F-FDG BAT), the pattern of BAT uptake was compared against that in the 
patient’s other scans. We identified considerable consistency across multiple scans with 
9/15 showing 18F-FDG BAT uptake in the same anatomical compartments across 
multiple scans. For 5/15 patients, there was uptake within more anatomical 
compartments on the index scan. 
This suggests that the ‘index’ scan provides a fairly accurate representation of 18F-FDG 
BAT uptake on scans with lesser BAT activity. As a consequence, the index PET/CT 
scan may provide a useful baseline against which other imaging modalities can be 
compared. 
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Chapter 6: Colocalisation analysis of 18F-FDG BAT 
uptake on serial PET/CT scans 
Colocalisation is a well-established technique in microscopy [214], particularly in the 
field of fluorescence and dual-colour confocal microscopy in which it is used to 
quantify the degree of agreement between two images or image stacks. The location of 
different fluorescently labelled molecules (fluorochromes) are compared to determine 
whether they occur in the same subcellular location (Figure 6-1, showing red and green 
channels corresponding to different fluorochromes). Colocalisation analysis has been 
used successfully in fluorescence microscopy to demonstrate that particular proteins are 
associated with organelles including plasma membrane [215], mitochondria [216] and 
nuclei [217]. 
There are essentially two approaches: 
• Intensity correlation in which pixel (or voxel) intensities in one image or image 
track (or ‘channel’) are compared with the signal intensities of corresponding 
voxels in another channel; 
• Object–based analysis [215] which evaluates the degree of spatial overlap of 
objects. Objects may be considered colocalised if either the centre of mass 
(centroid) of one object lies within the area of another (centre/particle 
coincidence; Figure 6-1 F); or the ‘nearest neighbour approach’ (Figure 6-1 G) 
in which two objects are considered colocalised if their centres of mass lie 
within a certain distance (e.g. the optical resolution of the microscope – typically 
0.2µm in light microscopy). 
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Figure 6-1: Object-based colocalisation analysis using centre/particle coincidence (from 
Bolte et al. [218]). 
 
The colocalisation of two images can be evaluated visually, quantitatively and 
statistically. Visual evaluation of colocalised images is the simplest approach in which 
images are either compared side-by-side or one image is superimposed over another to 
demonstrate that the tissues of interest occur in the same location. 
To date, co-occurrence of 18F-FDG BAT on serial PET/CT scans or between different 
imaging modalities (e.g. PET and MR) has taken the form of rather simplistic 
qualitative analysis in which images are juxtaposed images showing BAT in different 
compartments. Although this does provide a good representation of where 
colocalisation occurs, it is not possible to present all images, and one is invited to make 
the assumption that these selected images are representative in the absence of 
quantitative evidence. Therefore, quantitative object-based colocalisation analysis offers 
an alternative approach for comparing 18F-FDG BAT across different scans. 
Both the intensity correlation and object-based analyses may be subjected to statistical 
tests to quantify the degree of colocalisation. Pearson’s correlation coefficient (PCC) is 
the best known [219]. This describes the proportion of variability in one channel caused 
by variability in the second channel. This does not provide a true quantification of the 
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degree of colocalisation, but rather an estimate of the strength of association between 
two images. The coefficient varies from -1 (inverse correlation or exclusion), 0 (the 
absence of correlation) to +1 (perfect correlation), which can be difficult to interpret 
[214].  
Better suited to object-based analysis is Manders’ colocalisation coefficient (MCC), 
particularly when the numbers of objects differ between the two channels. This 
technique generates two coefficients: ‘M1’ (the proportion of objects in channel A that 
overlaps with channel B) and ‘M2’ (proportion of objects in channel B that overlaps 
with channel A) to describe the degree of fractional overlap [220], and the coefficient 
ranges from 0 (no overlap) to 1 (100% overlap). This is better suited to describing how 
images compare with each other, and as in this case of Chapter 5, how images compare 
with an index image. 
PCC and MCC may be used in three-dimensional analysis as part of wider object-based 
analysis. The major drawback of these techniques is the necessity to segment the object 
of interest from the background. This has already been addressed above by defining 
ROIs around areas of 18F-FDG BAT detected semi-automatically on PET/CT. 
Although prevalent within microscopy, the results can be ambiguous and do not take 
into account the level of overlap that could be expected by chance. Several approaches 
have been developed to address this by comparing the observed colocalisation 
coefficients against those of randomly generating images to generate some form of 
statistical significance. The observed coefficients between two channels may be 
considered significant if it is greater than 95% of randomised images. The principle is 
demonstrated in Figure 6-2 C, which shows a probability distribution curve from PCC 
measurements from multiple randomised images, while the red line indicates the PCC 
of the original images – which is significantly higher. D shows a means of summarising 
the results. 
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Figure 6-2: Probability distribution function from randomised images (from Bolte and 
Cordelières [218]). 
 
Various approaches for generating randomised images have been described. The 
approach described by Costes [221] scrambled one of the images or image stacks by 
splitting it up into blocks, which are then randomly shuffled. The block size is user-
defined, but should be equal to or greater than the size of the objects within the image, 
but in light microscopy is typically equal to the point spread function of the image. 
However this technique destroys the spatial relationships of the image, such that voxels 
are no longer adjacent to their original neighbours, and instead lie next to voxels from 
other parts of the image [214]. This has the effect of producing a probability distribution 
curve that is narrower than the original images, which result in spuriously high 
significance values [221, 222] 
An alternative approach is that of ‘frame translation’. Van Steensel [217] proposed 
comparing the observed colocalisation coefficient between two channels, with the 
coefficient obtained by incrementally shifting one of the channels in a single axis. Fay 
[223] described a similar method in which the random channels are generated by 
translating one image in all three axes. 
This technique, borrowed from microscopy, presents a novel alternative means to 
quantitatively analyse the distribution of 18F-FDG BAT on serial PET/CT scans. 
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6.1.1 Aims 
Building on the findings from Chapter 5, which showed a high level of concordance of 
18F-FDG BAT distribution across serial PET/CT scans, we set out to evaluate individual 
18F-FDG BAT deposits to determine whether they occur in fixed or variable locations 
over time, and whether they are activated in a piecemeal or global manner. From this we 
aim to determine whether the ‘index’ PET/CT scan (the scan showing maximal 18F-
FDG BAT activity) is a reliable standard against which other imaging modalities may 
be compared. 
6.1.2 Subjects and method 
The 38 serial 18F-FDG BAT positive scans for the 15 patients introduced in Chapter 5 
were reviewed. As described above ROIs corresponding to 18F-FDG BAT were selected 
semi-automatically by defining isocontours set at an SUV of 2.5 g/ml around areas of 
18F-FDG uptake within adipose tissue (as identified on CT). This was performed using 
the proprietary image fusion software Mirada XD 3.4 (Mirada Medical Ltd, Oxford, 
UK). 
The ‘index scan’ (the PET/CT scan with the largest volume of 18F-FDG BAT) was 
identified for each subject, which formed the baseline against which subordinate scans 
were compared. 
As patient positioning was not uniform across serial scans (Figure 6-3), it was necessary 
to register images with respect to the index scan using a combination of automatic rigid 
and non-rigid registration as appropriate using XD 3.4. The quality of image registration 
was verified visually using the in-built visualisation tool within Mirada XD 3.4, which 
displayed a mosaic composed of the index image, interspersed with parts of the 
registered subordinate image (Figure 6-4), as well as an overlay (Figure 6-5). 
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The registered images were imported into ImageJ 1.48 [224, 225] for analysis. ROIs 
were traced around the isocontours defined above, and converted to a mask. Subsequent 
colocalisation analysis was performed upon these stacks of mask images, all of which 
were registered to the index scan. 
Figure 6-3: Subordinate CT superimposed over the index CT prior to image registration. 
 
 
 
 
  
Figure 6-4: Graphical user interface of the visualisation tool within Mirada XD 3.4. 
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Figure 6-5: The same case shown in Figure 6-3 following automatic rigid registration. 
 
 
 
 
  
6.1.2.1 Image analysis 
Masks were created from the 18F-FDG BAT ROIs identified in Chapter 4 using ImageJ. 
Colocalisation analysis was performed upon these stacks of mask images using the 
ImageJ plugin JACoP (Just Another Colocalisation Plugin) 2.0 [218, 226] to determine 
whether individual 18F-FDG BAT depots occurred in the same sites on serial scans, and 
specifically whether they occurred in the same areas as on the index PET/CT scan. 
JACoP is a compilation of general colocalisation tools, and works with 3D stacks. 
Manders’ correlation coefficients were calculated to describe the fractional overlap of 
18F-FDG BAT on each subordinate scan with respect to the index scan (Figure 6-6). 
This produces 2 coefficients: ‘M1’ describes the proportion of ROIs from the index scan 
which overlap the subordinate scan, and ‘M2’ is the converse. Plundering set theory 
notation, ‘M1’ may be defined as ‘index ∩ subordinate’, and ‘M2’ as ‘subordinate ∩ 
index. 
Additionally, the number of 18F-FDG BAT ROIs within each scan, and the proportion 
which colocalised were recorded. 
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Figure 6-6: Visual representation of colocalisation analysis on serial PET/CT scans.  
 
6.1.2.2 Statistical analysis 
To determine whether the degree of colocalisation was greater than that expected by 
chance, the calculated colocalisation coefficients were compared with those derived 
from randomised images using the CDA (Confined Displacement Algorithm) plugin for 
ImageJ [222]. This implements a variation of the frame translation/image-shift method, 
but has the advantage of confining the randomisation to within a predefined envelope of 
potential interaction – in this case the body compartment, as we are only interested in 
colocalisation in parts of the body where BAT is likely to occur (Figure 6-7). The 
envelopes were constructed by automatic thresholding of CT images, to segment out 
background. Probability distribution curves were generated as a function of 
displacement, against which the baseline colocalisation coefficients were compared. 
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Figure 6-7: Production of an ‘envelope of interaction’ through segmentation of a CT 
image. 
  
6.1.3 Results 
6.1.3.1 Quantification of colocalised 18F-FDG BAT ROIs 
Figure 6-8 illustrates a typical colocalised image of the upper thorax for subject B, with 
the 18F-FDG BAT ROIs from the index scan (red) and subordinate scans (green), and 
areas of colocalisation as yellow. 
Figure 6-8: Axial PET/CT of 
the upper thorax showing 
colocalised 18F-FDG BAT 
ROIs between index 
(yellow) and subordinate 
(green) scans. 
 
 
 
The number of 18F-FDG BAT ROIs for each subject’s subordinate scans together with 
the number which colocalise with the index scans are presented in Figure 6-9. For each 
subject, the number of ROIs within each of their subordinate scans were compared with 
the index scan to determine which ROIs colocalised. The number of colocalised ROIs 
are shown as yellow; the ROIs on the subordinate scan which did not colocalise as 
green, and the index scan ROIs which did not colocalise as red. In most cases, the 
overwhelming majority of ROIs on subordinate scans colocalise with ROIs on the index 
scan. It is also noteworthy that those subjects with a high degree of ‘subordinate ∩ 
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index’ colocalisation, who had multiple subordinate scans (subjects B, F, I, J, M) tended 
to show a consistently high level of colocalisation across all their subordinate scans. 
This is exemplified by Figure 6-10, which shows slices through the supraclavicular 
fossa for two typical cases: subject I, a 22-year old female with Hodgkin’s lymphoma 
with three scans performed 13 months apart; and subject J, a 17-year old female with 
Hodgkin’s lymphoma with three positive scans over a five month period. This shows 
18F-FDG BAT uptake in the same area on 3 scans performed between February and July 
2011. Both cases demonstrate 18F-FDG BAT uptake within the subordinate scans occurs 
largely within the niduses of greatest radiotracer uptake on the index scan. Although 
larger 18F-FDG BAT deposits tended to fragment into smaller niduses, we identified a 
strong correlation between the number of 18F-FDG BAT ROIs and the total volume (r = 
0.83; Figure 6-11) indicating that the number of objects is a good indicator of volume. 
Figure 6-9: Stacked bar chart showing the proportion of colocalised 18F-FDG BAT ROIs 
for each subordinate scan with respect to the index scan. 
 
 
There was wide variation in the number of ROIs on subordinate scans between subjects 
ranging from 8 (subject G) to 242 (subject D), which had some bearing on the extent of 
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colocalisation. Although there was only a weak correlation between the number of ROIs 
on the subordinate scan and the extent of ‘subordinate ∩ index’ colocalisation (r = 
0.186; Figure 6-12), those with the lowest proportion of colocalised ROIs (subjects C, 
G, H and O) also had some of the lowest numbers of 18F-FDG BAT ROIs on their 
subordinate scans (Figure 6-13). 
Figure 6-10: Serial PET/CT scans showing colocalised 18F-FDG BAT ROIs for 2 subjects (I 
& J). 
Index scan 
August 2011 
Vol 258.9ml 
SUVmax 
22.2g/ml 
Subject I (22y female) Index scan 
February 2011 
Vol 409.7ml 
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Figure 6-11: Scatterplot showing strong correlation between number of 18F-FDG BAT 
ROIs and volume. 
 
 
Figure 6-12: Correlation between number of ROIs on subordinate scan, and percentage 
colocalised ROIs. 
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Figure 6-13: Proportion of 18F-FDG BAT ROIs on subordinate scans colocalising with 
index scan (subordinate ∩  index). 
 
 
6.1.3.2 Manders’ correlation and significance testing 
Manders’ overlap calculations with significance testing using the confined displacement 
algorithm produced the plots seen in Figure 6-14. The M1 coefficient (the proportion of 
18F-FDG BAT voxels on the index scan colocalising with the subordinate scan) is not 
pertinent to this study, as the index scans were selected on the basis of having the 
greatest volume of 18F-FDG BAT. Figure 6-14 ‘A’ shows the M2 correlations 
coefficients for the randomised images as a function of displacement. From this, a 
probability distribution curve is produced (Figure 6-14 ‘B’) which allows comparison of 
the original M2 coefficient (pink line at 0.89), with the randomised values (mean 0.13, 
95% confidence intervals of 0.02-0.41 denoted by black arrows).  
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Figure 6-14: Probability distribution curve of the randomised M2 coefficients. 
  A  
B  
 
With one exception (subject G), in whom no colocalisation occurred, all scans yielded 
an M2 coefficient greater than that expected by chance (Figure 6-15).  
Nineteen of the 23 subordinate scans (82.6%; belonging to subjects B to F, I to K, and 
M to O) yielded M2 coefficients greater than 0.7 (i.e. > 70% of the voxels within the 
18F-FDG BAT ROIs on the subordinate scan colocalised with those on the index scan). 
Two additional scans (subjects A and L) were just below this threshold (M2 coefficients 
of 0.69 and 0.67). Two scans (subjects G and H) yielded low M2 coefficients; subject H 
showed an M2 coefficient of 0.54. Subject G showed no colocalisation at all – this was 
an atypical case, as a section of paravertebral 18F-FDG BAT uptake on the index 
PET/CT scan could not be distinguished from an area of metabolically active pleural 
disease and was therefore excluded. 
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Figure 6-15: Manders' M2 colocalisation coefficients for each subordinate scan (red), 
with randomised M2 coefficients (grey boxes denotes 95% CI). 
 
 
As with the colocalisation of ROIs, those subjects who achieved a high M2 coefficient 
on one subordinate scan, tended to score consistently highly on multiple subordinate 
scans. 
If all voxels on the subordinate scans colocalised with the index scan, the M2 
coefficient would be 1. Partial colocalisation (i.e. when ROIs partially intersect, but few 
voxels coincide) is a potential explanation, but the strong correlation between the 
proportion of colocalised ROIs (identified in Figure 6-9) and corresponding M2 
coefficients (r = 0.8821, p < 0.0001; Figure 6-16) suggests that is not a major factor. If 
partial colocalisation were a major factor, a high number of colocalised ROIs would be 
accompanied by low M2 coefficient. 
To explore this possibility further, a Bland-Altman plot (Figure 6-17) was produced to 
compare the proportion of colocalised ROIs and the proportion of colocalised voxels 
(i.e. Manders’ coefficient). In all but two cases, there was no consistent bias, and that 
there was no consistent difference between the degree of colocalisation identified by the 
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two techniques. The two outliers are subjects C and O, both of whom demonstrated 
colocalisation in a small proportion of ROIs on the subordinate scan (26.5% and 38.5% 
respectively), but a greater proportion of colocalised voxels (M2 coefficients 0.73 and 
0.70 respectively). 
Figure 6-16: Scatterplot showing a strong correlation between the proportion of 
colocalised 18F-FDG BAT ROIs and M2 colocalisation coefficient. 
 
Figure 6-17: Bland-Altman plot comparing proportions of colocalised 18F-FDG BAT ROIs 
and M2 coefficients. 
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6.1.4 Summary 
In this study we used a modified method of colocalisation analysis to quantify the 
degree to which individual 18F-FDG BAT depots colocalise across serial PET/CT scans. 
We identified that the degree of colocalisation was dependent on the number of BAT 
deposits (i.e. the more deposits, the greater the degree of colocalisation). Nonetheless in 
14/15 cases the degree of 18F-FDG BAT colocalisation between serial PET/CT scans 
was high, and significantly higher than would be expected by chance. 
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Chapter 7: Identification and quantification of BAT on 
magnetic resonance imaging 
7.1 Basic principles of MR imaging 
7.1.1 MR physics 
MR imaging is made possible by the fact that some subatomic particles have magnetic 
polarity. Only nuclei with an odd number of nucleons (protons or neutrons) demonstrate 
this property (e.g. 1H, 11Na, 13C and 15P), and MR imaging primarily relies on 1H nuclei 
(single protons) due to their relative abundance (109 1H nuclei per 1 mm3 of tissue) 
compared with other nuclei (e.g. 88 M for 1H, 16 mM for 17O). 
Apart from spin, protons possess mass and charge, which generates magnetic properties 
similar to tiny dipole magnets. In nature they are randomly orientated due to the Earth’s 
magnetic field being extremely weak (approximately 5 x 10-5 Tesla, abbreviated to ‘T’). 
When subjected to a strong uniform static external magnetic field (‘B0’), such as that 
produced by the solenoid of an MR scanner, the protons align along (‘parallel’, a low 
energy state of approximately 0.2 µeV at 1 T) or against (‘anti-parallel’, a high energy 
state of approximately 0.4 µeV at 1 T) the magnetic field. If the number of parallel and 
anti-parallel protons were equal their magnetisations would cancel out resulting in no 
net magnetisation. In fact slightly more protons align parallel than anti-parallel; in the 
case of a 1 T magnetic field, approximately seven per million additional dipoles are 
parallel than anti-parallel, resulting in a tiny net magnetisation in the parallel direction 
(i.e. approximately 7 x 1019 protons per mm3 of water [227]). It is these ‘excess’ protons 
and the resulting net magnetisation that are detectable by MR imaging. The smaller the 
field, the smaller this difference, and the poorer the resulting signal, hence the rationale 
for high magnetic field strengths. 
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By convention, the net magnetisation may be resolved into two vectors: longitudinal mz 
(i.e. along the B0 or z axis) and transverse mxy, which combine to produce a net sum 
vector m (Figure 7-1). In a static magnetic field mxy = 0 as all the dipoles cancel each 
other out in the transverse direction. When the spin is perturbed by an external magnetic 
field, the protons precess around the direction of the magnetic field resulting in a 
magnetic moment (Figure 7-1) – akin to a spinning top. 
Figure 7-1: The magnetic vectors associated with a precessing proton (a) resolved into 
transverse (mxy) and longitudinal (mz) components (b) (adapted from Pooley et al. [228]). 
(a)  (b)  
 
The speed at which nuclei precess or ‘Larmor frequency’ (ω0) is a product of the 
magnetic field strength (B0) and a constant (Equation 7-1). This constant is the 
‘gyromagnetic ratio’ (γ) and is constant for particular nuclei e.g. H1 = 42.6 MHz/T, 13C 
= 10.7 MHz/T [229] 
Equation 7-1: The Larmor equation. 
 
 
Consequently at a field strength of 1.5 T, the Larmor frequencies for 1H and 13C nuclei 
are 63.9 MHz and 16.1 MHz respectively. The high gyromagnetic ratio of 1H produces 
a stronger signal than other nuclei, which makes it an attractive target for MR imaging. 
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7.1.2 Generating an MR signal 
This phenomenon is exploited in MR imaging. If the 1H nuclei are stimulated with a 
short radiofrequency (RF) pulse perpendicular to B0 at the appropriate Larmor 
frequency, protons precess together at the Larmor frequency (phase coherence), 
resulting in tipping of the net magnetisation vector away from Mz to Mxy (Figure 7-2). 
The duration and amplitude of the applied RF pulse determines the extent to which the 
net magnetisation is deflected away from B0. When the transverse RF pulse is switched 
off the protons precess in the transverse plane for a short time, inducing an alternating 
current in RF receiver coils within the MR machine via Faraday induction, which are 
then amplified. 
Figure 7-2: An RF pulse at the correct Larmor frequency displaces net magnetisation 
from being in a net longitudinal (z) direction (a) into the transverse (xy) plane (b) (adapted 
from Pooley et al. [228].) 
(a) (b)  
7.1.3 Free induction decay 
Once the deflecting RF pulse is switched off, the dipoles rapidly return to their original 
state. This manifests on the vector diagram as Mz increasing as longitudinal 
magnetisation recovers, and Mxy decreasing as transverse magnetisation dissipates. The 
speed at which this occurs varies between different tissue types. 
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There are two mechanisms by which the net magnetisation decays which form the basis 
for MR imaging sequences: ‘spin-lattice’ and ‘spin-spin’ relaxation. 
7.1.4 Spin-lattice relaxation (T1 recovery) 
The energised dipoles dissipate energy into the surrounding molecular lattice, resulting 
in them gradually realigning longitudinally parallel or anti-parallel to the B0 axis, with a 
corresponding increase in net Mz magnetisation. This occurs in an exponential manner 
(Figure 7-3) expressed algebraically in Equation 7-2 (where t = time, T1 = T1 recovery 
time in ms). 
The rate at which longitudinally recovery occurs is defined by the time constant T1 
which is the time it takes for Mz to recover to approximately 63% of its maximum value. 
T1 varies with magnetic field strength, and between tissues types. Large slow-moving 
molecules (e.g. fat) absorb energy resulting in a short T1 time. Small molecules (e.g. 
free water) are less effective at absorbing energy, resulting in a comparatively long T1 
time, and by extension the greater the proportion of free water within tissue, the longer 
its T1. 
Figure 7-3: T1 recovery curve of longitudinal magnetisation Mz (adapted from Pooley et al. 
[228]). 
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Equation 7-2: T1 longitudinal recovery curve equation. 
𝑀!(𝑡) = 𝑀! 1− 𝑒𝑥𝑝 −𝑡𝑇1  
The difference in T1 recovery time between tissues is the source of contrast in T1-
weighted images. In Figure 7-4 the T1 recovery curves of two tissues are schematically 
represented; tissue 1 with a short T1 recovery time, and tissue 2 with a longer T1 time. 
If images were acquired immediately after the deflecting RF pulse was switched off, 
there would be negligible signal. Conversely if images were acquired when all net Mz 
magnetisation had fully recovered (time point B on Figure 7-4) image contrast would be 
poor. Tissue contrast is greatest when the T1 curves are maximally separated (time point 
A on Figure 7-4) and are termed ‘T1-weighted’ images. These show tissues with long 
T1 times, which recover their longitudinal magnetisation slowly (e.g. water, 
cerebrospinal fluid, dental enamel and cortical bone) as dark, and tissue with short T1 
times (fat and soft tissue) as bright. 
Figure 7-4: T1 recovery curves for two tissues demonstrating maximum tissue contrast 
at time point A (adapted from Pooley et al. [228]). 
 
7.1.5 Spin-spin relaxation (T2 decay) 
Energy is also transferred between adjacent protons, causing some to precess at slightly 
different speeds, resulting in a loss of phase coherence (de-phasing), and a consequent 
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reduction in net transverse Mxy magnetisation (Figure 7-5). De-phasing is largely due to 
inhomogeneities within the magnetic field, but also varies between tissue types. The 
rate at protons de-phase and net transverse magnetisation decays is defined by the time 
constant T2, which is the time it takes for Mxy to decay to approximately 37% of its 
original value (Figure 7-5(b) and Equation 7-3). 
Figure 7-5: De-phasing of net Mxy magnetisation (a) results in a loss of net transverse 
magnetisation as shown on the T2 decay curve (b) (adapted from Pooley et al. [228]). 
(a) (b) 
 
 
Equation 7-3: T2 transverse magnetisation decay curve equation. 
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Local magnetic field variation is greatest in large molecules in which atoms are fixed. 
This results in low T2 times - indeed the T2 time in dental enamel, cortical bone and 
metal is so short, that it can only be imaged using specialised ultra short echo 
sequences. Field variation is least in freely moving molecules including water, which 
average out local magnetic field variations resulting in a high T2 time. Consequently the 
greater the water content within a tissue, the longer its T2 time. 
The difference in T2 between tissues is the source of contrast in T2-weighted images 
(Figure 7-6). If images were acquired immediately after the deflecting RF pulse was 
switched off, there would be poor contrast between tissues (time point A on Figure 7-6), 
conversely if images were acquired when all net Mxy magnetisation had fully decayed, 
signal intensity would be low (time point B). Therefore ‘T2-weighted’ images are 
acquired at a time point when the T2 decay curves are maximally separated and the 
tissue contrast is greatest. T2-weighted images show tissues with short T2 times which 
de-phase rapidly (e.g. fat and soft tissues) as relatively dark, while water and 
cerebrospinal fluid have very long T2 times and appear bright. 
Figure 7-6: T2 decay curves for two tissues showing effects of tissue contrast (adapted 
from Pooley et al. [228]). 
 
 
In reality, due to a combination of engineering imperfections in magnets and magnetic 
field distortion caused by the patient themselves, the spin-spin interactions are 
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amplified, and free-induction T2 decay occurs much quicker than would be expected. 
Instead, free induction decay of T2 is called T2*, and is in the order of a few 
milliseconds. 
7.1.6 MR sequences 
As discussed above, scans may be weighted to demonstrate the T1 or T2 characteristics 
of tissues. Weighting is determined by the adjusting the timing parameters TE and TR. 
TE (echo time) is the delay between the deflecting transverse RF pulse, and the point at 
which the resulting echo is measured. TR (repetition time) is the delay between 
respective transverse magnetisation pulses. 
T1-weighted images require a short TE (approximately 20ms to minimise effects of T2 
decay) and a relatively short TR (approximately 500 ms, to maximise T1 weighting). 
Conversely, T2-weighted images require a long T2 time (approximately 80 ms, to 
maximise T2 contrast), and a long TR (approximately 2,000 ms to minimise T1 effects). 
There are two main types of MR pulse sequences in clinical practice: spin-echo and 
gradient-echo sequences [230]. 
7.1.6.1 Spin-echo sequence 
As T2* decay occurs so much more rapidly that T2, the spin-echo pulse sequence was 
developed to counter the unwanted T2* effects whilst preserving the T2 effects of 
tissues. This technique re-phases the protons by applying a 180° RF pulse to the de-
phasing protons. This pulse has the effect of inverting the net magnetisation over to the 
opposite axis, such that more slowly precessing protons are ‘ahead’ and the faster 
precessing protons are ‘behind’. The protons re-phase when the faster precessing 
protons ‘catch up’ which induces a signal within the RF receiver coil. 
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A faster variant of this if the turbo spin-echo (or fast spin echo) pulse sequence, which 
applies multiple 180° refocusing pulses in rapid succession within each TR interval. By 
collecting a number of echoes in each TR interval, scanning time can be reduced. 
7.1.6.2 Gradient recalled echo (GRE) 
Scan time may also be reduced by reducing the tip angle. Thus far, we have described 
the transverse RF pulse as tipping the net magnetization at 90° to the B0 axis. An RF 
pulse of shorter duration would tip fewer protons transversely, resulting in a smaller ‘tip 
angle’ (e.g. 20° or 30°) and a correspondingly smaller transverse magnetisation. Unlike 
spin-echo sequences, GRE sequences do not employ a 180° refocusing pulse which 
allows for shorter TE times. As a result image acquisition is much faster, but is 
susceptible to magnetic field inhomogeneities. Consequently GRE images tend to be 
T2* weighted [230]. 
7.1.6.3 Fat-water separation techniques 
The fact that spin-spin relaxation differs between tissue types may be exploited to 
differentiate between them. 
The hydroxyl bonds in water exert a smaller magnetic field upon the proton than the 
carbon-hydrogen bond in lipid molecules. As a result protons in lipids precess at a 
different speed than in water [227]. Dixon is credited with using this ‘chemical shift’ to 
differentiate between fat and water [231]. By selecting a TE when the lipid and water 
protons are in-phase (TE = 4.2 msec at 1.5 T), their signal will be summated to produce 
a water plus fat image [230]. Imaging at a TE when the water and lipid protons are 
exactly out-of-phase (TE = 2.1 msec at 1.5 T) will result in a cancelling out of signal to 
produce a water minus fat image. 
Adding the in- and out-of-phase images produces a water-only image, and subtracting 
them produces a fat-only image (Figure 7-7). From these images the fat fraction may be 
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calculated using Equation 7-4, (where F = fat-only, W = water-only) and a fat fraction 
image generated. 
Figure 7-7: Dixon imaging with derived fat fraction image of a pork chopa. 
  
  
In-phase (IP) Out-of-phase (OP) Fat-only (F) Water-only (W) 
Equation 7-4: Calculation of fat fraction from Dixon images. 𝐹𝑎𝑡  𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = 𝐹𝐹 +𝑊 
Figure 7-8: Fat fraction image derived from Dixon images. 
 
 
0% fat fraction 
 
100% fat fraction 
 
The classical two-point Dixon method identifies a single peak fat peak based on the 
CH2 group and may not identify other species of fat e.g. -CH2-, -HC=CH- and –CH3 
[232]. Newer multi-peak techniques have been developed to address this including 
IDEAL-Quant and IDEAL-IQ (General Electric Medical Systems, Milwaukee, USA). 
                                                
a Acquired by the author using a 3-point IDEAL FSE pulse sequence with the following parameters: 
TR/TE = 133, 11.5, flip angle 90°, number of signal average 6, field of view = 200 x 200 mm, voxel size 
= 0.39 x 0.39 mm, slice thickness/spacing (mm) = 5/6 
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The IDEAL ‘iterative decomposition of water and fat with echo asymmetry and least-
squares estimation’ technique was developed by Reeder et al. [233] to address problems 
with artefacts with previous techniques, as well as in response to the introduction of 
modern multichannel RF receiver coils. The IDEAL technique produces uniform fat 
suppression and reduces artifacts from magnetic field inhomogeneities and chemical 
shift between fat and water. In addition IDEAL is approximately 30% faster than 
common Dixon methods, and produces a higher signal-to-noise ratio [234], and is 
therefore more accurate in fat quantification. In addition the IDEAL sequence 
automatically generates the four images shown in Figure 7-7. 
Adipose tissue comprises multiple different fat molecules, each with different chemical 
spectra [235]. Consequently the chemical spectrum of adipose tissue is complex and 
difficult to model [236]. Rapid T2* relaxation caused by iron overload in the liver has 
been shown to influence fat fraction estimation using Dixon methods [237]. 
7.2 BAT identification on MR 
Prior to the advent of PET, the only means of detecting BAT were post mortem, biopsy, 
or indirectly by measuring energy expenditure in response to BAT stimulation [2]. 
PET allows detection of BAT in vivo, but is hampered by various factors including the 
opportunistic nature of BAT detection, the requirement that the BAT be metabolically 
active in order that the 18F-FDG radiotracer is taken up, and its susceptibility to external 
factors - most notably temperature. 
Although some small prospective studies have subjected healthy volunteers to PET/CT 
for the purposes of BAT identification [43, 238, 239], the high ionising radiation burden 
[240] and the costly radiotracer limit the role of PET/CT role in BAT identification in 
larger populations [241]. The Ionising Radiation (Medical Exposure) Regulations 2000 
[242] require all medical ionising radiation exposures be justified, and it would be 
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difficult to justify the widespread use of PET solely for the purposes of BAT 
identification. Therefore there is a need for a reliable, non-invasive and safe method for 
BAT detection in vivo. Such a method would be a necessary prerequisite before the 
efficacy of novel pharmacological therapies which modulate weight through the 
manipulation of BAT could be tested. Unlike PET, MR does not require the 
administration of radioactive isotopes and also boasts superior spatial resolution, 
potentially allowing small BAT depots to be identified. Unlike PET, MR also has the 
potential to demonstrate BAT regardless of its level of metabolic activity [243]. 
7.2.1.1 Murine studies 
Increasingly efforts to identify BAT using MR have capitalised on the biochemical and 
morphological differences between BAT and WAT. MR spectroscopic studies have 
shown that both BAT and WAT exhibit a strong spectral peak corresponding to lipid 
(specifically fat containing the methylene group), but BAT also showed a prominent 
water peak, indicating high water content [241, 244, 245] of approximately 48.5%, 
compared with 7.1% in WAT [244]. MR spectroscopy has also revealed differences 
between the fat spectra of BAT and WAT, implying slightly different lipid profiles 
including lower levels of unsaturated triglycerides in BAT [244]. MR spectroscopy is 
able to separate lipid peaks and water with comparable sensitivity to tissue biopsy. A 
drawback of in vivo spectroscopy is the limited spatial resolution, therefore MR 
imaging-based methods should provide superior resolution. T1-weighted MR is able to 
separate fat and water in vivo, due to fat having a short T1 relaxation time (300 ms) 
compared with approximately 1,000 ms for water-containing tissues [246]. 
Further work has been directed into BAT identification on the basis of morphological 
differences between BAT and WAT, specifically that brown adipocytes contain 
numerous small intracellular lipid vacuoles, whereas WAT typically contain a large 
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unilocular lipid droplet and limited cytoplasm [36, 67, 247]. Consequently BAT has a 
higher water content than WAT [246]. Although size differences of adipocytes are 
below the typical spatial resolution of MR there is a positive correlation between 
adipocyte size and fat fraction [248]. Fat quantification techniques exploiting fat-water 
separation using methods based on the Dixon chemical-shift technique, and the time-
dependent phase difference between fat and water, have been shown to produce precise 
quantification of fat-fraction [249], with comparable accuracy to MR spectroscopy 
[250]. Consequently Dixon-based techniques have been used with some success in the 
quantification of body fat content [251], hepatic steatosis [249, 252] and fat content 
within muscle [232, 250]. The multi-peak spectral model used by IDEAL is 
undoubtedly more accurate than the single-peak model used in traditional Dixon 
imaging [253], and although the lipid profile of BAT and WAT differ subtly on MR 
spectroscopy, this does not impact significantly upon the overall fat fraction [254]. 
MR chemical-shift based water-fat separation techniques have successfully exploited 
differences in the fat and water fraction between BAT and WAT to identify in vivo BAT 
within rodents [245, 255, 256]. IDEAL was first used to characterise BAT was in 2010 
[241] on excised tissue samples and post mortem carcasses. This confirmed that BAT 
has a significantly lower fat fraction (58% ± 8%) than WAT (92% ± 2%). That BAT has 
a broader and lower fat fraction range (37-70%) than WAT (90-93%) has been 
confirmed on subsequent studies [241, 253, 257, 258]. 
A single study comparing in vivo MR and 18F-FDG PET against histological evaluation 
in rats [243], found that BAT volumes obtained from in- and out-of-phase MR (if 
preceded by a spectral presaturation inversion recovery – SPIR pulse) showed a 
significantly stronger correlation with histological findings (r = 0.89 p = 0.017) than 
PET/CT (r = 0.15 p = 0.78). 18F-FDG PET/CT consistently underestimated the true 
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volume of BAT, while conventional in- and out-of-phase imaging tended to 
overestimate BAT volume [243]. 
BAT also demonstrates greater vascularity and sympathetic innervation than WAT [67]. 
Dense vascularity and the abundance of iron-laden mitochondria gives BAT its 
distinctive reddish-brown colour [73]. Rich vascularity and the presence of iron is 
known to shorten T2* relaxation time [259, 260], In addition, as perfusion and oxygen 
consumption increase within metabolically active BAT, accumulation of 
deoxyhaemoglobin can also shorten T2* – indeed this is the basis for functional 
imaging. Consequently studies have sought to exploit the differences in iron content and 
blood flow between BAT and WAT, and its effect on T2 and T2* time. Significantly 
lower T2* values have been demonstrated in BAT than WAT [241, 253]. There is less 
consensus regarding whether T2 values differ between BAT and WAT [244, 261], 
although significant differences have only be described at high magnetic field strengths 
[261]. 
Variation in T2* values between studies (Table 7-1) have been attributed to differences 
in blood composition between live and dead animals [241]. The reciprocals of T2 and 
T2*, known as R2 and R2*, are directly proportional to iron concentration and 
have been validated in studies of hepatic and cardiac iron overload [262]. 
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Table 7-1: Fat fraction and T2* differences between BAT and WAT. 
Study BAT fat 
fraction (%) 
WAT fat 
fraction (%) 
BAT T2* (ms) WAT T2* 
(ms) 
Comments 
Rodents      
Hu et al., 2010 
[241] 
51 ± 8 
62 ± 7 
39-42% 
52-64% 
92 ± 2 
93 ± 2 
 
9 - 20 11 - 50 Juvenile 
Adults 
In vivo juvenile 
In vivo adult 
Hamilton et al., 
2011 [244] 
51.5%a 92.9%a - - MR 
spectroscopy 
of mice (n=7) 
Chen et al., 2012 
[261] 
- - 57.8 ± 3.9 b 83.1 ± 2.2 b In vivo rat 
study (n=9) 
Hu et al., 2012 
[253] 
61.8 ± 5.5 
90.2 ± 1.2 
95.2 ± 0.9 
98.8 ± 0.8 
13.3 ± 5.5 
18.0 ± 0.7 
22.3 ± 2.6 
23.7 ± 1.7 
Lean 
Obese 
Rasmussen et 
al., 2013 [258] 
43.7 ± 7.8 
43.0 ± 14.1% 
 
73.3 ± 10.4 
67.9 ± 15.6% 
  Ex vivo 
In situ 
Smith et al., 2013 
[256] 
30-90% >90% - - Mice (n=8) 
      
Humans      
Rasmussen, et 
al. [258] 
c.30% 67.7 ± 4.6% - - Neonates 
(n=22) 
Hu et al., 2012 
[263] 
41.9 ± 6.3% >90% - - Single post 
mortem case 
report 
Hu et al., 2013 
[264] 
29.7 
39.2-72.5 
52.0-80.6 
86.9-93.9 
89.8 
92.5-96.0 
87.4-91.3 
82.8-95.4 
14.7 
18.4-20.6 
12.5-19.4 
19.4-33.4 
21.6 
43.9-44.7 
28.8-35.0 
33.1-40.1 
Post mortem 
infant 
Infants (n=3) 
adolescents 
                                                
a Hamilton reports the water fraction in BAT at 48.5%, and within WAT as 7.1%, from which the fat 
fractions are calculated 
b T2 time rather than T2* 
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(n=3) 
Adults (n=2) 
Hu et al., 2013 
[265] 
36.0 ± 8.2 
68.7 ± 12.1 
 18.7 ±2.6 
17.2 ± 3.8 
 Infants (n=9) 
Teenagers (n-
18) 
Hu et al., 2013 
[266] 
38.2 ± 11.5 
72.5 ± 12.1 
77.9 ± 9.1 
86.2 ± 6.5 
18.8 ± 4.8 
18.0± 3.6 
21.0 ± 5.9 
27.2 ± 6.8 
Infants (n=12) 
Children 
(n=39) 
Van Rooijen et 
al., 2013 [267] 
65.2 ± 7.0 81.5 ± 5.4 - - Adults (n=11) 
Lundstrom et al., 
2014 [268] 
82.8 ± 5.0 86.2 ± 4.6 - - Adults (n=9) 
Hu et al., 2014 
[269] 
29.8 ± 8.0  - - Neonates 
(controls, n=5) 
 
Collectively, these studies have shown that murine BAT has different MR 
characteristics than WAT. Murine studies have tended to involve ex vivo scanning of 
excised tissue, post mortem scanning of rat carcasses or in vivo scanning of 
anaesthetised rodents. In vivo BAT imaging in rodents has also focussed on the 
interscapular fat pad as it is the largest and most easily identifiable BAT depot, and is 
classically a triangular or trapezoidal-shaped bi-lobed structure between the scapulae 
[245]. Knowledge of the distribution of BAT in adult humans is less predictable [244], 
and unlike rodents, adult humans do not possess a discrete BAT organ along the lines of 
the interscapular fat pad. 
7.2.1.2 Human studies 
There are comparatively few quantitative studies evaluating MR appearances of BAT in 
humans, and these have tended to focus on infants in whom BAT is more prevalent and 
extensive. Non-shivering thermogenesis has been studied in infants using thermography 
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[270], which although providing information on BAT activity, does not provide 
quantitative information on BAT volume [258]. 
MR appearances of BAT have been described in the context of disease, specifically 
hibernomas and phaeochromocytomas. BAT associated with phaeochromocytoma has 
been described as being of slightly higher signal intensity than muscle on T1-weighted 
imaging, and heterogeneously hyperintense with respect to muscle on T2-weighted 
imaging. High signal is maintained on chemical fat-suppressed T2-weighted imaging, 
with some loss of signal on fat-suppressed T1-weighted imaging [271]. The earliest 
non-oncological descriptions of BAT in infants on MR were case reports. Large BAT 
deposits were identified in a pre-term neonate using MR (and subsequently confirmed 
following biopsy), in whom it was described as a confluent soft tissue mass extending 
from the neck to the chest of intermediate signal intensity, homogenously iso-intense to 
muscle on T1-weighted imaging, and homogeneously hyperintense to fat on T2-
weighted imaging [272]. 
Subsequently, Dixon-based multi-echo water-fat MR was used to identify BAT in a 3-
month-old infant post mortem [263]. BAT exhibited a lower fat fraction (41.9 ± 6.3%) 
than WAT (>90%), while concomitant CT showed correspondingly higher attenuation 
values within BAT (20.8 ± 3.8 Hounsfield units) than WAT (approximately -60 HU to -
100 Hounsfield units), reflecting the differences in fat content. BAT was confirmed 
subsequently following biopsy. Differences in fat fraction have also used to identify 
interscapular BAT in 8 infants post mortem and confirmed on the basis of gene 
expression profiling [273]. 
Rasmussen et al. [258] identified in vivo BAT deposits in a cohort of 22 neonates, based 
on fat fraction maps with high levels of inter- and intra-observer reliability Although 
there was no validation against either PET/CT or histopathological analysis. 
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In a series of studies by Hu et al. [265, 266, 269], cohorts of neonates, infants, children 
and teenagers underwent GRE MR scanning to characterise BAT in vivo. BAT depots 
were manually identified around fat in the supraclavicular fossae based on a priori 
knowledge of likely BAT distribution. Nonetheless the fat fraction within BAT depots 
was lower than in subcutaneous WAT, although the difference diminished with age. 
These studies were limited by the fact that BAT was identified a priori without any 
histopathological confirmation or PET correlation. 
A small number of studies have also shown a lower fat fraction within BAT in adults, 
with validation against PET. Hu et al. [274], in a small study of adult oncology patients 
(n=2) who underwent PET/CT, compared the fat fraction and T2* relaxation times 
within the interscapular fat [sic] in two subjects, one 18F-FDG BAT positive and the 
other negative. Notwithstanding that the uptake was erroneously described as being 
within the interscapular region, whereas the uptake actually occurred within the 
supraclavicular fossae, a lower fat fraction and T2* value was observed within the 
supraclavicular fat of the 18F-FDG BAT positive subject than the negative subject (in 
whom values were indistinguishable from WAT).  
The same method of crude a priori identification was also used to characterise BAT in 
vivo in a heterogeneous cohort of nine subjects [264]. BAT was confirmed by PET/CT 
in 5 cases, and for the post mortem case by biopsy. This showed a progressively higher 
fat fraction with age; approximately 29.7 to 72.5% in children, 52.0 to 80.6% in 
adolescents and 86.9 to 93.9% in adults, which were, with the exception of one case, 
significantly lower than WAT. A similar trend towards higher T2* relaxation times with 
increasing age were also reported. The fat fraction within BAT was much higher than 
had hitherto been reporting in children and neonates, and were much closer to WAT. 
Lundström et al. [268], in a small study of 9 subjects using the same method of crude a 
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priori BAT identification, reported a high fat fraction (82.8 ± 5.0%) within BAT, which 
was nonetheless significantly lower than within WAT (86.2 ± 4.6%). 
These studies have all sought to characterise pre-defined areas of presumed BAT. 
Attempts at prospective identification solely on the basis of imaging findings without a 
priori knowledge are few and far between. In 2012, Gifford et al. [275] identified 
probable BAT solely on the basis of calculated fat fraction in two human adults, but did 
not provide histological confirmation nor correlation with PET/CT. Reddy et al. [188]a 
were able to visually identify BAT on anatomical fat-only spin-echo MR images in a 
single adult with a large volume of BAT. They reported moderate inter-observer 
variability, and provided PET/CT, histological and immunohistochemical confirmation. 
When applied to a wider sample visual identification tended to underestimate BAT on 
MR compared with PET/CT [276]. 
Chen et al. [277] also used spin-echo MR imaging to identify BAT in 5 human adults 
on the basis of water-saturation efficiency and water-fat contrast. Both techniques 
yielded similar BAT volumes to PET/CT. 
As the difference in fat fraction between BAT and WAT is thought to reduce with age 
[264, 266, 268], prospective BAT identification on the basis of fat fraction becomes 
increasingly difficult.  
Few have successfully identified BAT prospectively in adult humans without relying on 
a priori knowledge of likely BAT location [188, 258, 267, 273, 275], and have tended 
to focus on the interscapular fat pad and supraclavicular BAT depots. 
                                                
a The team of which the author is a member 
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Chapter 8: Retrospective identification and 
characterisation of BAT on MR in rats and humans 
In the preceding chapters, we showed that although the amount of 18F-FDG BAT 
demonstrated varies widely between (and within) individuals, uptake tends to occur in 
fixed locations on serial PET/CT scans. In this chapter we shall identify and 
characterise BAT on MR in adult humans, based on a priori knowledge of the 18F-FDG 
BAT uptake on PET/CT. 
Unlike 18F-FDG PET/CT which detects metabolically active BAT, MR may be able to 
identify anatomical rather than functional BAT, and that MR could be used to identify 
BAT irrespective of its level of metabolic activity. Therefore we hypothesise that the 
MR characteristics of BAT do not change significantly over time. 
8.1 Aims 
In this chapter we shall identify and characterise BAT on MR based on a priori 
knowledge. 
The first half of the chapter describes a post mortem murine study, in which we aim to 
characterise the fat fraction and T2* relaxation time of interscapular BAT and 
subcutaneous WAT within excised tissue specimens and in situ on a clinical 3T MR 
scanner. 
For the second half of the chapter we shall use the same MR sequences in adult humans 
in whom we have a priori knowledge of BAT location from concomitant PET/CT 
scans, to characterise BAT. 
In both cases we aim to determine whether there is a difference in the fat fraction and 
T2* relaxation times between BAT and WAT in rats and humans, and therefore whether 
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it would be possible to exploit these characteristics to identify BAT prospectively on 
MR. 
We shall also explore whether these MR characteristics vary over time, and therefore 
whether the MR appearances are affected by the functional status of BAT. 
8.2 Validation of an MR foodstuff phantom to test fat fraction 
In this study we seek to validate the IDEAL MR sequences using a phantom composed 
of foodstuffs of varying fat content. 
8.2.1 Subjects and methods 
8.2.1.1 Phantom development 
Universal containers containing foodstuffs of known fat content (olive oil 100% and 
20%, butter, semi-skimmed milk and 0.9% saline) were produced to validate the 3-point 
IDEAL sequence and fat calculation. 
Fat content was calculated based on advertised fat content, and fat fraction calculated 
using density approximations for each foodstuff obtained from The Physics 
Hypertextbook (http://physics.info/density). 
8.2.1.2 Scanning protocol 
Universal containers were scanned on a GE Optima MR360 1.5T MR scanner (General 
Electric Medical Systems, Milwaukee, USA) using a HD wrist coil. 
A three-point IDEAL 2D FSE was obtained in an axial plane through the universal 
containers using the following parameters: TR/TE (ms) = 105/13.75, field-of-view 
(mm) = 180 x 180, voxel size (mm) = 0.35 x 0.35 x 5, number of slices/slice gap (mm) 
= 3/5, number of signal averages = 9, bandwidth = 244.141. 
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8.2.1.3 Statistical and image analysis 
Fat fraction maps were generated using ImageJ [224, 225, 278] from the fat and water 
IDEAL images using the formula in Equation 7-4. Regions of interest were defined 
within each universal container, and the mean fat fraction compared with that derived 
from the advertised fat content. 
8.2.2 Results 
Mean fat fraction values from ROIs placed on the fat fraction maps (Figure 8-1) of the 
foodstuff phantoms were comparable to the advertised fat content (Table 8-1), although 
there was some signal heterogeneity within the liquids presumably as a result of eddy 
currents or flow phenomena. At very high fat fractions (e.g. pure olive oil) the 
calculated fat fraction was approximately 12% lower than the actual fat fraction. At 
lower fat fractions, the IDEAL sequence tended to overestimate the fat fraction 
compared to actual fat content.  
Figure 8-1: Calculated fat fraction images of various foodstuffs with known fat content. 
  
 
(a) Pure extra 
virgin olive oil 
(b) Butter 
(c) Semi-skimmed 
milk 
(d) Olive oil (20%) 
(e) Saline 0.9% 
(a)                      (b)                    (c) 
  
  
        (d)                          (e) 
Fat fraction 
 
100% 
 
 
 
 
 
 
 
 
 
 
0% 
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Table 8-1: Advertised and calculated fat fractions of foodstuff phantoms. 
 Advertised fat content (%) Calculated fat fraction (%) 
(a) Extra virgin olive oil 99.5a 86.9 ± 0.7 
(b) Butter 64.8 73.5 ± 1.7 
(c) Semi-skimmed milk 1.7 9.2 ± 3.3 
(d) Olive oil 20 25.0 ± 1.9 
(e) Saline 0.9% 0 5.9 ± 2.9 
8.3 Ex vivo and in situ BAT characterisation in rats using MR 
8.3.1 Subjects and methods 
8.3.1.1 Subject selection and preparation 
Four male Wistar rats (mean mass 300g, age 6-8 weeks) reared on an ad libitum diet 
were used. Two were kept warm (30°C) and two kept in the cold (4°C) for 8 hours prior 
to sacrificeb. The interscapular BAT, omental WAT and subcutaneous WAT were 
dissected from one of each group and photographed to demonstrate the macroscopic 
difference between BAT and WAT. 
The tissue specimens and rat carcasses were promptly transported to the MR scanner; 
those from the rats kept warm were transported at ambient temperature, and those from 
the cold rats were kept on ice. 
                                                
a Based on a reported fat content of 91.3g/100ml and a density of 0.918g/ml for olive oil; 1.8g/100ml and 
a density of 1.033g/ml for skimmed cows’ milk, 1.004 g/ml for 0.9% NaCl, 59g/100ml and density of 
0.911g/ml for butter, performed at 20°C and 1 atm (The Physics Hypertextbook 
http://physics.info/density) 
b All pre- and peri-mortem animal work was carried out by the Department of Life Sciences, University 
of Warwick 
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8.3.1.2 Scanning protocol 
The excised tissue samples and rat carcasses were scanned on a GE Optima MR360 
1.5T MR scanner (General Electric Medical Systems, Milwaukee, USA) using a HD 
wrist coil. 
A three-point IDEAL 2D FSE sequence was used to obtain images through the upper 
thorax of the rat carcasses to include the interscapular fat using the parameters shown in 
Table 8-2. In addition a 2D GRE T2* mapping sequence was performed upon the 
dissected tissue specimens and rat carcasses using the parameters with the same 
coverage as the IDEAL sequence, using the parameters summarised in Table 8-2. 
 
Table 8-2: MR scanning parameters for the ex vivo and in situ rat studies. 
 Dissected tissues Rat carcasses 
Parameter IDEAL T2* IDEAL T2* 
TR (ms) 400 64.8 303 64.2 
TE1a / ΔTEb (ms) / no. 14.2 2.3 / 4.9 / 6 13.1 2.5 / 5.0 / 6 
Flip angle - 20° - 20° 
No. of signal averages 9 1 6 1 
Bandwidth 195.312 244.141 325.547 244.141 
Slice thickness (mm) 2.7 2.7 2.7 2.7 
Field-of-view (mm) 120 x 120 120 x 120 120 x 120 120 x 120 
Voxel size (mm) 0.23 x 0.23 x 2.70 0.23 x 0.23 x 
2.70 
0.47 x 0.47 x 
2.70 
0.47 x 0.47 x 2.7 
Slices 7 7 12 12 
Slice gap (mm) 3 3 3 3 
 
                                                
a First TE 
b Echo spacing 
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8.3.1.3 Image calculation and analysis 
The interscapular fat pad was identified on the anatomical fat-only IDEAL images, as 
this is the most easily identifiable BAT deposit within rodents. Regions of interest were 
drawn around the margins of the interscapular fat pad and excised BAT, together with 
corresponding ROIs within the subcutaneous adipose tissue, and transposed onto the fat 
fraction and T2* images. 
Fat fraction maps were generated from the fat and water IDEAL images according to 
the equation in Equation 7-4 using ImageJ. T2* relaxation maps were calculated using 
the open source MRIAnalysisPak [279] plugina for ImageJ. T2* relaxation curves were 
constructed using exponential decay, which uses a simplex algorithm to fit the values 
from each image in a stack to the formula in Equation 8-1. 
Equation 8-1: Formula describing the mono-exponential decay for T2* relaxation. 𝑆! = 𝑆!𝑒𝑥𝑝 −𝑇𝐸!𝑇2  
8.3.1.4 Statistical analysis 
Calculated fat fraction and T2* values for BAT and WAT were compared using 
Kruskal-Wallis test with Dunn’s correction for pairwise comparisons. 
8.3.1.5 Ethics 
Ethical approval was obtained from the National Research Ethics Committee at 
Birmingham East, North and Solihull Research Ethics Committee (NHS REC reference 
11/H1206/3). 
                                                
a Developed by the Center for Comparative Neuroimaging (CCNI) at the University of Massachusetts 
Medical School and The Small Animal MRI Laboratory at Harvard Medical School/Brigham & Women’s 
Hospital. Available from imagej.nih.gov/ij/plugins/download/misc/MRIAnalysisPak 
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8.3.2 Results 
8.3.2.1 Ex vivo scanning of excised tissue specimens 
Figure 8-2 demonstrates the macroscopic differences between BAT and WAT, 
specifically the characteristic deep red/brown colour of BAT reflecting its high 
mitochondrial content and greater vascularity. 
The calculated fat fraction images demonstrate differences in fat fraction between the 
excised tissue specimens to which a false colour scale has been applied (Figure 8-3). At 
both 4°C and 30°C, BAT has a green/yellow colour (corresponding to a fat fraction of 
approximately 60%), while WAT is coloured orange (corresponding to a fat fraction of 
approximately 80%). The areas of blue correspond to skeletal muscle fragments. 
Figure 8-2: Dissected BAT and WAT specimens from male Wistar rates kept in the cold 
(4°C) and warm (30°C). 
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Figure 8-3: Calculated fat fraction maps showing (from left to right) interscapular BAT, 
omental WAT and subcutaneous WAT specimens, from rats kept at (a) 4°C, and (b) 30°C. 
(a) 
 
0  100% 
(b) 
 
 
At both 4°C and 30°C, interscapular BAT showed a lower fat fraction than both omental 
and subcutaneous WAT (Figure 8-4 and Table 8-3) which was statistically significant 
(p<0.001). 
All pairwise comparisons were found to be significantly different except for the two 
interscapular BAT groups; although the fat fraction within interscapular BAT excised 
from the rat kept at 4°C (58.9 ± 10.1%) was lower than that kept at 30°C (62.4 ± 8.6%), 
this was not statistically significant. At both temperatures, omental WAT showed a 
slightly higher fat fraction (82.5 ± 2.0% at 4°C, 81.4 ± 3.1% at 30°C) than subcutaneous 
WAT (80.7 ± 4.2% at 4°C, 78.0 ± 4.9% at 30°C) which was statistically significant 
(p<0.001). 
0                                 100 
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Figure 8-4: Box and whisker plot (showing 1-99 percentiles) showing fat fractions within 
dissected interscapular BAT, omental WAT and subcutaneous WAT. 
 
 
Table 8-3: Fat fraction and T2* values within excised BAT and WAT samples. 
 Mean fat fraction 
±SD (%) at 4°C 
Mean fat 
fraction ±SD (%) 
at 30°C 
Mean T2* value 
±SD (ms) at 4°C 
Mean T2* value 
±SD (ms) at 
30°C 
Interscapular BAT 58.9 ± 10.1 62.4 ± 8.6 13.7 ± 4.9 20.5 ±10.2 
Omental WAT 82.5 ± 2.0 81.4 ± 3.1 34.6 ± 15.7 39.4 ± 18.9 
Subcutaneous WAT 80.7 ± 4.2 78.0 ± 4.9 37.6 ± 16.8 32.9 ± 16.5 
 
The T2* relaxation times within interscapular BAT specimens were lower than for both 
omental and subcutaneous WAT (Figure 8-5). This was statistically significant at both 
4°C and 30°C (Table 8-3 and Figure 8-6). The mean T2* value within the BAT 
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specimen from the rat kept at 4°C (13.7 ± 4.9 ms) was significantly lower than at 30°C 
(20.5 ± 10.2 ms, p<0.001). 
Figure 8-5: T2* map of (from left to right) interscapular BAT, omental WAT and 
subcutaneous WAT specimens, from rats kept at (a) 4°C, and (b) 30°C. 
(a) 
 
0 100 ms 
(b) 
 
Figure 8-6: Box and whisker plot (showing 1-99 percentiles) showing T2* values within 
dissected interscapular BAT, omental WAT and subcutaneous WAT. 
 
 
A scatterplot of calculated fat fraction against T2* relaxation time (Figure 8-7) for ROIs 
drawn around interscapular BAT (red), omental (yellow) and subcutaneous (green) 
WAT demonstrate that BAT and WAT form discrete data clusters. 
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Figure 8-7: Scatterplot of fat fraction and T2* value for the ex vivo specimens at 4°C. 
 
8.3.2.2 In situ scanning of rat carcasses 
Axial IDEAL fat-only images through the upper thoracic region demonstrate the 
classical triangular bi-lobed interscapular fat pad in the dorsal subcutaneous fat (Figure 
8-8). As with the ex vivo samples, the calculated fat fraction within interscapular BAT 
was significantly lower than subcutaneous WAT in situ (p<0.001) for rats kept at both 
4°C and 30°C (Table 8-4 and Figure 8-9), although the fat fraction within interscapular 
BAT at 30°C was significantly higher (62.2 ± 6.5%) than at 4°C (44.7 ± 5.4, p<0.001). 
Although the T2* times within interscapular BAT (28.2 ± 101.7 ms at 4ºC, and 19.1 ± 
3.1 ms at 30ºC) were significantly shorter than in subcutaneous WAT (57.1 ± 113.2 ms 
at 4ºC, and 26.0 ± 12.8 ms at 30ºC; Figure 8-10) the small size of the ROIs within the 
rat kept at 4ºC resulted in very wide standard deviations. 
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Figure 8-8: Axial fat-only IDEAL MR sequence through the upper thorax at the level of the 
interscapular fat pad (yellow arrow) at (a) 4°C and (b) 30°C, showing low fat fraction 
within the interscapular BAT (c) and (d). 
(a) Fat only image (4°C) (b) Fat only image (30°C) 
  
(c) Fat fraction map (4°C) (d) Fat fraction map (30°C) 
 
0 100 % 
 
 
Table 8-4: Fat fraction and T2* values within in situ BAT and WAT 
 Mean fat 
fraction ±SD 
(%) at 4°C 
Mean fat 
fraction ±SD 
(%) at 30°C 
Mean T2* value ±SD 
(ms) at 4°C 
Mean T2* 
value ±SD 
(ms) at 30°C 
Interscapular BAT 44.7 ± 5.4 62.2 ± 6.5 28.2 ± 101.7 19.1 ± 3.1 
Subcutaneous WAT 72.9 ± 7.3 83.0 ± 3.5 57.1 ± 113.2 26.0 ± 12.8 
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Figure 8-9: Box and whisker plot (with Tukey’s hinges) showing fat fraction of in situ BAT 
and WAT within rat carcasses at 4°C and 30°C. 
 
 
Figure 8-10: T2* map through the upper thorax showing shorter T2* relaxation time within 
the interscapular fat pad (yellow arrow) at (a) 4°C and (b) 30°C. 
(a) (b) 
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8.4 In vivo BAT characterisation in adult humans using MR 
8.4.1 Subjects and methods 
8.4.1.1 Subject selection 
Twenty-four adult patients were recruited (14 females, 10 males; mean age 43.9 ± 18.9 
years, range 18-78). Recruitment occurred in two waves; the first was an opportunistic 
sample (n=13) of whom only two exhibited prominent quantities of 18F-FDG BAT 
(‘BAT06’ and ‘BAT13’). In addition two patients did not undergo concomitant PET/CT 
scans (‘BAT03’ and ‘BAT04’), and therefore their BAT status was not known. 
Consequently a second more defined group of subjects were recruited from the 
population studied in chapters 3-4 (BAT13-18) on the basis of having high 18F-FDG 
BAT uptake on PET/CT. 
In addition six BAT negative controls were identified and recruited on the basis of 
consistently absent 18F-FDG BAT uptake on serial PET/CT scans (BAT19-24). These 
patients were also selected to be age- and sex-matched to patients BAT13-18. 
8.4.1.2 Scanning protocol 
Scanning was performed on a GE Signa HDxt 3T MR scanner (General Electric, 
Milwaukee, USA) with a quad-channel cardiac receiver coil placed anteriorly across the 
upper thorax and cervical region. 
A 3-point IDEAL FSE pulse sequence was performed with the following parameters: 
TR/TE = 440/10.7 to 11.2 ms, flip angle = 90°, number of signal averages (NEX) = 3, 
field of view = 300 x 300 to 380 x 380mm, voxel size (mm) 0.59 x 0.59 to 0.7 x 0.7. 
Various slice thicknesses were obtained to explore to impact of volume averaging, i.e. 5 
mm with 5.3 cm spacing (BAT01-13, 20) and 2.3mm with 2.8mm spacing (BAT03, 13-
24). Between 30 and 33 contiguous axial slices were acquired in an interleaved manner 
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from the upper cervical to mid-thoracic region during free breathing. In addition T2* 
mapping sequences were obtained with the same coverage as the IDEAL sequences for 
12 patients (BAT13-24) with the following parameters: TR/TE1/ ΔTE (ms) = 
300/3.2/5.4, flip angle = 20°, number of signal averages = 0.75. 
To assess MR changes within BAT over time, serial scans were obtained for some 
patients (BAT01, 06-08, 10, 11 and 13). 
8.4.1.3 Image analysis 
Following data reconstruction, fat fraction maps were produced offline from the 
separated fat and water images as described above using ImageJ. T2* maps were also 
produced offline using the MRIAnalysisPak plugin for ImageJ . 
Fat fraction images maps were then thresholded with a lower limit set at 50% to exclude 
non-fat tissues. 
Two methods of BAT identification were used: manual segmentation of fat in the 
supraclavicular fossae, and transposition of 18F-FDG BAT ROIs from PET scans onto 
the MR. WAT regions of interest were defined by freehand segmentation within the 
dorsal subcutaneous adipose tissue. 
8.4.1.3.1 Method 1 - manual segmentation of supraclavicular fat 
In chapter 5 we showed that 18F-FDG BAT, when present, occurs in the supraclavicular 
fossae in 92.6% cases. ROIs were defined within the supraclavicular fossae using the 
‘eroded range limited’ technique validated by Lundström et al. [268, 280], based on the 
assumption that BAT, if present, will most likely occur in these anatomical areas. Crude 
‘BAT’ ROIs were defined manually within the supraclavicular fossae on contiguous 
slices, after which a lower range limit on fat fraction of 50% was set to exclude non-
fatty tissues, followed by morphological edge erosion to reduce edge effects from 
adjacent tissue interfaces (Figure 8-11). 
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Figure 8-11: Crude supraclavicular ROIs superimposed over thresholded fat fraction 
images. 
(a) Superimposition of crude ROI over the 50% 
thresholded fat fraction image 
(b) Following application of a morphological 
edge erode algorithm to exclude tissue 
interfaces 
  
8.4.1.3.2 Method 2 - transposition of 18F-FDG BAT ROIs from PET/CT to MR 
PET/CT scans containing 18F-FDG BAT ROIs were registered to the MR scans using 
Mirada XD 3.4 image fusion software (Mirada Medical Ltd, Oxford, UK) employing a 
combination of automatic rigid and non-rigid registration, with manual placement of 
fiducial markers as necessary. Where multiple positive PET/CT scans had been 
performed for a patient, the index scan with the greatest 18F-FDG BAT volume was 
used. The quality of image registration was verified visually using the in-built 
‘chequerboard’ visualisation tool (Figure 8-12 A). The extent of deformable registration 
applied was also assessed using a displacement grid (Figure 8-12 B), in which the 
length and direction of the arrows represent the magnitude and direction of deformation. 
The magnitude of deformation was compared across different anatomical areas (viz. 
neck, upper and mid mediastinum, supraclavicular fossae and axillae) to determine the 
impact of arm position (i.e. whether the PET/CT was acquired with the arms elevated or 
alongside the torso) on the degree of deformation required to register images. Areas 
where image registration proved unsuccessful (typically the axillae), or where large 
degrees of deformation were required, were not included in further BAT analysis. 
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Figure 8-12: Verification of PET/CT and MR co-registration. 
(a) ’Chequerboard’ validation of co-registered 
PET/CT and MR images 
 
(b) Displacement grid showing the degree of 
deformation required to register the images 
 
 
18F-FDG BAT ROIs defined in chapter 4 were then transposed onto the MR scans 
(Figure 8-13 a). WAT ROIs were manually defined within the dorsal subcutaneous 
adipose tissue, and non-adipose tissue was excluded from analysis by thresholding the 
fat fraction images, with a lower limit set at 50% (Figure 8-13 b). 
Figure 8-13: Position of 18F-FDG BAT and subcutaneous WAT ROIs. 
(a) Transposed 18F-FDG BAT ROIs (red) 
transposed upon the fat fraction map (red), and 
manually defined WAT ROIs (yellow) 
(b) 18F-FDG BAT ROIs overlaid upon the 
thresholded fat fraction image to exclude non-
adipose tissue (black) 
  
8.4.1.4 Statistical analysis 
The impact of arm position (i.e. whether PET/CT scans were performed with the arms 
up or down) on the degree of deformation required for PET/CT and MR image co-
registration was analysed using Kruskal Wallis analysis with Bonferroni post tests. 
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Calculated fat fraction and T2* values for BAT and WAT were compared using the 
unpaired t-test, and fat fraction across serial scans were compared using ANOVA. 
Analysis was performed using GraphPad Prism version 5.00 for Windows (GraphPad 
Software, San Diego, California, USA). Significance was defined as p < 0.05. 
8.4.1.5 Ethics 
Written informed consent was obtained from human participants and appropriate ethical 
approval was obtained from the National Research Ethics Committee at Birmingham 
East, North and Solihull Research Ethics Committee (NHS REC reference 11/H1206/3). 
NHS Trust approval was obtained from the Research and Development office of 
University Hospitals Coventry and Warwickshire NHS Trust. 
8.4.2 Results 
8.4.2.1 Impact of arm position upon quality of image registration 
Kruskal Wallis analysis with Bonferroni post tests showed that arm position had the 
greatest impact upon the extent of image deformation in the axillae, but had no 
significant impact in the neck, mediastinum, supraclavicular fossa (SCF), or 
paravertebral regions (Figure 8-14). Therefore subsequent analysis of BAT was not 
performed in the axillae when the index PET/CT scans were acquired with the arms 
elevated. 
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Figure 8-14: Pairwise comparison of magnitude of image deformation required to register 
PET/CT and MR according to arm position. 
 
8.4.2.2 Sample demographics 
Patients recruited during the first wave of opportunistic recruitment tended to be older 
(mean age 50.3 ± 20.7 years, range 21-78). In addition there was considerable variation 
in the 18F-FDG volume on the concomitant PET/CT scan (Table 8-5); with only two 
showing more than 100 ml of 18F-FDG BAT (‘BAT06’ and ‘BAT13’). BAT13 was an 
outlier in terms of the volume of BAT and was the subject of a case report published 
separately [188]. 
Three patients underwent multiple 18F-FDG BAT positive PET/CT scans and have 
already been studied in chapters 5 and 6 (and the corresponding patient identifiers 
denoted within parenthesis in Table 8-5): ‘BAT06’ (patient D) underwent 4 scans of 
which 2 were positive; ‘BAT09’ (patient H) underwent 2 PET/CT scans, both of which 
were positive; and BAT10 (patient E) underwent 4 scans of which two were positive.  
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In these cases the index PET/CT scan was used as a standard against which the MR 
scan was compared. The remainder (except for ‘BAT03’ and ‘BAT04’) had only a 
single 18F-FDG BAT positive scan. 
Table 8-5: Opportunistic sample of patients (n=13) recruited to the first phase of the 
study. 
Subject Age 
(years) 
Sex 18F-FDG BAT volume 
(ml) [percentile] 
Diagnosis 
BAT01 65 Male 7.4 [22nd] Lymphoma 
BAT02 67 Male 19.1 [37th] Lung cancer 
BAT03 37 Female - Thyrotoxicosis 
BAT04 78 Male - Multinodular goitre 
BAT05 65 Female 17.5 [34th] Bowel cancer 
BAT06 (D) 53 Female 324.8 [97th] Metastatic melanoma 
BAT07 26 Male 3.0 [9th] Testicular seminoma 
BAT08 21 Male 24.2 [45th] Hodgkin’s lymphoma 
BAT09 (H) 61 Male 43.6 [59th] Gastro-intestinal stromal tumour 
BAT10 (E) 30 Female 47.9 [62nd] Hodgkin’s lymphoma 
BAT11 73 Female 52.9 [64th] Gastro-intestinal stromal tumour 
BAT12 27 Female 45.6 [61st] Hodgkin’s lymphoma 
BAT13 24 Female 561.5 [100th] Hyperparathyroidism-jaw tumour 
syndrome 
 
The second sample of six patients recruited (Table 8-6) on the basis of having high 
levels of 18F-FDG BAT uptake on PET/CT were on average younger (mean age 36.7 ± 
16.1 years, range 18-56), including one who was re-recruited from the first wave 
(BAT13). In addition, six age (± 5 years) and sex-matched controls were identified and 
recruited on the basis of showing consistently absent 18F-FDG BAT uptake across serial 
PET/CT scans. 
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Table 8-6: Recruited patients with high 18F-FDG BAT uptake (n=6), and age- and sex-
matched controls (n=6). 
Subject Age 
(years) 
Sex 18F-FDG BAT volume 
(ml) [percentile] 
Diagnosis 
18F-FDG BAT positive subjects 
BAT13 24 Female 561.5 [100th] Hyperparathyroidism-jaw tumour syndrome 
BAT14 56 Female 312.6 [97th] Mucinous rectal cancer 
BAT15 27 Male 270.6 [94th] Hodgkin’s lymphoma 
BAT16 18 Male 441.4 [99th] Teratoma 
BAT17 54 Female 275.2 [95th] Bowel cancer 
BAT18 41 Female 149.4 [85th] Solitary pulmonary nodule 
     
18F-FDG BAT negative controls 
BAT19 24 Female 0 Lymphoma 
BAT20 54 Female 0 Submandibular gland carcinoma 
BAT21 29 Male 0 Seminoma 
BAT22 23 Male 0 Hodgkin’s lymphoma 
BAT23 59 Female 0 Non-Hodgkin’s lymphoma 
BAT24 41 Female 0 Vaginal carcinoma 
8.4.2.3 Difference in fat fraction between BAT and WAT 
Mean fat fraction was significantly lower within 18F-FDG BAT ROIs transposed from 
positive PET/CT scans (74.0 ± 6.5%) than subcutaneous WAT ROIs (78.8 ± 6.0%, p = 
0.0016). Figure 8-15 shows the aggregate mean fat fractions for all patients within the 
study. It is noteworthy that although the mean fat fraction in 18F-FDG BAT ROIs is 
lower than subcutaneous WAT, there is considerable overlap. Therefore a single cut-off 
point to differentiate between BAT and WAT is unlikely to be generalisable to all 
patients. 
Overall, the fat fraction within crude SCF ROIs (78.7 ± 4.6%) did not differ 
significantly from subcutaneous WAT (p = 0.4562), even if analysis is confined to those 
patients with evidence of 18F-FDG BAT uptake on PET/CT (p = 0.3072). The fat 
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fraction within crude supraclavicular fossa ROIs did not differ significantly between 
18F-FDG BAT positive (78.5 ± 4.6%) and negative individuals (79.5 ± 5.1%, p = 0.6; 
Figure 8-16). 
Figure 8-15: Scatter dot plot showing mean WAT and BAT fat fractions. 
 
Figure 8-16: Fat fraction within crude supraclavicular fossa ROIs in 18F-FDG BAT positive 
and negative individuals. 
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At an individual level the fat fraction within the supraclavicular fossa was comparable 
to subcutaneous WAT in most cases (Table 8-7). Only five patients (BAT02-05, 13) 
showed a significantly lower fat fraction within the supraclavicular fossa than in 
subcutaneous WAT. For BAT03 and BAT04, the true BAT status could not be 
determined as they did not undergo concomitant PET/CT scans. The remaining subjects 
showed either no significant difference in fat fraction between the supraclavicular fossa 
and subcutaneous WAT, or a lower fat fraction within WAT. Three patients (BAT07, 
20 and 21) showed a fat fraction within subcutaneous WAT below 70%; of these 
BAT07 had a low volume of 18F-FDG BAT on PET/CT (7.0 ml), and BAT20-21 were 
18F-FDG BAT negative. This erroneously low fat fraction is likely due to the 
subcutaneous fat layer being thin, increasing the effects of volume averaging artefact. 
There is a weak positive correlation between BMI and fat fraction (Figure 8-17) within 
both subcutaneous WAT (r2 = 0.22) and 18F-FDG BAT (r2 = 0.23), albeit not 
statistically significant. This points towards higher fat fractions with increasing 
adiposity, and lower fat fractions within leaner subjects, possibly indicating a greater 
propensity to volume averaging artefact. 
Figure 8-17: Variation in WAT and 18F-FDG BAT fat fraction with BMI. 
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Table 8-7: BAT and WAT fat fraction (on first MR scan) according to patient. 
Subject Mean WAT 
fat fraction 
(±  SD) % 
Crude SCF ROIs Transposed 18F-FDG BAT ROIs 
Mean fat 
fraction (±  SD) 
P value Mean fat fraction (±  
SD) 
P value 
BAT01 83.0 ± 3.2 80.5 ± 5.8 0.0789 76.4 ± 5.5 0.0173 
BAT02 82.3 ± 2.8 79.1 ± 4.9 0.0237* 72.5 ± 6.4 <0.0001 
BAT03 83.5 ± 1.6 78.9 ± 5.0 <0.0001* - - 
BAT04 81.1 ± 2.7 77.3 ± 6.1 0.0013* - - 
BAT05 84.3 ± 1.3 79.3 ± 5.5 0.0034* 70.3 ± 7.4 <0.0001 
BAT06 77.8 ± 2.4 79.2 ± 5.6 0.073 74.5 ± 6.3 0.0002 
BAT07 62.7 ± 4.6 68.0 ± 4.9 0.0004 70.5 ± 6.5 0.0548 
BAT08 73.6 ± 4.6 74.4 ± 5.4 0.2526 59.6 ± 6.1 0.0003 
BAT09 78.2 ± 3.2 78.9 ± 5.1 0.3528 74.6 ± 7.5 0.0643 
BAT10 82.7 ± 2.2 84.2 ± 4.7 0.0243 78.2 ± 6.0 0.0001 
BAT11 82.0 ± 2.2 81.8 ± 5.6 0.427 76.6 ± 6.5 0.0005 
BAT12 78.2 ± 3.4 77.5 ± 5.4 0.296 74.7 ± 5.5 0.002 
BAT13 83.1 ± 1.3 81.0 ± 5.0 0.0293 81.2 ± 4.2 <0.0001 
BAT14 83.2 ± 2.4 84.0 ± 4.4 0.0879 81.4 ± 6.5 0.0011 
BAT15 76.2 ± 7.3 76.0 ± 4.8 0.4262 68.8 ± 7.3 <0.0001 
BAT16 73.1 ± 5.9 72.0 ± 5.3 0.1538 66.7 ± 6.8 <0.0001 
BAT17 82.1 ± 3.3 82.4 ± 5.5 0.3609 81.1 ± 6.3 0.0698 
BAT18 77.3 ± 3.7 79.2 ± 5.1 0.0139 73.7 ± 7.6 <0.0001 
BAT19 78.7 ± 3.6 79.9 ± 5.4 0.3088 - - 
BAT20 67.4 ± 5.1 71.3 ± 5.1 0.0087 - - 
BAT21 69.1 ± 6.9 74.8 ± 6.1 0.0008 - - 
BAT22 82.1 ± 2.8 85.2 ± 4.9 <0.0001 - - 
BAT23 85.8 ± 2.2 84.4 ± 5.7 0.0844 - - 
BAT24 81.0 ± 3.0 82.4 ± 5.3 0.0365 - - 
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8.4.2.3.1 Impact of MR slice thickness upon fat fraction 
The BMI-dependent variation in fat fraction within both WAT and 18F-FDG BAT is 
much more pronounced on MR images acquired with a slice thickness of 2.5mm (r2 = 
0.45 for 18F-FDG BAT and 0.316 for WAT) than at 5mm (r2 = 0.06 for 18F-FDG BAT 
and 0.002 for WAT; Figure 8-18). This implies that narrower slice thickness may have 
greater sensitivity in detecting differences in fat fraction with increasing BMI. 
Figure 8-18: Variation in WAT and 18F-FDG BAT fat fraction according to MR slice 
thickness 
 
8.4.2.4 Difference in T2* relaxation time between BAT and WAT 
The mean T2* values within the crude supraclavicular fossae (SCF) ROIs defined in 
section 8.4.1.3.1 were highly variable. T2* relaxation times tended to be slightly higher 
within the SCF of BAT negative individuals (BAT19-24) than those with evidence of 
18F-FDG BAT on PET/CT (Table 8-8) although the differences were not statistically 
significant (Figure 8-19). 
In most cases the T2* values within the SCF was higher than within the subcutaneous 
WAT, whereas one would expect the converse: a lower mean T2* value within the SCF 
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of BAT positive individuals. This pattern was only evident in three patients (BAT13-
15), in whom the difference was statistically significant in one (BAT13). 
In the case of transposed 18F-FDG BAT ROIs, no significant difference between the 
T2* values of BAT and WAT were identified except for a spuriously high BAT T2* 
value in BAT16 (Table 8-8). 
Table 8-8: T2* relaxation times within BAT and WAT. 
Subject Mean WAT 
T2* value (±  
SD) in ms 
Crude SCF ROIs Transposed 18F-FDG BAT ROIs 
Mean T2* value (±  
SD) in ms 
P value Mean T2* value (±  
SD) in ms 
P value 
BAT13 15.9 ± 11.1 3.3 ± 7.9 <0.0001 14.1 ± 9.6 0.3252 
BAT14 29.7 ± 17.7 26.4 ± 18.1 0.2467 32.0 ± 18.9 0.4544 
BAT15 9.0 ± 7.1 5.4 ± 13.9 0.0704 10.9 ± 7.2 0.0997 
BAT16 29.5 ± 8.3 38.2 ± 21.9 0.0403 40.5 ± 24.5 0.0007 
BAT17 33.0 ± 14.7 80.5 ± 69.2 0.0004 54.7 ± 48.8 0.2273 
BAT18 30.5 ± 14.9 87.2 ± 63.6 <0.0001 52.0 ± 41.6 0.0011 
BAT19 31.4 ± 11.3 97.2 ± 69.6 <0.0001 - - 
BAT20 28.1 ± 9.0 50.8 ± 0.0 0.0024 - - 
BAT21a - - - - - 
BAT22 30.4 ± 10.7 68.3 ± 51.3 0.0001 - - 
BAT23 49.2 ± 20.9 84.5 ± 73.0 0.4067 - - 
BAT24 24.4 ± 15.1 45.6 ± 45.8 0.0287 - - 
 
Overall there was no significant difference in mean T2* relaxation time between either 
the SCF ROIs or transposed 18F-FDG BAT ROIs, and subcutaneous WAT (Figure 
8-20). This, in conjunction with the large variation in these T2* relaxation data make 
this an unreliable discriminator of BAT in this study. 
 
                                                
a No T2* data were available for BAT21 
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Figure 8-19: T2* relaxation times within crude supraclavicular fossa ROIs in 18F-FDG BAT 
positive and negative individuals. 
 
Figure 8-20: Scatter dot plot showing mean WAT and BAT T2* relaxation time for each 
MR scan. 
 
8.4.2.5 Variation in fat fraction on serial MR scans 
Eight patients underwent serial MR scans, of whom six showed evidence of 18F-FDG 
BAT activity on PET/CT (Table 8-9). In most cases fat fraction within the 
supraclavicular fossa ROIs showed little variation over time (Figure 8-21). It is 
noteworthy that the patients who did show significant variation in fat fraction over time 
were BAT20, in whom 18F-FDG BAT uptake was consistently absent across three 
PET/CT scans, and BAT03 who did not undergo PET/CT. BAT06, a 53-year old female 
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who showed 324.8ml of 18F-FDG BAT on PET/CT showed a change in fat fraction of 
3% which was not statistically significant.  
Table 8-9: Serial fat fraction measurements in the supraclavicular fossae. 
Subject Scan 1 
SCF fat fraction (%) 
Scan 2 
SCF fat fraction (%) 
Scan 3 
SCF fat fraction (%) 
P value 
BAT01 80.5 ± 5.8 80.4 ± 5.7 - 0.9566 
BAT03 78.9 ± 5.0 81.7 ± 4.9 - 0.0147 
BAT06 79.2 ± 5.6 75.8 ± 5.0 - 0.1760 
BAT07 68.0 ± 4.9 66.2 ± 5.2 - 0.1162 
BAT08 74.4 ± 5.4 75.0 ± 5.3 - 0.6679 
BAT11 81.8 ± 5.6 81.5 ± 5.8 - 0.8298 
BAT13 81.0 ± 5.0 81.3 ± 5.1 82.9 ± 5.4 0.2211a 
BAT20 71.3 ± 5.1 78.4 ± 5.8 - <0.0001 
 
Figure 8-21: Variation in fat fraction within supraclavicular fossa ROIs on serial MR 
scans. 
 
 
Several patients also showed unexpected variation in subcutaneous WAT fat fraction 
over time (Table 8-10 and Figure 8-22). The most significant variation in WAT fat 
                                                
a Performed using one-way analysis of variance (ANOVA) 
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fraction was seen in BAT03, 06, 08, 13 and 20. It is noteworthy that two of these 
(BAT03 and 20) also showed variability in fat fraction within the supraclavicular fossa, 
implying that fluctuations within the supraclavicular fossae may be erroneous. 
Table 8-10: WAT fat fraction measurements on serial MR scans. 
Subject Scan 1 
WAT fat fraction (%) 
Scan 2 
WAT fat fraction (%) 
Scan 3 
WAT fat fraction (%) 
P value 
BAT01 83.0 ± 3.2 83.1 ± 2.8 - 0.8729 
BAT03 83.5 ± 1.6 82.9 ± 1.7 - 0.0428 
BAT06 77.8 ± 2.4 82.8 ± 2.0 - <0.0001 
BAT07 62.7 ± 4.6 63.4 ± 5.4 - 0.700 
BAT08 73.6 ± 4.6 76.7 ± 4.0 - 0.0047 
BAT11 82.0 ± 2.2 81.4 ± 2.1 - 0.1982 
BAT13 83.1 ± 1.3 82.0 ± 1.5 83.3 ± 2.9 <0.0001a 
BAT20 67.4 ± 5.1 77.6 ± 4.5 - <0.0001 
 
Figure 8-22: Variation in fat fraction within subcutaneous WAT on serial MR scans. 
 
 
                                                
a Performed using one-way analysis of variance (ANOVA) 
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There was significant variation in calculated fat fraction within transposed 18F-FDG 
BAT regions of interest for BAT06, BAT11 and BAT13 (Table 8-11 and Figure 8-23) 
although the magnitude of the differences was small (-4.3% in BAT06, 5.4% in BAT11 
and -1.3% in BAT13). This variation does not appear to follow a seasonal variation 
(Figure 8-24). 
Table 8-11: Serial fat fraction for 18F-FDG BAT regions of interest. 
Subject Scan 1 
BAT fat fraction (%) 
Scan 2 
BAT fat fraction (%) 
Scan 3 
BAT fat fraction (%) 
P value 
BAT01 76.4 ± 5.5 76.8 ± 6.7 - 0.91 
BAT06  74.5 ± 6.3 70.8 ± 6.4 - 0.001 
BAT07 70.5 ± 6.5 67.5 ± 6.4 - 0.51 
BAT08 59.6 ± 6.1 60.4 ± 7.2 - 0.85 
BAT11 76.6 ± 6.5 82.0 ± 6.5 - 0.0016 
BAT13 81.2 ± 4.2 79.9 ± 5.1 83.0 ± 4.6 <0.001 
Figure 8-23: Variation in fat fraction within 18F-FDG BAT on serial MR scans. 
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Figure 8-24: Seasonal variation in fat fraction within transposed 18F-FDG BAT ROIs. Red 
lines correspond to BAT06, 11 and 13 in whom the fat fraction varied significantly. 
 
8.5 Summary 
In this chapter we compared fat fraction and T2* relaxation times within BAT and 
WAT in rats and humans. 
In a post mortem murine study we found that interscapular BAT fat fraction and T2* 
time were significantly lower in both excised tissue specimens and when scanned in 
vivo. We identified variation in BAT fat fraction with temperature, suggesting that fat 
fraction is dynamic in response to the functional state of BAT. 
In adult humans, we found that the mean fat fraction within BAT (identified a priori 
using transposed 18F-FDG BAT ROIs from PET/CT) was significantly lower than 
within subcutaneous WAT. The mean fat fraction within the ROIs defined in the 
supraclavicular fossae (the area most likely to contain BAT based on previous work in 
chapter 5) and subcutaneous WAT did not differ significantly which calls into question 
the effectiveness of this method of segmentation. There was considerable variation in 
BAT fat fraction between patients therefore a single cut off value to differentiate BAT 
and WAT is unlikely to be generalisable to all patients. 
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No consistent difference in T2* relaxation time was observed between subcutaneous 
WAT and BAT (using either method of a priori identification). We also identified that 
BAT is oftentimes more prominent on the fat only IDEAL sequence than on the fat 
fraction maps. 
We also identified significant variation in fat fraction within both supraclavicular fossae 
and subcutaneous WAT on serial scans. Causes for variation in BAT and WAT will be 
discussed further in chapter 10, but include seasonal variation in fat composition and 
variation in BMI (though no variation in BMI was seen to account for the WAT 
variation in this study). Variation may also be due to technical factors including 
measurement error, image mis-registration or volume averaging artefact due to 
difference in position within the scanner. 
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Chapter 9: Prospective identification of BAT in rats and 
adult humans on MR imaging 
9.1 Introduction 
In the previous chapter we identified a difference in fat fraction between BAT and WAT 
in both rats post mortem and adult humans in vivo. 
In the previous chapter we intimated that there might be a difference in MR signal 
between BAT and WAT on the fat-only IDEAL MR sequences. Chen et al. similarly 
found that signal intensity of BAT was lower than WAT using FSE sequences [261]. 
In this chapter we shall explore whether it is possible to identify BAT prospectively on 
MR solely on the basis of its MR characteristics, without recourse to a priori 
knowledge. 
9.2 Aims 
In this chapter we will evaluate the contrast between BAT and WAT on the fat-only 
IDEAL FSE MR sequence. We then aim to determine the possibility of identifying 
BAT prospectively solely on the basis of perceived differences in signal intensity. 
In this chapter we will aim to identify BAT on the basis of differences in fat fraction. 
The identified BAT will then be compared retrospectively against the 18F-FDG BAT 
uptake on the index PET/CT scans. 
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Study I: Visual identification of BAT on fat-only IDEAL MR images 
9.2.1 Subjects and methods 
9.2.1.1 Subject selection 
The scans of the 16 adult patients (9 females, 7 males; mean age 44.2 ± 19.3 years, 
range 18 – 73 years) recruited in the previous chapter on the basis of having 18F-FDG 
BAT uptake on PET/CT (162.3 ± 177.7 ml, range 3.0 – 561.5 ml) were evaluated. 
Seven patients (BAT06, BAT13-18) showed high volumes of 18F-FDG BAT uptake on 
PET/CT (i.e. above the 85th percentile), whereas five (BAT01, 02, 05, 07, 08) were 
below the 50th percentile. 
9.2.1.2 Scanning protocol 
As detailed in the previous chapter, scanning was performed on a GE Signa HDxt 3T 
MR scanner (General Electric, Milwaukee, USA) using the scanning parameters 
summarised in the previous chapter. 
9.2.1.3 Image analysis 
Raw DICOM (Digital Imaging and Communications in Medicine) images of the fat-
only IDEAL MR sequences were analysed offline using ImageJ. 
To quantify differences in perceived signal intensity between BAT and WAT on these, 
the contrast to noise ratio (CNR) between 18F-FDG BAT regions of interest (previously 
identified in chapter 4) and subcutaneous WAT (defined in chapter 8) was calculated on 
a slice-by-slice basis for each patient using Equation 9-1. CNR describes the 
relationship of signal intensity between two regions on an MR image, scaled to image 
noise (normally taken to be background air). 
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To compensate for variations in MR signal within each slice arising from RF non-
uniformity or inhomogeneities in the receiver coil, a field bias map was also subtracted 
semi-automatically using the A posteriori shading correction 514 v3 plugin [281] for 
ImageJ. 
Equation 9-1: Contrast to noise formula. 𝐶𝑁𝑅   = 𝑆𝑖𝑔𝑛𝑎𝑙!"# − 𝑆𝑖𝑔𝑛𝑎𝑙!"#𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑  𝑛𝑜𝑖𝑠𝑒  
 
The images of selected patients were reviewed by two reviewers; rater 1 a speciality 
registrar in clinical radiology with approximately 5 years’ experience, and rater 2 a 
specialty registrar in endocrinology – both with approximately 2 years’ experience in 
BAT imaging. Rater 1 reviewed all MR scans (BAT01, 02, 05-18), while rater 2 only 
reviewed the MR scans for patients with high 18F-FDG BAT volumes on PET/CT 
(BAT06, 13-18).  
The raw DICOM images were reviewed on a dedicated PACS (picture archiving and 
communications system) workstation in optimal lighting conditions without reference to 
the PET/CT scans. The only permitted image manipulations were magnification, 
contrast enhancement and edge enhancement. 
Each observer drew ROIs around areas of presumed BAT on the fat-only IDEAL 
images, identified on the basis of perceived lower signal intensity than adjacent WAT 
(henceforth referred to as ‘BATprosp’).  
As the MR coverage was less than that of the PET/CT scans, the 18F-FDG BAT 
volumes were recalculated based on the MR scan coverage. Volumetric images were 
produced from these truncated 18F-FDG BAT ROIs, and both observers’ prospectively 
identified BAT ROIs using ImageJ 3D viewer (Figure 9-1), from which volumes were 
calculated using the 3D Objects Counter v2.0 [282] plugin for ImageJ. 
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Figure 9-1: Surface-rendered image 
showing truncated 18F-FDG BAT within 
the supraclavicular fossae (BAT06). 
 
 
9.2.1.4 Statistical analysis 
Contrast-to-noise ratio between 18F-FDG BAT and WAT ROIs was analysed 
graphically using a box and whisker plot. The relationship between BMI and 18F-FDG 
BAT volume, and CNR was evaluated using Spearman’s correlation. 
BATprosp volumes were compared with those derived from truncated 18F-FDG BAT 
ROIs using Bland-Altman plots to assess overall agreement, to determine whether the 
level of agreement varied according to the volume of 18F-FDG BAT. The level of 
agreement between each rater’s BATprosp ROIs and 18F-FDG BAT ROIs, and 
interobserver agreement was evaluated using intraclass correlation coefficient (ICC)a 
using an online statistical calculatorb. ICC is a descriptive statistic used on quantitative 
parametric (or at least interval) data organised into groups (in this case patients). It 
describes how strongly values in the same group resemble each other, and can be used 
to assess the reproducibility of quantitative measurements made by different raters 
measuring the same quantity. ICC is considered superior to simple correlation as it may 
                                                
a ICC of 0 - 0.2 indicates poor agreement, 0.3 - 0.4 indicates fair agreement, 0.5 – 0.6 indicates moderate 
agreement, 0.7 – 0.8 indicates strong agreement, and >0.8 indicates almost perfect agreement 
b Statistics Toolbox. Department of Obstetrics and Gynaecology, the Chinese University of Hong Kong. 
http://department.obg.cuhk.edu.hk/researchsupport/IntraClass_correlation.asp 
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be adjusted for the effects of the scale of measurements to take into account differences 
in measurements between groups, and may be used for more than two raters [213]. 
The proportion of BATprosp and 18F-FDG BAT ROIs which colocalise were determined 
visually and analysed using percent pairwise agreement, and the degree of variability 
calculated using Cohen’s or Fleiss’ kappa as appropriate using the online calculator 
ReCal3 [283]. 
Colocalisation analysis was performed upon image stacks to determine the extent to 
which BATprosp and 18F-FDG BAT ROIs intersect using the JACoP (‘Just Another 
Colocalisation Plugin’) and CDA (‘Confined Displacement Algorithm’) plugins for 
ImageJ [218, 284], as described in chapter 6. Manders’ correlation coefficients were 
calculated to describe the fractional overlap of BATprosp and 18F-FDG BAT ROIs. This 
yields two coefficients: ‘M1’ describing ‘BATprosp ∩ 18F-FDG BAT’, and ‘M2’ 
describing ‘18F-FDG BAT ∩ BATprosp’). Pearson’s correlation coefficients were also 
calculated for each pair of scans to quantify the overall level of agreement. To 
determine whether the degree of colocalisation was greater than that expected by 
chance, images were compared with a series of randomised images generated using a 
variation of the frame translation/image-shift method (as described in chapter 6). 
9.2.2 Results 
9.2.2.1 Differences in BAT and WAT signal intensity on fat only IDEAL 
sequences 
We identified a variation in signal intensity between MR slices along the B0 axis 
(Figure 9-2), which renders direct comparison of signal intensities on fat-only IDEAL 
MR images meaningless therefore. The contrast between BAT (derived from transposed 
18F-FDG BAT ROIs) and subcutaneous WAT, however, was unaffected by slice 
position (Figure 9-3). 
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Figure 9-2: Variation in signal intensity within BAT and WAT along the B0 axis in a single 
patient (BAT13). 
 
Figure 9-3: BAT:WAT signal ratio for 18F-FDG BAT ROIs and matched WAT ROIs in a 
single patient (BAT13). 
 
In most cases the MR signal within subcutaneous WAT was higher than within 18F-
FDG BAT ROIs on fat-only IDEAL sequences, with a consequent positive contrast to 
noise ratio (CNR). The exception was BAT07, with a mean CNR of -3.28 (Figure 9-4). 
This may be an aberrant result as BAT07 also had the lowest 18F-FDG BAT volume 
(3.0 ml). 
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The higher the CNR, the greater the contrast between the two tissues of interest. Figure 
9-4 demonstrates that higher CNRs occurred in those patients in whom scans were 
acquired with thicker slices of 5mm (BAT01, 02, 05-12) than at 2.5mm (BAT13-18). 
There is an apparent inverse correlation between CNR and 18F-FDG BAT volume (r2 = 
-0.397), although this was not statistically significant (p = 0.1278). This does, however, 
suggest that thinner slices may be associated with reduced contrast between presumed 
BAT and WAT on MR, likely due to increased background noise. 
Figure 9-4: Box and whisker plot showing variation in contrast to noise ratio between 
patients. 
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9.2.2.2 Prospective visual identification of BAT on the basis of perceived 
differences in signal intensity with respect to subcutaneous WAT 
Due to the MR scans having a smaller coverage than the PET/CT from which the 18F-
FDG BAT ROIs were transposed, BAT volumes were recalculated to encompass the 
areas imaged by MR (‘truncated 18F-FDG BAT’). In addition, as co-registration of 
PET/CT with MR was not always successful in the axillae, axillary BAT was excluded 
from analysis. Consequently the truncated 18F-FDG BAT volumes within the areas 
imaged by MR were considerably lower than the total 18F-FDG BAT volume identified 
on PET/CT (Table 9-1). 
Both reviewers tended to underestimate BAT volume compared to that derived from 
truncated 18F-FDG BAT ROIs – particularly at higher 18F-FDG BAT volumes. The 
mean absolute difference between BATprosp volume (for both raters) and truncated 18F- 
FDG BAT volume was 46.5 ± 44.2 ml (Figure 9-5), although the level of bias was 
higher for rater 2 than for rater 1. Rater 1 overestimated BATprosp volumes in those 
patients with very low 18F-FDG BAT volumes (BAT01, 07, 08), although it should be 
noted that rater 1 reviewed all MR scans, whereas rater 2 only reviewed those scans 
with high volumes of 18F-FDG BAT (BAT06, 13-18). 
Overall there was considerable inter-rater variability (ICC = 0.1154, indicating poor 
agreement). The BATprosp volumes generated by rater 1 showed a stronger correlation 
with truncated 18F-FDG BAT volume (ICC = 0.3809, indicating fair agreement) than for 
rater 2 (ICC = 0.0181, indicating poor, indeed almost no, agreement). Although the ICC 
for BATprosp volumes was higher for rater 1 than rater 2, it does not necessarily follow 
that the BATprosp ROIs were colocalised with 18F-FDG BAT on PET/CT. 
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Table 9-1: BATprosp ROIs and volumes identified by raters. 
    Rater 1 Rater 2 
Patient 18F-FDG 
BAT 
volume 
(ml) 
Truncated 
18F-FDG 
BAT volume 
(ml) 
Truncated 
18F-FDG 
BAT ROIs 
(n) 
BATprosp 
ROIs (n) 
BATprosp 
volume 
(ml) 
BATprosp 
ROIs (n) 
BATprosp 
volume 
(ml) 
BAT01 7.4 3.6 6 5 22.2 - - 
BAT02 19.1 9.2 14 10 4.5 - - 
BAT05 17.5 10.6 16 2 2.0 - - 
BAT06 324.8 102.1 73 12 22.1 39 3.3 
BAT07 3.0 2.6 5 20 12.1 - - 
BAT08 24.2 5.3 7 15 17.2 - - 
BAT09 43.6 23.3 13 11 2.7 - - 
BAT10 47.9 12.8 31 12 11.5 - - 
BAT11 52.9 13.2 22 6 4.9 - - 
BAT12 45.6 20.9 34 7 1.8 - - 
BAT13 561.5 154.4 98 54 64.4 18 7.8 
BAT14 312.6 107.6 152 41 16.3 12 1.9 
BAT15 270.6 45.9 101 33 16.6 9 1.2 
BAT16 441.4 69.4 181 14 6.4 8 1.3 
BAT17 275.2 72.3 155 31 12.3 9 1.3 
BAT18 149.4 67.2 125 48 24.6 10 1.7 
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Figure 9-5: Bland-Altman plot of BATprosp and truncated 18F-FDG BAT volumes for rater 1 
(red) and rater 2 (blue). 
 
9.2.2.3 Colocalisation analysis of BATprosp and 18F-FDG BAT ROIs 
Although the intra-class correlation between BATprosp volumes truncated 18F-FDG BAT 
volumes was higher for rater 1 than rater 2, this provides no detail about whether the 
individual ROIs themselves are coincident. 
Visual inspection of a typical image upon which BATprosp ROIs for rater 1 (coloured 
orange) and rater 2 (coloured red) and 18F-FDG BAT ROIs (coloured yellow) have been 
superimposed (Figure 9-6) shows colocalisation in the mediastinum. 
Figure 9-6: Colocalised BATprosp and 18F-FDG BAT ROIs in a single patient (BAT06). 
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From this the proportion of colocalised ROIs is calculated (Figure 9-7). A higher 
proportion of BATprosp ROIs coincided with 18F-FDG BAT (51.6 – 100.0%) in patients 
with high BAT volumes on PET/CT (BAT06, 13-18), than for those with lower BAT 
volumes (Table 9-2). 
A greater proportion of the BATprosp ROIs identified by rater 1 colocalised with 18F-
FDG BAT ROIs than for rater 2 (Table 9-2 and Figure 9-7). 
Figure 9-7: Stacked bar chart showing the proportion of colocalised BATprosp and 
truncated 18F-FDG BAT ROIs for each ratera. 
 
In seven cases identified by rater 1 (BAT06, 13-18), all of whom showed high BAT 
volumes on PET/CT, more than half of the BATprosp ROIs coincided with 18F-FDG 
BAT. Most prominent is BAT06 in whom all of the 12 BATprosp ROIs identified by 
rater 1 coincided with 18F-FDG BAT, compared with 15/39 BATprosp ROIs identified by 
rater 2. 
There was no colocalisation in six cases (BAT01, 02, 05, 07, 10 and 12), all of whom 
had comparatively small 18F-FDG BAT volumes. All cases evaluated by rater 2 showed 
                                                
a Hatched bars denote rater 2, and non-hatched bars denote rater 1 
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at least some coincidence between BATprosp and 18F-FDG BAT, although as stated 
previously rater 2 only evaluated the scans of patients with prominent 18F-FDG BAT 
uptake (in whom the likelihood of colocalisation was highest). 
Although a high proportion of BATprosp ROIs colocalised with 18F-FDG BAT for both 
raters, the average pairwise agreement tended to be low (Table 9-2), likely due to the 
small number of BATprosp ROIs compared to the number of 18F-FDG BAT ROIs. 
Consequently Cohen’s κ values indicate no overall agreement between truncated 18F-
FDG BAT and BATprosp for either rater. 
Table 9-2: Coincidence statistics for BATprosp and 18F-FDG BAT ROIs for each rater. 
 Rater 1 Rater 2 
Patient Coincident 
BATprosp ROIs 
(%) 
Pairwise 
agreement 
(%) 
Cohen’s 
κ  
Coincident 
BATprosp ROIs 
(%) 
Pairwise 
agreement 
(%) 
Cohen’s 
κ  
BAT01 0.0 0.00 -0.984 - - - 
BAT02 0.0 0.00 -0.946 - - - 
BAT05 0.0 0.00 -0.246 - - - 
BAT06 100.0 16.44 0.000 38.5 15.46 -0.536 
BAT07 0.0 0.00 -0.471 - - - 
BAT08 20.0 33.33 -0.127 - - - 
BAT09 27.3 14.29 -0.734 - - - 
BAT10 0.0 0.00 -0.673 - - - 
BAT11 16.7 0.04 -0.427 - - - 
BAT12 0.0 0.00 -0.395 - - - 
BAT13 51.9 20.90 -0.550 22.2 3.57 -0.278 
BAT14 65.9 16.27 -0.179 33.3 2.50 -0.105 
BAT15 72.7 21.82 -0.172 33.3 2.80 -0.118 
BAT16 71.4 5.41 -0.044 50.0 2.16 -0.044 
BAT17 51.6 9.41 -0.189 33.3 1.86 -0.077 
BAT18 56.3 19.85 -0.170 20.0 1.50 -0.127 
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9.2.2.4 Quantification of colocalised BATprosp and 18F-FDG BAT ROIs 
Colocalisation coefficients were calculated for each rater’s BATprosp ROIs with respect 
to the 18F-FDG BAT ROIs. As there were no coincident BATprosp and 18F-FDG BAT 
ROIs in six patients (BAT01, 02, 05, 07, 10, 12), no further colocalisation analysis was 
performed on these cases. Pearson’s correlation coefficient, a marker of association 
between a pair of scans, fell within that expected by chance in two cases: BAT11 (for 
rater 1) and BAT18 (for rater 2). In all other cases the degree of correlation was greater 
than that expected by chance. There was, however, considerable variation in the 
Pearson’s correlation coefficients between raters, with consistently higher values for 
rater 1 than rater 2. The values were nonetheless low with only three cases having a 
Pearson’s correlation coefficient above 0.2 (BAT06, 13, 15). 
Correlation was not significant for BAT11. The correlation was strongest for BAT06, 
13 and 15 – all with large volumes of BAT on PET/CT. The degree of fractional overlap 
between BATprosp and 18F-FDG BAT (i.e. Manders’ M1 coefficient) was higher for rater 
1 in all cases (Figure 9-8). 
Manders’ M1 correlation coefficient was higher in patients with high 18F-FDG BAT 
volumes (BAT06, 13-18), than for those with smaller volumes (BAT08-11). This is not 
altogether surprising, as the larger the ROIs, the greater the likelihood of colocalisation 
by chance. This is borne out by Figure 9-9, which shows a strong positive correlation 
between truncated 18F-FDG BAT volume and the M1 coefficient for rater 1 (r2 = 0.84). 
A weak inverse correlation between truncated 18F-FDG BAT volume and M1 
colocalisation correlation coefficient was identified for rater 2 although this was not 
statistically significant (r2 = -0.32, p = 0.50). 
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In light of the comparatively high M1 and low M2 colocalisation coefficients, the low 
Pearson’s coefficients are likely due to the disparity between the high number of 18F-
FDG BAT ROIs, and the low number of BATprosp ROIs. 
Figure 9-8: Pearson’s colocalisation coefficients (red bar) with randomised values (grey 
bars with 95% CI) of BATprosp ROIs against 18F-FDG BAT ROIs for each rater. 
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Table 9-3: Manders’ colocalisation coefficients for each rater against 18F-FDG BAT. 
 Rater 1 Rater 2 
Patient M1a M2b M1 M2 
BAT06 0.552 0.119 0.245 0.015 
BAT08 0.060 0.202 - - 
BAT09 0.101 0.055 - - 
BAT11 0.020 0.007 - - 
BAT13 0.399 0.170 0.124 0.006 
BAT14 0.493 0.074 0.331 0.005 
BAT15 0.455 0.163 0.389 0.01 
BAT16 0.410 0.037 0.211 0.003 
BAT17 0.321 0.054 0.287 0.005 
BAT18 0.290 0.106 0.141 0.003 
 
Figure 9-9: Scatterplot of 18F-FDG BAT volume against M1 colocalisation coefficients for 
rater 1 (red) and rater 2 (blue). 
 
                                                
a Fraction of BATprosp ROIs colocalising with truncated 18F-FDG BAT ROIs (BATprosp ∩ 18F-FDG BAT) 
b 18F-FDG BAT ∩ BATprosp 
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9.2.2.5 Inter-rater variability 
On the preceding pages we described considerable variation between raters 1 and 2 in 
terms of the number of BATprosp ROIs, and the proportion which correctly colocalise 
with 18F-FDG BAT. 
The proportion of colocalised BATprosp ROIs across both raters, described by the 
pairwise agreement (Table 9-4), was highest for BAT13 at 24.1%, but considerably 
lower for the rest. Consequently the Cohen’s κ measure of inter-rater agreement was 
low (indeed negative) in all cases, indicating no overall agreement. 
Although the proportion of colocalised ROIs between raters was low, the degree to 
which rater 2’s BATprosp ROIs overlapped those of rater 1 (i.e. ‘M2 correlation 
coefficient’) was quite high in some patients, e.g. 58.6% of BATprosp voxels identified 
by rater 2 for BAT13 colocalised with those defined by rater 1, and over 40% of 
BATprosp voxels for BAT15 and 17 colocalised with those of rater 1. 
This is in contrast to the low M1 values, in which no more than 7% of rater 1’s BATprosp 
voxels colocalised with those of rater 2. This likely reflects differences in the number of 
ROIs as, with the exception of BAT06, rater 1 tended to identify more ROIs. Also, as is 
evident on Figure 9-6, the BATprosp ROIs identified by rater 1 tended to be larger (101.3 
± 62.8 voxels) than for rater 2 (29.9 ± 15.4 voxels). 
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Table 9-4: Inter-rater variability statistics for raters 1 and 2. 
Patient Colocalised 
ROIs (n) 
Pairwise 
agreement (%) 
Cohen’s 
κ 
Pearson’s colocalisation 
coefficient 
M1a M2b 
BAT06 4 8.5 -0.383 0.0493 0.026 0.092 
BAT13 14 24.1 -0.143 0.2034 0.070 0.586 
BAT14 2 3.9 -0.454 0.0484 0.016 0.147 
BAT15 5 13.5 -0.233 0.1095 0.029 0.403 
BAT16 0 - - - - - 
BAT17 4 0.1 -0.306 0.1532 0.050 0.464 
BAT18 2 3.7 -0.245 0.0724 0.019 0.276 
9.3 Identification of BAT using MR and 18F-FDG PET/CT in an 
human adult with histological and immunohistochemical 
confirmation [188] 
Thus far, we have relied on PET/CT as the standard against which MR has been 
compared. 
This is an opportune point to address the issue of whether 18F-FDG BAT uptake 
genuinely represents BAT, by summarising a case report for BAT13, an exemplar with 
the greatest volume of 18F-FDG BAT (561.5 ml) in our study, or for that matter, in the 
wider BAT literature.  
‘BAT13’, a 25-year old Caucasian female was diagnosed with hyperparathyroidism-jaw 
tumour (HPT-JT) syndrome on the basis of biochemical and radiological findings. 
PET/CT (performed using the parameters summarised chapter 3) showed a 0.5 mm right 
inferior parathyroid adenoma, and a giant cell granuloma in the right mandible, as well 
as extensive areas of avid 18F-FDG uptake within the suprasternal, supraclavicular and 
mediastinal fat. 
                                                
a Fraction of rater 1’s BATprosp ROIs intersecting with those of rater 2 (‘rater 1 ∩ rater 2’) 
b Rater 2 BATprosp ∩ rater 1 BATprosp 
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An IDEAL MR sequence was also performed (using the parameters summarised in 
chapter 8) which showed a distinct area of low signal intensity within the suprasternal 
notch, corresponding to the avid 18F-FDG uptake on PET/CT. 
The mandibular lesion was enucleated, which histopathological analysis showed to be a 
giant cell granuloma. Genetic analysis confirmed the diagnosis of HPT-JT, which 
showed her to have a heterozygous mutation for a T to C nucleotide substitution in exon 
2 of CDC73 (c.191T>C), also called the HRPT2 gene, which encodes for parafibromin 
[285]. 
During surgery, a sample of adipose tissue corresponding to an area of avid 18F-FDG 
uptake on PET/CT consistent with BAT, was also excised from the suprasternal region 
(shown by the white arrows in Figure 9-10). Staininga with haematoxylin and eosin 
(H&E) demonstrated small multilocular adipocytes with multiple small lipid vacuoles 
characteristic of brown adipocytes (Figure 9-11a, denoted by the white arrow), in 
contrast to the large unilocular white adipocytes. Immunohistochemical staining with 
Vectastain Elite ABC Kit (Vector Laboratories, PK-6101) and rabbit anti-UCP1 (1:500, 
Sigma U6382) confirmed BAT due to the presence of abundant mitochondria 
containing UCP1 (Figure 9-11b). 
In publishing this case our group was the first to show BAT in a live adult human on 
both PET/CT and MR with immunohistochemical confirmation, [188]. In addition, this 
case formed part of an MD thesis [124]. 
                                                
a  Histopathological and immunohistochemical analysis performed by Dr Yen C. Yeo, Consultant 
Histopathologist at University Hospitals Coventry and Warwickshire NHS Trust 
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Figure 9-10: Fused (a) 18F-FDG PET/CT and (b) fat-only IDEAL MR images of the upper 
thorax. 
(a) (b) 
  
Figure 9-11: Histopathological specimens from the suprasternal adipose tissue stained 
with (a) H&E and (b) UCP1 confirming BAT. 
(a) (b) 
  
9.4 Study II: prospective identification of BAT using fat fraction 
images 
In the previous chapter we demonstrated differences in fat fraction between BAT and 
WAT both ex vivo and in situ for rats. We showed the difference to be much less in 
adult humans. In this study we aim to identify an optimum threshold for separating BAT 
from WAT using fat fraction images in the hope that regions of BAT can be 
prospectively identified. 
WAT                             BAT 
  213 
9.4.1 Subjects and methods 
9.4.1.1 Subject selection 
Four male Wistar rats (mean mass 300g, age 6-8 weeks) reared on an ad libitum diet 
were sacrificed and underwent MR scanning as described in chapter 8. 
In addition, 16 adult humans with evidence of 18F-FDG BAT on PET/CT also 
underwent IDEAL MR as previously described in chapter 8. 
9.4.1.2 Image analysis 
MR images were post-processed offline using ImageJ to produce fat fraction maps. Fat 
fraction values of constituent voxels within 18F-FDG BAT and subcutaneous WAT 
ROIs defined previously were measured using the ‘individual pixel calculation in ROI’ 
macro for ImageJ. For the human subjects, a fat mask was produced with a lower 
threshold set heuristically at 50% fat fraction to exclude areas which were not 
predominantly fat. 
9.4.1.3 Statistical analysis 
Receiver operator characteristic analyses (ROC) were performed to determine the 
optimal thresholds for classifying BAT [286]. The ROC curve plots true positivity rate 
(sensitivity) against false positive rate (100-specificitiy) for different cut-off points. The 
area under the curve (AUC), a measure of how well a parameter distinguishes between 
two groups, and the optimal threshold for discriminating between BAT and WAT was 
chosen using Youden’s J statistic (Equation 9-2) [287], which may be used in ROC 
analysis to identify the point on the ROC curve, furthest above the line of unity (i.e. the 
line of no-discrimination) [288]. 
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Equation 9-2: Youden's J statistic for calculating the optimal cut-off point for ROC 
analysis. 𝐽 = 𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 + 𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 − 1 
 
Regions of presumed BAT were prospectively identified (BATprosp) by segmenting the 
fat fraction images according to these thresholds, and an edge erode algorithm applied 
to remove tissue interfaces. 
In the adult human sample the accuracy of the BATprosp ROIs was tested using 
colocalisation analysis against 18F-FDG BAT ROIs derived from co-registered PET/CT. 
Volumes derived from the BATprosp ROIs were also compared to truncated 18F-FDG 
BAT using Bland-Altman plots and intraclass correlation coefficients. 
9.4.2 Results 
9.4.2.1 ROC analysis of dissected interscapular BAT in rats 
Receiver operator characteristic (ROC) analysis of the voxels within the ex vivo WAT 
and interscapular BAT specimens showed excellent tissue separation (Figure 9-12), 
with an AUC of 0.928. 
Figure 9-12: ROC curve for excised murine interscapular BAT samples. 
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Adopting an upper threshold of 75% fat fraction and lower threshold of 40% correctly 
classified BAT 99.6% of the time with a specificity of 84.7%. Applying these 
thresholds to the fat fraction image of excised tissue BAT and WAT specimens (Figure 
9-13) successfully segmented BAT, shown by the user-defined red ROIs. Following 
edge erosion, the BATprosp ROIs become much more defined (Figure 9-14). The optimal 
cut-off, as defined by Youden’s J statistic was a fat fraction of 73.6%, with a sensitivity 
of 86.7% and specificity of 88.1%. 
Figure 9-13: Fat fraction images of (from left to right) ex vivo interscapular BAT, omental 
WAT and omental WAT (thresholded at 40-75%) from rats kept at (a) 4ºC and (b) 30ºC. 
(a) (b)  
  
Figure 9-14: Fat fraction images following edge erosion of the samples in Figure 9-13 
(a) (b) 
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9.4.2.2 ROC analysis of in situ interscapular BAT in rats 
For the identification of in situ BAT high AUCs of 0.997 (95% CI 0.994 – 1.000, p 
<0.0001) for the rat housed at 30ºC, and 0.998 (95% CI 0.996 – 1.001) for the rat 
housed ante mortem at 4ºC were identified, indicating excellent separation between 
interscapular BAT and subcutaneous WAT (Figure 9-15). An upper threshold set at 
70% fat fraction and a lower threshold of 50% fat fraction correctly classified BAT with 
a sensitivity of 100% and specificity of 98.73%. Applying these thresholds to the fat 
fraction images of the rat housed at 30ºC produced excellent segmentation of the 
interscapular fat pad (white arrow in Figure 9-16), while excluding subcutaneous WAT 
(yellow arrow). The mask produced following thresholding (Figure 9-16b) includes 
interfaces between adipose tissue and muscle, which are effectively removed following 
application of the edge erode algorithm (Figure 9-16c). Youden’s index identified the 
optimal cut-off point to discriminate BAT and WAT in the rat housed at 30ºC to be 
75.8% fat fraction (sensitivity 99.3%, specificity 94.9%), and 57.8% (sensitivity 99.4%, 
specificity 96.7%) for the rat housed at 4ºC. 
Figure 9-15: ROC curve for in situ interscapular BAT for the rat housed at 30ºC. 
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Figure 9-16: (a) Axial fat fraction 
images through the upper thorax of 
the rat housed at 30ºC (thresholded at 
50-70% fat fraction); (b) mask and (c) 
following edge erosion. 
(a) 
  
(b) (c) 
  
9.4.2.3 ROC analysis of in situ BAT in adult humans 
ROC analysis showed marked variation in AUC across human adults (Table 9-5 and 
Figure 9-17). 
Fat fraction was most effective in distinguishing between BAT and WAT for ‘BAT06’ 
in whom the high AUC of 0.924 indicates high discriminatory power, and the optimal 
cut-off value of 80% fat fraction detected BAT with a sensitivity of 84.1% and 
specificity of 88.8%. Similar levels of sensitivity and specificity were also obtained for 
‘BAT02’ and ‘BAT05’ in whom the optimal cut-off values to differentiate between 
BAT and WAT were comparable at 80.1% and 81.0% respectively. A high AUC 
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(0.838) was also seen for ’BAT08’, with high sensitivity and specificity, although the 
optimal cut-off value was markedly lower at 68.1%. 
Table 9-5: Receiver operator statistics for BAT and WAT discrimination within 18F-FDG 
BAT positive human adults (n=16). 
Patient AUC for voxels (95% CI) J statistic Optimal cut-off 
(% fat fraction) 
Sensitivity | Specificity 
BAT01 0.678 (0.651 – 0.705) 0.372 81.0 0.547 | 0.825 
BAT02 0.842 (0.832 – 0.853) 0.594 80.1 0.783 | 0.812 
BAT05 0.899 (0.888 – 0.909) 0.830 81.0 0.844 | 0.986 
BAT06 0.924 (0.921 – 0.926) 0.729 80.0 0.841 | 0.888 
BAT07 0.248 (0.226 – 0.271) 0.208 71.8 0.300 | 0.908 
BAT08 0.838 (0.813 – 0.863) 0.567 68.1 0.752 | 0.811 
BAT09 0.599 (0.586 – 0.611) 0.223 74.8 0.387 | 0.836 
BAT10 0.560 (0.545 – 0.575) 0.280 78.3 0.349 | 0.927 
BAT11 0.662 (0.649 – 0.676) 0.432 77.9 0.489 | 0.944 
BAT12 0.578 (0.568 - 0.588) 0.238 73.2 0.332 | 0.906 
BAT13 0.500 (0.496 - 0.504) 0.218 78.3 0.264 | 0.955 
BAT14 0.533 (0.530 – 0.537) 0.2084 79.2 0.286 | 0.923 
BAT15 0.762 (0.757 – 0.765) 0.391 74.9 0.775 | 0.616 
BAT16 0.710 (0.706 – 0.714) 0.278 68.8 0.559 | 0.708 
BAT17 0.557 (0.553 – 0.561) 0.201 85.3 0.348 | 0.853 
BAT18 0.577 (0.572 – 0.581) 0.208 71.2 0.300 | 0.908 
 
Fat fraction was only moderately effective in discriminating BAT and WAT in four 
patients (BAT01, 11, 15, 16), of whom two had large BAT deposits. In eight patients, 
however, ROC analysis showed fat fraction to be a poor means of discriminating 
between BAT and WAT (BAT07, 09, 10, 12-14, 17, 18). The AUC was lowest for 
‘BAT07’ (0.248) in whom the subcutaneous adipose tissue layer was very thin, 
rendering the WAT ROIs susceptible to the effects of volume averaging. 
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Somewhat surprisingly, ROC analysis showed fat fraction to be less effective in 
discriminating between BAT and WAT in many patients with large 18F-FDG BAT 
deposits on PET/CT (BAT13, 14, 17, 18), and that of the four cases with high AUC 
values (BAT02, 05, 06 and 08) three had small BAT volumes. 
The patients with the highest AUCs had an optimal cut-off of 80.0 – 81.0% fat fraction, 
but there was considerable variation across the sample. Even allowing for the low AUC, 
the sensitivity is unacceptably low in many cases, with nine patients having a sensitivity 
below 50% (BAT07, 09-14, 17, 18) of whom four had a sensitivity below 30%. 
Therefore, although it is possible to identify a cut-off for some cases, it is not possible 
to identify a single universal cut-off point to differentiate BAT and WAT in all adult 
humans. 
Figure 9-17: Typical ROC curves for BAT and WAT discrimination in human adults, 
showing examples of good (a), moderate (b) and poor (c) BAT discrimination. 
(a) BAT06 (AUC = 0.924) 
 
(b) BAT15 (AUC = 0.762) 
 
(c) BAT17 (AUC = 0.557) 
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9.4.2.4 Prospective identification of BAT based on heuristic fat fraction 
thresholding 
Fat fraction images were thresholded with a lower limit set at 50% to exclude non-fat 
tissues. The upper limits were defined for each patient separately according to the J 
statistic arising from ROC analysis (Table 9-5) to exclude WAT. 
Figure 9-18 shows a typical image for BAT06 in which thresholded BATprosp (green) 
and 18F-FDG BAT (red) voxels are merged, with areas of colocalisation shown as 
yellow. Unlike the technique of visual identification which produced discrete ROIs, this 
heuristic technique produced less defined ROIs which made ROI-based analysis 
impractical, therefore voxel-based analysis was performed. 
Figure 9-18: Merged colocalised 18F-FDG BAT and edge-eroded BATprosp ROIs (BAT06). 
 
 
Colocalisation analysis showed many of the 18F-FDG BAT ROIs intersected with 
BATprosp ROIs, most notably BAT02, 05, 07 and 15 (Table 9-6). A higher degree of 
colocalisation occurred in three patients (BAT02, 05, 06), although the Pearson’s 
correlation coefficients and Manders’ overlap coefficients were typically low indicating 
low levels of colocalisation. In most cases the degree to which the BATprosp ROIs 
colocalised with the 18F-FDG BAT ROIs derived from PET/CT were no greater than 
expected by chance (BAT01, 02, 08-13, 17, 18). 
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Furthermore this technique tended to underestimate BAT volume in patients with large 
18F-FDG BAT volumes on PET/CT (Figure 9-19).  
Table 9-6: Colocalisation statistics for BATprosp and 18F-FDG BAT ROIs (following edge 
erosion). 
Patient BATprosp 
volume 
(ml) 
Intersect
ing ROIs 
Pearson’s 
colocalisation 
coefficient; R 
(d=0) 
R (d = 
rand)a 
95% CI Sig M1b M2c 
BAT01 323.21 2/6 0.005 0.003 -0.001 | 0.012 No 0.093 0.000 
BAT02 306.81 11/14 0.021 0.012 0.000 | 0.029 No 0.190 0.002 
BAT05 570.97 12/16 0.024 0.005 -0.002 | 0.013 Yes 0.290 0.002 
BAT06 609.33 3/7 0.119 0.036 0.018 | 0.054 Yes 0.311 0.047 
BAT07 61.58 4/5 0.004 0.010 -0.001 | 0.005 Yes 0.038 0.000 
BAT08 26.44 0/7 0 0 0 No 0 0 
BAT09 108.18 6/13 0.010 0.012 -0.001| 0.037 No 0.037 0.004 
BAT10 175.53 7/31 0.006 0.034  -0.000 | 0.011  No 0.045 0.001 
BAT11 289.95 11/22 0.013 0.006 -0.001 | 0.017 No 0.214 0.001 
BAT12 56.335 8/34 0.016 0.007 0.000 | 0.017 No 0.042 0.007 
BAT13 235.00 23/98 0.005 0.01 0.002 | 0.227 No 0.023 0.005 
BAT14 66.71 31/152 0.004 0.022 0.006 | 0.050 Yes 0.013 0.010 
BAT15 28.82 59/101 0.055 0.013 0.002 | 0.026 Yes 0.067 0.051 
BAT16 18.28 65/181 0.053 0.004 -0.002 | 0.015 Yes 0.042 0.075 
BAT17 401.23 65/155 0.014 0.014 0.007 | 0.022  No 0.095 0.008 
BAT18 9.72 11/125 0.005 0.002 -0.001 | 0.010 No 0.004 0.013 
 
                                                
a Mean Pearson’s correlation coefficient for the randomised images. 
b M1 = proportion of 18F-FDG BAT ROIs overlapping BATprosp ROIs. 
c M2 = proportion of BATprosp ROIs overlapping 18F-FDG BAT ROIs. 
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Figure 9-19: Bland-Altman plot of BATprosp and 18F-FDG BAT ROIs. 
 
9.5 Summary 
In this chapter we evaluated two methods for identifying BAT prospectively on MR: 
visual inspection based on perceived differences in signal intensity on fat-only IDEAL, 
and semi-automatic discrimination based on differences in fat fraction. 
Visual inspection was moderately successful in identifying BAT in some cases, 
particularly in the hands of a radiologist. This technique did tend to underestimate 
volume in patients with larger volumes of 18F-FDG BAT on PET/CT however. 
Although we discovered significant differences in fat fraction between BAT and WAT 
in adult humans in vivo (chapter 8), it was not possible to define a single cut-off point to 
differentiate these tissues. Therefore we used receiver operator curve analysis to 
heuristically identify optimum thresholds for each patient. This technique was 
moderately effective in a small number of patients but produced inconsistent results, 
with fairly poor levels of colocalisation against 18F-FDG BAT uptake. 
Both techniques underestimated BAT volume – particularly in those patients with 
higher 18F-FDG BAT volumes. BAT is dynamic, therefore it is possible that it involuted 
in the interval between the PET/CT sand MR scans. Conversely, in cases where these 
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techniques appear to have overestimated BAT volume, it is possible that this 
represented hitherto unidentified BAT (particularly given that BAT on the PET/CT 
scans was not maximally stimulated). This is considered unlikely as many BATprosp foci 
lay within the dorsal subcutaneous adipose or tissue layer which is not known to contain 
BAT.  
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Chapter 10: Discussion 
10.1 Summary of the thesis 
Following the serendipitous discovery of 18F-FDG BAT on PET/CT scans in adult 
humans, coupled with insights into its effects on body weight and metabolism, interest 
in BAT research in humans has piqued [2, 289]. Prior to this, BAT was considered to be 
largely absent in adult humans, or at the very most of little if any physiological 
importance [290]. The current view is that BAT persists into adulthood in the majority 
of humans [187], in whom it continues to play a significant metabolic role, and its 
absence or dysfunction has been linked to obesity [23, 42, 291]. Indeed, the potential 
importance of BAT is such, that its reclassification as a new human organ has been 
advocated [24, 189, 292]. 
In chapter 1 we summarised the physiological role of BAT, and highlighted its 
importance in human metabolism research as a potential means of managing obesity. 
Any novel pharmacological interventions which seek to regulate human obesity through 
the manipulation of BAT, would require the development of a reliable biomarker. The 
ultimate aim of this thesis is to evaluate the reliability of 18F-FDG PET/CT and MR 
imaging as imaging biomarkers for in situ BAT in human adults. 
In chapter 2 we described how 18F-FDG PET/CT has been used to demonstrate 
metabolically active BAT in humans. To date, most studies evaluating the prevalence of 
BAT in humans have involved retrospective analyses of PET/CT scans performed 
within clinical settings, typically for the diagnosis, staging and monitoring of 
oncological disease. Despite PET/CT scanning protocols being developed to suppress 
physiological 18F-FDG uptake within BAT to reduce the risk of false positive diagnoses, 
PET/CT remains the standard against which other imaging modalities are compared in 
the field of BAT research. Due to the lack of standardisation in these retrospective 
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studies, there is considerable variation in 18F-FDG BAT prevalence throughout the 
literature, and there is currently no consensus regarding BAT prevalence within human 
adults [189]. 
In chapters 3 and 4 we performed a large retrospective study of 18F-FDG BAT 
prevalence on 3,295 consecutive PET/CT scans in 2,685 individuals at a single 
institution. We found that, for a single scan, the point prevalence of 18F-FDG BAT is in 
the order of 5%. This is undoubtedly an underestimate of the true prevalence, as we 
found that the likelihood of an individual demonstrating 18F-FDG BAT increases the 
more PET/CT scans an individual undergoes – plateauing at approximately 30%. We 
evaluated the impact of different demographic and meteorological factors upon the 
prevalence, volume and level of activity of 18F-FDG BAT and found that 18F-FDG BAT 
is highly variable both between and within individuals. 
In chapters 5 and 6 we explored the distribution patterns of 18F-FDG BAT in a subgroup 
of 15 patients who, having undergone multiple PET/CT examinations, showed evidence 
of 18F-FDG BAT on multiple scans. We found that that 18F-FDG BAT uptake not only 
occurs within the same anatomical compartments across serial scans within an 
individual, but often occurred within fixed depots. From this we proposed that, each 
individuals ‘index scan’ (i.e. the scan with the greatest volume of 18F-FDG BAT) was a 
reliable representation of the pattern of 18F-FDG BAT uptake on their other positive 
scans, and could therefore be used as a standard against which other imaging modalities 
could be compared. 
In chapter 7 we described how MR imaging has hitherto been used to discriminate BAT 
and WAT based on histological differences, most notably fat fraction and T2* 
relaxation time. Although shown to be an effective means of tissue discrimination in in 
murine studies and in human children, results in human adults have been less consistent. 
Therefore for chapter 8, we performed IDEAL MR scans in 16 adult humans with 18F-
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FDG BAT uptake on PET/CT. BAT (identified a priori by co-registering with PET/CT) 
had a lower signal intensity on IDEAL MR than subcutaneous WAT, and that fat 
fraction within BAT was significantly lower. 
In chapter 9 we sought to exploit these differences to identify BAT prospectively. 
Identifying BAT on the basis of visually perceived differences in signal intensity on raw 
DICOM images was reasonably effective in patients with large 18F-FDG BAT volumes, 
but tended to underestimate BAT volume. Although there was considerable inter-rater 
variability, this technique proved fairly effective in a single patient with copious 
quantities of 18F-FDG BAT, whom we singled out in a case report [188]. 
10.2 Determinants of BAT prevalence on 18F-FDG PET/CT 
This study, a moderately large retrospective study of BAT prevalence on 3,295 
consecutive PET/CT scans at a single centre, showed evidence of BAT in 5.7% of 
individuals (and 5.3% of scans) which is broadly similar to the figures reported in other 
retrospective PET-based studies [38, 127-136, 182, 186, 187, 190, 193-199, 204]. 
Inclusion of multiple scans for the same patient has the potential to introduce bias as 
each scan is not independent, and as a result some authors have restricted their analyses 
to patients’ initial scans to avoid clustering [293]. We found that such an approach had 
little appreciable impact on prevalence, which in our study reduced only slightly to 
5.5%. 
In any event, these estimates of point prevalence are undoubtedly underestimates. 
Dedicated prospective studies suggest that the true prevalence may be much higher than 
retrospective studies suggest – somewhere between 33% [42] and almost 100% on some 
PET/CT studies [43, 44], and 84% on post-mortem studies [37], although the latter 
studies tended to be much smaller.  
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We showed that the absence of 18F-FDG BAT uptake on a single scan is a poor 
predictor of overall BAT status (overall sensitivity 48.9%). Furthermore the likelihood 
of an individual having 18F-FDG BAT increased the more scans they had, therefore the 
overall sensitivity of 48.9% is likely an upper estimate. By calculating the cumulative 
18F-FDG BAT prevalence on serial scans, we showed that prevalence on the first is 
4.7%, increasing by 5.8% for each additional scan before plateauing at approximately 
30% for those with 6 or more scans. Lee et al. [187], in an analysis of serial PET/CT 
scans on 145 patients, showed that the mean probability of identifying BAT increased 
by 13% with each additional scan, increasing from 8.5% for a single scan, to 65% with 
more than four scans. Similarly Rousseau et al. [191] identified that the prevalence 
increased the more scans a patient underwent. These figures are comparable to some of 
the dedicated prospective PET studies. 
10.2.1 Demographic factors 
In line with most other studies [38, 127, 128, 135, 185-187, 194, 199], we identified a 
much higher prevalence of 18F-FDG BAT in females than males (8.7% versus 2.5%), a 
trend that was apparent across almost all age groups. This has been interpreted as 
representing a genuine sexual dimorphism in adult humans [38, 199, 294]. Some 
studies, however, have revealed a similar 18F-FDG BAT prevalence in males and 
females [42]. Therefore it has been suggested that the reported differences in prevalence 
between sexes may be erroneous, particularly in light of recent prospective studies 
which have reported a very high 18F-FDG BAT prevalence in males [43]. Nedergaard et 
al. [189] concluded that there is probably no real difference in true BAT prevalence 
between the sexes – at least not for younger individuals, and probably reflects different 
activation thresholds between sexes. Apropos of this, we identified significant 
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differences in 18F-FDG BAT prevalence between sexes for older adults (over 40 years), 
but not in those who were younger (below 40 years). 
We did not evaluate whether there were differences in 18F-FDG BAT prevalence 
between ethnic groups, although similar prevalences have been reported in south Asian 
[295], Korean [190] and black South African [198] populations, as in Caucasian 
populations. 
It is recognised that for a given temperature, a higher proportion of females than males 
feel cold [296] which may be related to differences in adiposity, and may be the cause 
or effect of differences in 18F-FDG BAT prevalence between sexes. 
We identified a higher prevalence of 18F-FDG in those with normal BMI than for those 
who were overweight or obese in line with other studies [43, 191, 297]. In light of this, 
and the differences in obesity levels between the sexes, it is tempting to ascribe 
differences in 18F-FDG BAT prevalence to BMI, although we found no significant 
difference in mean BMI between males and females. BMI does not, however, accurately 
reflect adiposity in different ethnic groups, sexes and for those at the extremes of BMI 
due, in part, to differences in body proportion and its inability to differentiate between 
fat and fat-free mass [298]. More accurate quantification of lean body mass (LBM) may 
alternatively be obtained by using the formulae devised by Morgan et al. [299] which 
takes into account sex, weight and height (Equation 10-1). Alternatively whole body 
composition analysis using the ‘BodPod’ air-displacement plethysmography method 
may be used. 
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Equation 10-1: Equations for calculating lean body mass. 
𝑳𝑩𝑴   𝒎𝒆𝒏 = 𝟏.𝟏𝟎×𝒘𝒆𝒊𝒈𝒉𝒕  𝒊𝒏  𝒌𝒈 − 𝟏𝟐𝟖× 𝒘𝒆𝒊𝒈𝒉𝒕  𝒊𝒏  𝒌𝒈𝒉𝒆𝒊𝒈𝒉𝒕  𝒊𝒏  𝒄𝒎   𝟐   
𝑳𝑩𝑴   𝒘𝒐𝒎𝒆𝒏 = 𝟏.𝟎𝟕×𝒘𝒆𝒊𝒈𝒉𝒕  𝒊𝒏  𝒌𝒈 − 𝟏𝟒𝟖× 𝒘𝒆𝒊𝒈𝒉𝒕  𝒊𝒏  𝒌𝒈𝒉𝒆𝒊𝒈𝒉𝒕  𝒊𝒏  𝒎 𝟐   
 
We also identified an inverse correlation between age and 18F-FDG BAT prevalence, 
with BAT being most prevalent in those who were younger, in line with comparable 
large retrospective studies [204]. For both age and BMI, males tended to show a 
consistently lower prevalence than females, a similar observation to that described by 
Persichetti et al. [204] who identified that the association between 18F-FDG BAT and 
BMI was more evident in women. Some studies found that age and BMI co-vary, and 
that lower prevalence figures with increasing age have may be attributed to increasing 
BMI with age [36, 113], although we identified no such correlation. An alternative 
hypothesis for the age-related decrease in BAT postulates that the stimulatory effects of 
sex hormones are lost with increasing age, resulting in BAT involution [189]. 
The demographics of the study sample merit further comment; a high proportion of the 
sample were older adults (mean age 61 years) with the greatest number of PET/CT 
scans being performed in the 60-70 year group). Given the large disparity between 18F-
FDG BAT prevalence with age (approximately 30% in those under 30 years, falling to 
approximately 5% in those above 60 years), the sample is skewed towards older age 
groups which yield an erroneously low overall prevalence figure. Therefore it may be 
illuminating to present an age-standardised prevalence. 
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10.2.2 Glycaemic status 
Glycaemic status also correlated with 18F-FDG BAT prevalence, being much more 
prevalent in those who were normoglycaemic (6.5%), than those with impaired fasting 
glycaemia (4.4%) or diabetes mellitus (1.9%). As for age and BMI, females showed a 
consistently higher prevalence than males. In hyperglycaemic states, the amount of 
glucose available for transport into metabolically active tissues is increased, and would 
compete with 18F-FDG, resulting in less FDG being taken up than in normogylocaemic 
states. 
The appropriateness of using 18F-FDG PET/CT to gauge the prevalence of BAT has 
been questioned. As described in chapter 2, 18F-FDG PET/CT relies on uptake of the 
radiolabelled glucose analogue 18F-FDG, which is somewhat at odds with the belief that 
preferred substrate for BAT is triglyceride stored within the tissue [300]. Decreased 
lipid content within activated BAT has been described [67, 266], as has loss of free fatty 
acids within interscapular BAT in mice following noradrenergic stimulation [301]. 
Lipolysis of these lipid stores is thought to account for the higher CT attenuation values 
within active BAT compared to inactive BAT [302, 303]. As the lipid stores become 
expended, lipid is actively taken up from the circulation, regulated by β–adrenergic 
activated transcription of the lipoprotein lipase gene [304, 305]. The current view is that 
although fatty acids are required to activate UCP1 initially [306], the brown fat 
mitochondria are then able to metabolise carbohydrates in addition to fatty acids. This 
view is supported by the high levels of enzymes which oxidise carbohydrate including 
pyruvate within brown adipocyte mitochondria [307]. Further evidence comes from 
studies of cold acclimatised rodents, in which energy expenditure is up to three times 
higher than the basal level, of which 75% occurs within BAT. The respiratory quotient 
(a form of indirect calorimetry estimated from exhaled CO2) allows the metabolised 
substrate to be derived; lipid metabolism would yield a respiratory quotient of 0.70, 
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whereas these rodent studies actually yield a respiratory quotient of 0.80-0.85, implying 
a mixture of carbohydrate and fatty acid substrates [98]. Indeed it has been suggested 
that one of the functions of BAT is that of glucose disposal [189]. 
10.2.3 Circadian fluctuation 
Univariate analysis also identified a correlation between photoperiod and BAT 
prevalence. Using binary logistic regression analysis, we sought to identify the variables 
which correlate most strongly with 18F-FDG BAT prevalence. All methods of 
multivariate binary logistic regression returned models which identified age (younger), 
sex (female), BMI (lower) and time of day (earlier) as independent predictors of higher 
18F-FDG BAT prevalence. The same determinants were also identified when regression 
analysis was restricted to patients’ first scans, implying that the perceived problem of 
data clustering highlighted above is not significant.  
Several studies have shown short photoperiods to be associated with BAT activation in 
the Djungarian (Siberian) hamster (Phodopus sungorus) through activation of 
lipoprotein lipase [308], as well as increasing both mass and GDP-binding within brown 
adipocyte mitochondria [309]. Similar findings have been reported in other small 
mammals [310-313] and humans [127].  
Short photoperiod has also been shown to suppress prolactin secretion from the pituitary 
in male golden (Syrian) hamsters (Mesocricetus auratus) [314]. Prolactin has been 
shown to induce UCP1 in sheep [315], although the consensus view is that prolactin has 
a suppressor effect upon BAT activity within hamsters [316, 317] and humans [318]. 
Indeed Tan et al. [319] suggest that excessive nocturnal light exposure in modern 
societies may be a contributory factor to human obesity. Multivariate analysis, however, 
did not show photoperiod to be a significant predictor of 18F-FDG BAT status. 
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Prevalence varied throughout the day, with a significant drop in prevalence from its 
highest level at 09:00 (7.0%), dropping to 0% at 17:00. Although this may reflect 
diurnal temperature fluctuations, we did not have access to hour-by-hour temperature 
data to test this hypothesis. A circadian rhythm of 18F-FDG uptake within interscapular 
BAT in mice has been described [320], although the authors describe peak uptake 
occurring after 9 hours of daylight, whereas we showed a peak in prevalence in the 
morning which then diminished throughout the day. 
Alternatively, variation in BAT prevalence may accompany circadian rhythms in 
physiological processes. Many hormones, for example, have been shown to modulate 
BAT activity including prolactin, melatonin and corticosteroids, all of which show 
circadian variation. Low corticosteroid levels (e.g. following adrenalectomy in rats) 
have been shown to increase purine nucleotide binding in BAT, which normalises 
following corticosteroid infusion [321]. Melatonin production closely mirrors BAT 
activity [2], and melatonin binding sites have been identified in the cell membrane of 
mature brown adipocytes in Siberian hamsters, which have been implicated in 
mediating photoperiodic effects [322]. It has been therefore been suggested that 
melatonin may induce both hypertrophy and activation of BAT [319]. This would seem 
plausible, as melatonin biosynthesis within the pineal gland follows both a circadian and 
seasonal variation, and declines with age [323, 324], presenting a possible mechanism 
for decreased 18F-FDG BAT with age. In rats no change in interscapular BAT mass or 
activity was observed following pinealectomy [325]. Nonetheless melatonin 
supplements have been suggested as a novel therapeutic means of stimulating BAT 
activity in humans [319]. 
Cyclical changes may also be the result of variations in adenosine 3':5' cyclic 
monophosphate (cAMP), which have been shown to fluctuate during the wake-sleep 
cycle in the anteroventral-medial hypothalamus, and on a seasonal basis within 
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interscapular BAT [326]. This may account for our findings of a strong seasonal trend 
in 18F-FDG BAT prevalence, being highest in the winter months, and lowest in the 
summer. There was a moderately strong inverse correlation between mean monthly 
temperature and 18F-FDG BAT prevalence, with the highest prevalence in February 
(10.8%) and the lowest in July (1.6%), albeit not statistically significant. Saito et al. 
[42], in a dedicated study in which patients were scanned in the summer and again in 
the winter, following acute cold exposure to maximise 18F-FDG BAT activity, found 
that uptake was much more prevalent in the winter. 
Not only does BAT show quantitative seasonal variation, qualitative variation in terms 
of composition within BAT has been described in the big brown bat (Eptesicus fuscus) 
[327], which has been attributed to different rates of fatty acid oxidation throughout 
hibernation. Seasonal variation in the morphology of BAT adipocytes has also been 
reported in the non-hibernating common shrew (Sorex araneus), specifically an increase 
in capillary vascularity and mitochondrial cristae density [328], implying greater 
activity. It is feasible, therefore, that human BAT may undergo similar morphological 
seasonal variation. 
10.2.4 Effect of temperature upon 18F-FDG BAT 
The stimulatory effect of cold upon BAT recruitment in rodents is well known [2, 329]. 
Most comparable retrospective studies have found a similar pattern [38, 128, 129, 194], 
but not all [191]. On average, 18F-FDG BAT positive scans were acquired at lower 
temperatures than negative scans, but the effect of outdoor temperature is less clear-cut 
than other determinants. Although there is a clear inverse correlation between all 
temperature metrics and 18F-FDG BAT prevalence on univariate analysis (with the 
highest prevalence within winter months), multivariate analysis yielded inconsistent 
results. One technique indicated lower mean temperature in the preceding 3 days to be a 
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significant predictor, whereas the stepwise techniques identify the preceding day’s mean 
temperature and preceding 3 days’ mean temperature to be significant predictors. This 
inconsistency may be due to an underlying problem with multicollinearity between the 
temperature variables. Nonetheless, there is a pattern of increased prevalence with lower 
temperatures, and it would seem plausible that a lag period would be necessary between 
exposure to a cold stimulus, and activation of BAT. Increased 18F-FDG BAT has been 
widely reported as an acute response to cold weather [194], most likely through cold-
induced sympathetic stimulation via adrenergic receptors, which in turn drives glucose 
uptake. 
The effect of temperature regulation is evident in prospective studies including by Saito 
et al. [42] who identified that following exposure to cold (19ºC) for 2 hours, 17/32 
young adults (23-35 years) and 2/24 older adults (38-65 years) showed substantial 18F-
FDG BAT uptake, which was also confirmed histopathologically. On repeat scanning at 
27ºC, no 18F-FDG BAT uptake was evident. Similarly Zukotynski et al. [200] compared 
the prevalence of 18F-FDG BAT in children and young adults before and after a change 
in scanning protocol; when scanned in cool conditions (21ºC), 18F-FDG BAT 
prevalence was 27% and remained fairly constant throughout the year. When scanned in 
warm conditions (24ºC), the prevalence dropped to 9% and showed greater seasonal 
variation. 
That cold exposure activates 18F-FDG BAT is borne out by the fact that dedicated 
prospective studies, in which ambient temperature was reduced to around 16°C in 
combination with light clothing, showed a BAT prevalence in excess of 33% [36, 42-
44, 113], much higher than in retrospective studies. Some prospective studies have 
sought to augment cold exposure by immersing feet in cold water to induce sympathetic 
activation of BAT. This technique has been criticised as being un-physiological, insofar 
as BAT is selectively innervated by dedicated sympathetic neurones which are activated 
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by cold-sensitive centres in the brain, and is not normally innervated by general 
sympathetic outflow [2, 189]. 
Nonetheless, this highlights how responsive BAT is to small changes in temperature. 
The highly dynamic nature of BAT is well recognised. Short term exposure to cold 
(4°C) for 4 hours is sufficient to increase glucose uptake within BAT 2.3 fold [84], 
while exposure to thermoneutral conditions for 2.5 hours results in significantly 
decreased GDP binding within BAT [330]. BAT activity respond to temperature 
fluctuations within 30 minutes [43], and some authors suggesting it responds within as 
little as 10 minutes [331]. Therefore, although multivariate analyses imply it is the 
temperature in the preceding days which is an important determinant, implying some 
sort of sustained exposure to activate 18F-FDG BAT, it captures the temperature to 
which individuals have been exposure better than temperature on the scan date. The 
majority of scans were performed before midday (2,019/3,269, 61.8%), therefore the 
mean temperature on the scan date may not be an accurate representation of the ambient 
temperature on the morning of the scan. As discussed above, analysis of changes in 18F-
FDG BAT prevalence against hour-by-hour temperature data may yield further 
information, rather than use of a daily mean. 
This also highlights the opportunistic and probabilistic nature of BAT detection on 
retrospective 18F-FDG PET/CT studies. Although cumulatively we surmised, based on 
analysis of serial scans, that 18F-FDG BAT prevalence was approximately 30%, this is 
almost certainly an underestimate. Some individuals consistently failed to show any 
evidence of 18F-FDG BAT despite undergoing multiple PET/CT scans, which may 
indicate that they may be genuinely BAT negative. The low prevalence on retrospective 
PET/CT-based studies is, at least in part, due to the fact that scanning protocols are 
optimised to suppress physiological 18F-FDG uptake which could potentially result in 
false positive tumour diagnoses. Dedicated prospective studies, on the other hand, 
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optimise scanning protocols to seek to maximally stimulate 18F-FDG BAT. At our 
institution, ambient temperature within the PET suite is maintained at approximately 
24ºC - sufficient to abolish most BAT activity. This has significant implications for our 
study. Not only is brief exposure to low ambient temperatures able to activate BAT, but 
exposure to warm temperatures (for as little at 15 minutes at 24°C) is sufficient to 
deactivate it in most subjects [192, 200, 202, 332-334]. Therefore BAT, even if present, 
may be quickly rendered metabolically inactive following a short period of warming.  
There is compelling evidence in the literature that 18F-FDG uptake within fat truly 
represents brown (or at least beige) fat [189]. We provided histopathological 
confirmation of this in a single exemplar based on characteristic histological and 
morpholological features of BAT (i.e. small multilocular adipocytes) and 
immunohistochemical staining with UCP1 antibody. The expression of UCP1 has 
hitherto been considered specific to BAT [36]. More recently the specificity of UCP1 
has been challenged following the identification of UCP1 in both interscapular BAT 
and beige fat deposits in rodents [273]. Quantitative real-time PCR studies indicate that 
expression of the molecular marker Zic1 is a better discriminator, being largely absent 
in beige fat [64]. 
10.2.5 Determinants of 18F-FDG BAT volume and activity 
Most studies have categorised 18F-FDG BAT in a binary fashion into either ‘present’ or 
‘absent’. Far fewer studies have sought to quantify the volume and activity of 18F-FDG 
BAT [133], which can vary considerably both between, and within individuals. Human 
neonates are estimated to have between 40g and 200g of BAT, and human adults 
between 100g and 200g [125, 335, 336]. Therefore in chapter 4 we sought to identify 
which factors were predictive of 18F-FDG BAT volume and metabolic activity (using 
SUVmax as a surrogate marker). 18F-FDG BAT volume and SUVmax showed a very 
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strong positive correlation, indicating that larger volumes of 18F-FDG BAT were 
associated with greater metabolic activity, therefore it is likely that similar factors affect 
both. Alternatively, larger volumes may represent confluent sheets which take up 18F-
FDG homogenously, whereas smaller volumes may manifest as dispersed islands within 
larger areas of WAT, which would take up 18F-FDG in a much more heterogeneous 
manner. Histological studies have shown that BAT often exists as islets scattered 
throughout larger sheets of WAT and skeletal muscle tissues [36, 337]. 
A similar pattern of determinants was observed with 18F-FDG BAT volume and 
SUVmax as with prevalence, possibly due to the data being skewed by the large number 
of 18F-FDG BAT negative scans. On average, 18F-FDG BAT volume and SUVmax 
were higher in those who were female, younger and leaner which accords with the 
findings of similar large retrospective studies [38, 105, 127, 128, 134]. Time of day 
correlated weakly with volume and SUVmax, as did all temperature metrics. 
A different pattern emerges if analysis is restricted to those scans with evidence of 18F-
FDG BAT uptake. Age becomes the strongest correlate, with higher volumes and 
SUVmax in younger individuals, which supports the classical assumption that BAT 
involutes with age. Sex, BMI and glycaemic status were no longer found to correlate 
with either volume or SUVmax. Although sex is not a significant correlate, we did 
identify a sex dimorphism, with males showing a lower 18F-FDG BAT volume and 
SUVmax for age, BMI and glycaemic status. Furthermore, females’ response to change 
in BMI and glycaemic status tended to be slightly more blunted than in males. 
Nonetheless these differences were not significant. 
The strength of the correlation between time of day or ambient temperature, 
(particularly minimum temperature on the day preceding the scan) and both 18F-FDG 
BAT and SUVmax also increased when analysis is confined to positive scans. We 
identified a somewhat counterintuitive positive correlation between ambient 
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temperature (i.e. volume and activity increase with increasing ambient temperature) and 
both volume and SUVmax. Closer inspection of the data suggests that both 18F-FDG 
BAT volume and SUVmax peak at between 0°C and 10°C, and drops off either side of 
this. 10°C is by no means warm, and is certainly sufficiently cold to activate BAT. It is 
also possible that cold exposure is only effective to a point; Freeman et al. [97] found 
that in warm acclimatised rats, a maximal response to cold stimulus was reached by 
19°C. The effect of sub-zero outdoor temperatures in BAT activation may be offset by 
the turning up of central heating and wearing of warmer clothes. 
We identified a difference between sexes in terms of in BAT activity and volume with 
temperature; at lower temperatures women tended to have higher 18F-FDG BAT volume 
than males which may point to differences in temperature sensitivity between the sexes 
as discussed above. Higher levels of UCP1 have been reported in the interscapular fat 
pad of female rats compared with males, which implies a lower temperature threshold 
for cold-induced thermogenesis in females [338]. This trend was not apparent for 
SUVmax, for which females’ response appeared blunted. It has been suggested that, on 
average, women feel cold at a higher temperature than men [296]. Nonetheless, these 
differences were not statistically significant. 
Time of day correlated with 18F-FDG BAT volume but less so with SUVmax, reflecting 
the highly dynamic nature of 18F-FDG BAT. Unlike BAT prevalence, volume and 
SUVmax showed no consistent seasonal variation, with some individuals showing 
higher BAT volumes in the Spring and Summer months. Unlike BAT prevalence, which 
showed an acute response (i.e. varying with time of day), volume and SUVmax 
correlated most strongly with the minimum temperature in the preceding day, but also 
with temperature in the preceding 3 days, week and month to a lesser extent. The 
presence of BAT, and likely its level of metabolic activity, is likely an acute response to 
short periods of cold weather (in the order of 1-7 days) rather than to prolonged periods 
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of average cold weather [194], although is it feasible that sustained exposure to cold is 
necessary to induce BAT hyperplasia or beige fat transdifferentiation. 
It may be that prolonged cold exposure induces BAT hyperplasia or beige fat 
transdifferentiation, in which case a higher prevalence would follow sustained cold 
exposure. While acute cold exposure is sufficient to activate BAT [43, 44], a fact 
exploited in prospective studies of BAT prevalence in humans, this would only be 
sufficient to activate extant BAT (or beige fat) deposits. To effect a significant change 
in 18F-FDG BAT volume (and activity, which strongly co-varies), may require either 
BAT hyperplasia or transdifferentiation of WAT into beige fat, which may require a 
sustained stimulation. Chronic cold exposure is believed to increase BAT volume [39, 
129, 194], with no significant correlation identified between ambient temperature on the 
day of scanning and either 18F-FDG BAT volume or SUVmax. Our results broadly 
mirror this, although the effect of chronic exposure on BAT volume and SUVmax is 
less clear-cut. 
For both 18F-FDG BAT mass and SUV, multivariate stepwise Tobit regression analysis 
returns a model which includes age, sex, BMI, time of day as independent predictors of 
18F-FDG BAT mass. Although we initially chose to measure 18F-FDG BAT mass, this 
bears a linear relationship with volume, and is therefore effectively interchangeable with 
volume. Outdoor temperature was also identified as a significant independent predictor 
of both volume and SUVmax; maximum temperature on scan date and time of scanning 
for volume, and maximum temperature on the day of scanning and preceding day for 
SUVmax. Again, there is a perplexing positive correlation between preceding day’s 
maximum temperature and both 18F-FDG BAT volume and SUVmax. A possible 
explanation for this would be that 18F-FDG BAT, rather than being stimulated by cold 
per se, is activated by change in temperature, i.e. the abrupt transition from a high 
maximum temperature on the preceding day, followed by a low temperature on the day 
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of scanning. However, we identified no significant differences between 18F-FDG BAT 
positive and negative scans in this regard. 
We employed Tobit analysis to enable inclusion of the numerous negative scans [133]. 
If, as our study of 18F-FDG BAT prevalence suggests, BAT is not ubiquitous, and rather 
than BAT activity being on a continuum, is genuinely and consistently absent in some 
individuals, it would be erroneous to include these individuals in such an analysis. It 
would be nonsensical to attempt to identify determinants of 18F-FDG BAT volume or 
activity in individuals who, despite concerted attempts at stimulation, may never 
possess BAT. To address this, conventional multivariate regression on normalised 
(log10) 18F-FDG BAT volume data was performed which returned a model that only 
included age and minimum temperature on the day preceding the scan as significant 
independent predictors of 18F-FDG BAT volume. Although it was not possible to 
normalise SUVmax data, it is likely that similar determinants are predictive of both 18F-
FDG BAT volume and activity given the strong correlation between them (r = 0.844). 
Pace et al. [134] reported similar findings, including that age and outdoor temperature 
were independent predictors of SUVmax. Alternatively, the Tobit analysis could have 
been performed on the subgroup of individuals who showed 18F-FDG BAT uptake on at 
least one scan, whom we know to be capable of expressing BAT. 
Although outdoor temperature seems to be predictive of 18F-FDG BAT volume and 
activity, it was not been possible to conclusively separate the effects of various 
temperature metrics to identify which is most significant due to significant collinearity - 
this would be better tested with a prospective study. 
Our finding that increasing age is predictive of lower 18F-FDG BAT volume may have 
implications for future therapies which aim to modulate BAT activity. If BAT volume 
does diminish with age, any therapy which stimulates BAT may be less effective in 
older adults. 
  241 
10.3 Colocalisation of 18F-FDG BAT on serial PET/CT scans 
10.3.1 18F-FDG BAT distribution is fairly constant within individuals 
In chapters 5 and 6 the distribution pattern of 18F-FDG BAT uptake in sequential 
PET/CT scans in 15 patients was analysed. In all cases 18F-FDG BAT uptake occurred 
within the thorax (mediastinum, supraclavicular or paravertebral compartments), and 
within the cervical/supraclavicular regions in 92.6% of scans similar to that described 
by Ouellet et al. [133]. Therefore, when validating an imaging modality for the 
purposes of BAT identification, restricting the coverage to the thorax, or even the 
supraclavicular fossae/neck should permit sufficient anatomical coverage. 
We identified a super-linear relationship between the number of compartments and 
volume (i.e. a quadrupling of the number of compartments containing 18F-FDG BAT, 
results in a greater than four-fold increase in BAT volume). The anatomical 
compartments were of unequal size. If, therefore, 18F-FDG BAT appeared within the 
smaller anatomical compartments before the larger compartments, a super-linear 
relationship may result. This does not appear to be the case; the largest compartment 
was the cervical/supraclavicular region which accounted for the majority of instances 
(20/25) in which only a single compartment contained 18F-FDG BAT. This could 
indicate some form of augmented or exponential response, such that 18F-FDG BAT 
uptake accelerates as temperature decreases. 
Inter-rater reliability calculations indicate that, although 18F-FDG BAT volumes 
fluctuate widely within individuals, the pattern of distribution within anatomical 
compartments remains fairly consistent, with 9/15 patients showing uptake within the 
same anatomical depots on serial scans. 
Following on from the work in chapter 4, in which we calculated 18F-FDG BAT 
volumes, we were able to identify the ‘index scan’ for each patient (i.e. that with the 
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greatest 18F-FDG BAT volume). We found that the pattern of 18F-FDG BAT uptake on 
the index scan was generally representative of uptake on scans with lower 18F-FDG 
BAT activity (in 14/15 patients). Although, being a retrospective study, we were unable 
to determine whether the 18F-FDG BAT uptake on the index scan represented 
maximally stimulated BAT - in all likelihood it was not, and still underestimates the 
true volume of BAT. 
10.3.2 High degree of 18F-FDG BAT colocalisation on serial PET/CT scans 
In this study we sought to determine whether 18F-FDG BAT depots occur within 
reproducible locations across serial PET/CT scans (i.e. whether it colocalises).  
We explored two object-based colocalisation approaches: one testing whether ROIs 
intersect, and the other using voxels. Although both techniques showed a high degree of 
colocalisation (often exceeding 80%), neither were perfect. If all 18F-FDG BAT uptake 
on the subordinate scans coincided with uptake on the index scans, there would be 
100% colocalisation. This may be due to errors in image registration resulting in partial 
colocalisation. The PET is acquired over a period of 30 minutes or so, while the CT is 
acquired over seconds, therefore 18F-FDG uptake within adipose tissue may erroneously 
appear in adjacent structures due to movement. We used a technique in which we 
adopted a high SUV threshold of 2.5 g/ml to semi-automatically segment 18F-FDG 
BAT, and used the CT to restrict the resulting ROIs to adipose tissue. Therefore 18F-
FDG BAT uptake lying outside this envelope will have been excluded. Both the index 
and subordinate scans would be expected to be affected equally, but this may reduce the 
available voxels for colocalisation. Post acquisition image registration is imperfect, 
therefore genuine colocalisation between subordinate and index scans, particularly in 
scans with low 18F-FDG BAT volumes, may go undetected. 
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Furthermore, despite collimation on the PET scanner, areas of avid 18F-FDG uptake 
often show a rim of intermediate radiotracer uptake around a metabolically avid central 
nidus, which in our experience, became more pronounced around higher activity depots. 
We sought to minimise this by setting a high SUV threshold of 2.5g/ml to maximise 
specificity at the expense of reduced sensitivity, and exclude intermediate level 18F-
FDG uptake within the rim of 18F-FDG BAT deposits (i.e. SUV 1.0 – 2.5 g/ml). We 
also found that this resulted in better anatomical delineation of 18F-FDG BAT deposits. 
This threshold was higher than that used in comparable studies [133], and would 
therefore be expected to underestimate BAT. This would tend to impact on the less 
metabolically active subordinate scans, but should not have a major impact on the 
proportion of 18F-FDG BAT on the subordinate scans which colocalises with BAT on 
the index scan. 
The index scan is a fairly abstract construct. It was only possible to identify the index 
scan retrospectively based on the presumption that it demonstrates the greatest volume 
of 18F-FDG of all the patient’s scans, but there is no way of knowing the extent to which 
BAT was activated, and certainly not whether it was maximally stimulated. Given the 
scanning protocol adopted at our institution, the index scans are unlikely to represent 
maximally stimulated BAT. It is possible (and in the case of subject H, highly likely) 
that what we took to be index scans do, in fact, show sub-maximally stimulated BAT, 
and are in effect subordinate scans themselves. It would only be possible to test this 
hypothesis prospectively. Nonetheless, these data indicate that the uptake on the 
subordinate and index scan tends to occur in fixed sites on serial scans, and is likely to 
occur in the same site on a maximally stimulated scan, and that uptake within the index 
scan would likely correspond to that on a PET/CT scan acquired in a state of maximal 
BAT activation.  
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For the most part, both techniques performed well, and there was no consistent bias 
between them. Simple comparison of ROIs to determine whether they intersect is only 
semi-quantitative and would not reflect the true extent to which colocalisation occurs. 
Manders’ technique for colocalisation of individual voxels is truly quantitative, but is 
susceptible to the size of the objects being colocalised (and may therefore be affected by 
our adoption of a high SUV cut-off); a single large colocalised object and innumerable 
tiny colocalised objects would produce a very low figure for the first technique, and a 
very high technique for the second. Manders’ approach does have an additional 
advantage: for a busy image with multiple objects in both image stacks, some objects 
will overlap by chance which may be confused with genuine colocalisation. Manders’ 
approach allows the measured colocalisation coefficient to be compared against 
multiple randomly generated images to determine whether it is significantly greater than 
that expected if there was only random overlap. We demonstrated that in most cases the 
degree of colocalisation between 18F-FDG BAT uptake on serial scans was greater than 
that expected by chance. 
By analysing sequential scans in 15 subjects using quantitative colocalisation, we have 
demonstrated that 18F-FDG BAT uptake occurs in consistent locations on serial scans, 
and that BAT uptake on subordinate scans tends to also be evident on the index scan. 
Therefore, when a patient has undergone multiple PET/CT scans, the distribution of 18F-
FDG BAT on the index scan can be taken as being representative. 
We have also shown that as activity reduces, the 18F-FDG BAT deposits fragment into 
multiple small deposits, and localise to the foci of greatest 18F-FDG BAT on the index 
scan, while other depots switch off (or demonstrate low activity below our segmentation 
threshold). Although this would imply that simple quantification of BAT on the basis of 
simple numerical comparison of ROIs may be misleading, the number of ROIs are a 
good indicator of total 18F-FDG BAT volume. 
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Consistent areas of 18F-FDG BAT uptake may imply fixed depots of classical BAT, 
which are up and down-regulated in much the same manner as a dimmer light switch, 
rather than beige fat, which one might expect to follow a much less consistent 
anatomical distribution manner. 
10.4 Limitations of PET/CT in the identification of 18F-FDG BAT 
PET/CT is subject to several limitations, which limit its role in the field of BAT 
research. Most studies evaluating BAT prevalence have been retrospective 
observational studies of PET/CT scans performed as part of routine oncological 
treatment. Although some small studies have used PET/CT in healthy volunteers solely 
for the purposes of BAT identification, the high ionising radiation burden and costly 
radiotracer limits its role in larger populations, and would be difficult to justify 
ethically. 
The commonest indication for the 18F-FDG PET/CT scans was the assessment of cancer 
and its metastases, therefore the samples may not be truly representative of the wider 
population. Although some studies have reported a lower 18F-FDG BAT prevalence in 
patients with active cancer [191, 203, 339], the consensus is that there is no correlation 
between the presence of 18F-FDG BAT and of metastatic disease [133, 189]. 
PET/CT suffers from the significant disadvantage that it is only imaging metabolically 
active BAT. BAT is a highly dynamic facultative tissue and is only activated when non-
shivering thermogenesis is required [2]. Even within the same individual BAT volume 
and SUVmax varies considerably between serial scans, even under controlled 
conditions [340]. As glucose uptake is directly proportional to metabolic activity [341, 
342], inactive BAT will not accumulate 18F-FDG and will not, therefore, be visible on 
PET/CT scans. The observation that some scans are apparently BAT negative, does not 
mean it is absent. Nor for that matter does it even indicate that it is not metabolically 
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active. The activity may merely be at a low level below the threshold we set. 
Alternatively the volume of active BAT may lie below the spatial resolution of PET. 
This is problematic as the scanning protocol is designed to suppress physiological 18F-
FDG uptake within BAT. The opportunistic nature of BAT detection means that ad hoc 
identification of BAT on PET will inevitably underestimate its true prevalence. This is 
borne out by the fact that prospective studies have shown a consistently higher 
prevalence than retrospective studies. The extent to which PET/CT underestimates BAT 
is apparent in studies of genetic expression profiles, which show BAT to be highly 
prevalent [56], even in subjects without evidence of 18F-FDG BAT uptake [56, 105]. 
We sought to address this by evaluating patterns of uptake on serial scans, and found 
that uptake occurs in a fairly constant pattern within individuals.  
The reliability of serial SUV measurements and their reproducibility may also be 
questioned. Longitudinal studies indicate that serial SUV measurements vary by 10-
13% within the same patient, which may be reduced to 3-4% with good quality 
assurance programmes [343] and are therefore reproducible [344]. SUVmean has been 
shown to have higher reproducibility on serial PET scans than SUVmax [345], as the 
former derives its activity from a larger number of voxels, rather than a single voxel as 
in SUVmax. 
The duration between 18F-FDG administration and image acquisition may also affect 
SUV values. Our current protocol, scanning at 60 minutes post injection allows 
SUVmax to peak in 33.3% of cases, with the remainder peaking between 145 and 360 
minutes post injection. Therefore scanning at 60 minutes may generate low SUVmax 
values [346]. SUVmax has also been shown to vary with age; Wehrli et al. [347] 
reported higher SUVmax values in the skin, adipose tissue and skeletal muscle with 
increasing age, which may accompany age-related differences in BMI.  
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Following the introduction of PET/CT in the 1990s, unexpected 18F-FDG uptake was 
described in a symmetrical distribution in the neck and thorax, but the realisation that 
this could represent BAT did not come until 2002 [131]. Nedergaard et al. [101] 
considered that, based on the glucose uptake patterns, and the response of this tissue to 
physiological and pharmacological stimuli, the evidence that this tissue represented 
BAT was overwhelming. The only means of determining true BAT status is to subject 
biopsy specimens to immunohistochemical analysis. Areas of 18F-FDG activity within 
fat have been confirmed histopathologically as being BAT based on the characteristic 
histological appearances and the presence of the UCP1 protein as determined by testing 
with anti-UCP1 antibodies [36]. There are, however, few studies in which histological 
confirmation of BAT has been provided as BAT depots are not readily accessible 
surgically, and have typically been sampled opportunistically during thyroid surgery. 
Sampling of BAT in human adults is also hampered by the fact that BAT forms small 
islets within larger sheets of WAT [36]. Therefore although we only had the opportunity 
able to provide histological confirmation in a single case (BAT13), there is ample 
evidence in the literature to allow us to extrapolate this to other 18F-FDG BAT positive 
patients. PET/CT tends to underestimate BAT volumes, and traditional Dixon MR tends 
to overestimate BAT when compared to histopathological analysis, therefore the gold 
standard is autopsy [243]. 
There is nonetheless an element of doubt regarding the true nature of the tissue which 
we presume represents BAT on CT. There is compelling physiological and histological 
evidence that 18F-FDG uptake within fat does represent BAT, which is further supported 
by immunohistochemical staining of excised samples with UCP1. We had the 
opportunity to obtain a sample of fat corresponding to an area of avid 18F-FDG BAT 
uptake in an exemplar patient. This showed the histological characteristics of BAT, and 
stained positive for UCP1. 
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More recently the specificity for UCP1 has been called into questions as it has been 
shown to be present in both classical BAT as well as transdifferentiated beige fat [56]. 
As discussed previously, we showed a high degree of 18F-FDG BAT colocalisation on 
serial PET/CT scans, which may imply classical BAT rather than beige fat 
More recently, beige adipocytes have been identified as a distinct type of thermogenic 
fat in mice and humans [57, 63]. These beige adipocytes exhibit an intermediate 
phenotype between that of BAT and WAT in both rodents [62, 348] and, more recently, 
in humans [92, 273]. Indeed it has been suggested that cold-induced BAT is 
predominantly derived from transdifferentiation of white adipocytes [62, 92]. The 
specificity of UCP1 for classical BAT has also been undermined by the discovery that 
beige adipocytes also express UCP1 [60], but do not arise from the adipomyocyte 
lineage from which classical brown adipocytes are derived [48, 50, 51]. Similarly the 
presence of the transcription factor PRDM16, previously considered specific to classical 
BAT [50] has also been identified in beige adipocytes [189]. 
Wu et al. [57] found that the gene expression profile with adult humans BAT was closer 
to that of mouse beige adipocytes than to classical murine adipocytes, and concluded 
than BAT in human adults is in fact beige fat. UCP1 positive fat within the 
supraclavicular fossa in humans has also been identified as being beige fat on the basis 
of novel immune-histochemical markers and gene expression, specifically Zic1 [273]. 
Jespersen et al. [56] found that the gene expression profile of classical BAT (i.e. up-
regulation of miR-206, miR-133b, LHX8 and Zic1, and down-regulation of HoxC8 and 
HoxC9) co-exists with markers of beige adipocytes (TBX1 and TMEM26) within 
supraclavicular fat in humans, which points to classical BAT and beige fat co-existing. 
This could account for our findings of high (but not perfect) colocalisation between 
subordinate and index PET/CT scans; those areas which consistently colocalise may 
represent classical BAT which may be wound up or down in response on external 
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stimuli, while those that do not colocalise may represent transdifferentiated beige fat. If 
the totality of BAT evident on PET scans was transdifferentiated beige fat, the pattern 
of 18F-FDG BAT could be expected to be much more variable. 
The inherent limitations of PET in identifying BAT are well recognised and have been 
discussed above. These compromise the reliability of PET as a standard against which 
other imaging modalities can be compared. Foremost among these is the fact that 
maximum activity of PET is not always present on the scan. We sought to address this 
by using the ‘index’ PET/CT scan as the standard, as well as showing that 18F-FDG 
BAT uptakes occurs in a consistent pattern within an individual on serial scans. 
Nonetheless these scans were performed for purposes other than the identification of 
BAT, and therefore undoubtedly underestimate its true extent.  
10.5 MR studies 
The fact that PET/CT only shows metabolically active BAT limits its ability to act as a 
gold standard in both a research and clinical setting. Inactive BAT is not demonstrated 
on PET/CT, and as a result would underestimate both its prevalence and volume. MR 
has been advocated as an alternative means of identifying anatomical BAT independent 
of its activity. We showed BAT activity to be highly variable in response to small 
changes in ambient temperature. In addition MR does not carry the significant ionising 
radiation burden of PET/CT which precludes its widespread use in healthy individuals, 
nor does it require the administration of expensive radiopharmaceuticals. 
Building on our work on PET/CT, we were able to transpose 18F-FDG BAT ROIs onto 
co-registered MR scans. From this we were able to characterise the signal 
characteristics of BAT and WAT on MR, specifically the calculated fat fraction and T2* 
relaxation time. 
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Ex vivo murine MR spectroscopy have shown differences in composition of BAT and 
WAT [244]. The most prominent of which is the prominent water peak within BAT 
which in WAT water forms a comparatively small part. In addition differences in the 
spectral patterns of BAT and WAT, including a lower proportion of unsaturated 
triglycerides in BAT compared with WAT, showed that BAT has a prominent water 
peak. Furthermore the fat peaks were more broadly spread out due to their iron content 
and induced magnetic field inhomogeneities. 
MR exploits the fact that hydrogen nuclei within BAT and WAT have different resonant 
frequencies, and therefore has the potential to identify BAT independent of its degree of 
activation. Previous studies have successfully identified in situ BAT in rodents in both 
active [349] and inactive [241, 245, 255] states. In rodents BAT has been shown to have 
a lower fat fraction (37-70%) than WAT (90-93%), as well as being more 
heterogeneous [241]. 
10.5.1 Phantom validation of fat fractions derived from IDEAL MR 
Fat fractions were calculated from IDEAL MR sequences which have hitherto been 
validated as producing reliable estimations of fat fraction. Nonetheless a phantom study 
in which we scanned five phantoms containing foodstuffs of different fat fraction 
showed some discrepancy between the reported fat content and the calculated fat 
fraction. This could be due to errors in the technique, post acquisition analysis or eddy 
currents within the fluid phantoms. Estimations of the fat content were calculated using 
approximations of density which may not be universally applicable, which could 
introduce further error. 
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10.5.2 Studies of fat fraction and T2* relaxation time in rats 
We had an opportunity to conduct a post mortem study on four rats; two kept cold (4°C) 
and two kept warm (30°C) in the 8 hours prior to sacrifice. One rat from each group was 
dissected to excise WAT and interscapular BAT, while the remainder were scanned in 
situ. Many BAT studies have used rats and mice due to the ease with which BAT may 
be identified a priori as a macroscopically distinct conglomeration within the 
interscapular fat pad. 
Mean fat fraction within the excised tissue specimens was significantly lower in BAT 
(58.9-62.4%) than WAT (78.0-82.5%), although BAT fractions were consistent 
irrespective of the temperature at which the rats were housed ante mortem. This was not 
the case when scanned in situ. Although BAT fat fraction was lower than WAT in both 
rats, BAT fat fraction within the rats housed at 4°C was significantly lower (44.7%) 
than that those housed at 30°C (62.2%). A similar pattern has been described by Smith 
et al. [256] who showed that fraction fluctuated in relation to temperature, reducing 
from 79.4% at 30°C, 61.8% at 23°C and 50.9°C at 16°C. This fluctuation in mean fat 
fraction follows recent change in BAT activity. It is probable that, prior to sacrifice, 
interscapular BAT within the rat kept at 4°C was active (as indicated by the lower fat 
fraction, implying lipolysis), while that within the rat kept at 30°C was likely inactive. 
We identified a significantly lower T2* relaxation time within BAT than WAT in 
excised tissues. The T2* relaxation time of BAT excised from the rat kept at 4°C was 
significantly shorter than from the rat housed at 30°C. This also points to different 
degrees of metabolic activity between the two rats, with higher BAT perfusion/activity 
within the rat kept in the cold. This was not mirrored when scanned in situ, where the 
mean T2* time within BAT at 4°C (28.2 ± 101.7 ms) was higher than at 30°C (19.1 ± 
3.1 ms). The large standard deviation (particularly at 4°C) makes it difficult to draw 
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conclusions from these results, and did not prove helpful in discriminating between 
tissues types in rats when scanned in situ. It is noteworthy that there is a moderate 
positive correlation between fat fraction and T2* time (r = 0.6). This could indicate that 
as BAT becomes more active in lipid metabolism, fat fraction reduces, and has shown 
to be accompanied by an increase in local blood flow and increased iron content within 
mitochondria which in turn shortens T2* [241]. BAT is more highly vascularised than 
WAT in order that heat can be dissipated throughout the body. Although it has been 
suggested that MR techniques which measure tissue perfusion may have a role in 
separating BAT and WAT, we were unable to show this. 
10.5.2.1 Limitations of animal studies 
Most animal studies in BAT research have tended to involve ex vivo scanning of 
excised tissue samples, post mortem scanning of carcasses, or in vivo scanning of 
anaesthetised rodents. Scanning post mortem is potentially problematic due to 
differences in temperature, and the absence of respiratory motion, cardiac motion and 
vascular flow. 
Lower fat fractions have been reported when scanning in vivo compared with post 
mortem which has been attributed to the absence of tissue perfusion [255], which may 
account for our observed differences between the ex vivo and in situ samples. It may be 
that this arises from differences in tissue preparation. Dissecting tissue could, by 
increasing available surface area for example, alter passive diffusion of oxygen 
compared with the in vivo samples. 
For the rat housed at 30°C, mean BAT fat fraction was similar when scanned ex vivo or 
in situ. In the rat housed at 4°C however, the BAT fat fraction increases from 44.7% 
when scanned in situ, to 58.9% in the excised tissue specimens. This could be due to 
some underlying change in metabolic state, including that the effects of BAT activation 
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(i.e. localised lipolysis) are reversed following tissue manipulation. Preparation of 
specimens in microscopy has been shown to induce cell stress as evidenced by absence 
of glycogen in BAT [350]. 
In vivo animal studies are further limited by the necessity of administering general 
anaesthesia to immobilise the animal. Although it has been suggested that the tissue 
characteristics of BAT are more reflective of chronic thermal exposure and should 
persist [256], inhalational volatile anaesthetic agents can acutely affect sympathetic 
activity and BAT activity [2, 351], resulting in a reduction in blood flow and oxygen 
consumption within tissues.  
10.5.2.2 Dynamic nature of BAT 
We also identified a small but significant difference in fat fraction between omental and 
subcutaneous WAT at both temperatures. This suggests that WAT is not homogenous 
and that its composition varies according to site. The fat fraction with human WAT 
varies according to location, with deep subcutaneous WAT containing a higher 
proportion of saturated fatty acids than superficial subcutaneous WAT, and visceral fat 
containing an even higher proportion [352]. These variations may reflect the underlying 
metabolic activity of the tissue. Therefore using subcutaneous WAT as a standard may 
not accurately reflect the full range of fat fraction within WAT. This should be borne in 
mind in any study which uses WAT fat fraction as a baseline against which BAT is 
compared. 
In line with other murine studies, we identified BAT on the basis of a priori knowledge 
of its likely anatomical location (i.e. within the interscapular fat pad). Any attempt at 
identifying BAT prospectively on the basis of fat fraction would require it to have a 
significantly different fat fraction than WAT. As discussed above WAT is not 
metabolically inert and varies in both composition and morphology according to 
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anatomical site, season and diet [353]. This may affect fat fraction would hamper any 
technique which seeks to differentiate BAT and WAT on the basis of fat fraction. 
As discussed, BAT is also biochemically and histologically dynamic. Seasonal variation 
in fat composition within BAT has been described in the big brown bat (Eptesicus 
fuscus) [327], which has been attributed to different rates of fatty acid oxidation 
throughout hibernation. Seasonal variation in the morphology of BAT adipocytes has 
also been reported in the non-hibernating common shrew (Sorex araneus) [328]. As 
both hibernating and non-hibernating small mammals show seasonal variation in BAT 
composition, it is probable that human BAT may follow a similar pattern. The dynamic 
nature of BAT has also been shown in CT studies which have shown a higher CT 
attenuation in areas of active BAT than inactive BAT [302, 335] likely reflecting 
localised lipolysis. A corresponding decrease in lipid content in activated BAT has also 
been shown histopathologically in rats [302]. 
The morphological appearances of brown adipocytes vary according to functional state 
[37, 60, 62]. When stimulated by cold exposure or diet, lipid vacuoles within brown 
adipocytes are small and numerous. When the brown adipocytes are quiescent (i.e. 
warm ambient temperature or in fasting animals) the vacuoles increase in size before 
eventually coalescing into a single large vacuole [354]. This supports the hypothesis 
that BAT, if quiescent, accrues intracellular lipid thereby acquiring a WAT-like 
phenotype. 
Multiple studies have confirmed that BAT composition changes according to its level of 
activity. An inverse correlation between fat-fraction and UCP1 activity indicates that fat 
fraction varies in response to the degree of metabolic activity [256]. Remodelling of 
BAT has also been described in interscapular BAT in mice incrementally exposed to 
low temperatures [301]. Similarly actively cooling human neonates with hypoxic 
ischaemic encephalopathy to 33°C for 48 hours has been shown to a significantly lower 
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fat fraction compared with controls [269]. Remodelling of BAT involves a reduction in 
lipid content [67, 266, 268], higher vascularity and mitochondrial content [67, 266], 
increased perfusion [125] and blood oxygenation [266, 355]. BAT stimulation 
(following norepinephrine injection or prolonged cold exposure) results in a reduction 
in the proportion of unsaturated and polyunsaturated fatty acids. 
BAT composition also varies with age, with higher levels of saturated fatty acids in 
juvenile rats than adults [350]. Variation in fat fraction with age has also been reported 
on MR in rodents [241, 253]. Differences in fat fraction between BAT and WAT in 
adult humans are less marked than in infants [268]. With increasing age, BAT is known 
to become phenotypically and spectroscopically similar to WAT [350] - particularly 
when quiescent [354]. 
Obesity is associated with BAT acquiring a more WAT-like phenotype, with higher fat 
fraction and decreased T2* relaxation times on MR [253]. At one extreme, genetic 
knock-out studies in obese obs/obs mice in whom UCP1 has been disabled, BAT fat 
fraction was much higher than in lean mice [248], and is almost as high as in WAT. 
These data suggest that the MR characteristics of BAT vary in response to acute cold 
exposure, and that cold stress depletes intracellular lipid stores within BAT, and are 
therefore reflective of tissue activity. Methods of BAT identification which rely on fat 
fraction may be less effective in detecting metabolically inactive BAT due to their 
increased fat fraction. 
The activation state of BAT has further implications with respect to MR. It is 
recognised that the chemical shift of the spectral peaks of BAT and WAT are 
temperature dependent which could affect the ability of Dixon-based techniques for fat 
quantification. It has been suggested that a temperature increase in active BAT could 
affect the chemical shift position of fat and water molecules [356] which could impact 
upon their corresponding fat fraction. It has been suggested that MR, and in particular 
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MR spectroscopy, should be able to discriminate between BAT and WAT irrespective 
of the tissue’s metabolic activity [244] as BAT and WAT spectra should be affected 
equally. The small temperature increase generated by non-shivering thermogenesis is 
unlikely to make a significant difference in vivo – probably amounting to less than a 2% 
change in the resulting BAT fraction [241], although lower fat fractions have been 
reported when scanning in vivo compared with post mortem. 
It was believed that MR had the potential to detect BAT regardless of its state of 
metabolic activation [243]. It appears that fat fraction within BAT varies according to 
its level of metabolic activity. Therefore MR would demonstrate functional rather than 
structural BAT. Ultimately it is not the volume that will determine the degree of 
uncoupling and therefore non-shivering thermogenesis, but the activity. 
10.5.3 Studies of fat fraction and T2* relaxation time in adult humans 
BAT studies in adult humans are hampered by the fact that, unlike in rodents, BAT does 
not form discrete easily identifiable depots which can be identified on the basis of a 
priori knowledge alone. We used two approaches to circumvent this, and thereby 
identify and characterise in vivo BAT in adult humans; the first was a probabilistic 
approach, and the second involved transposition of 18F-FDG BAT ROIs from PET/CT 
onto co-registered MR scans. 
For our probabilistic approach, we built on our findings from chapter 5 which showed 
that 18F-FDG BAT, when present, occurred within the supraclavicular fossae and neck 
in 93% of scans. By defining ROIs around these compartments, and applying 
thresholding (to exclude non-fat) and morphological edge erosion (to exclude tissue 
interfaces) we were able to define ROIs within minimum operator bias. The 
probabilistic technique has been used with some success previously by Lundström et al. 
[268, 352], who used it to detect a 2% decrease in BAT fat fraction following 3 hours of 
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cold exposure using a gradient echo sequence at 1.5T. We identified no significant 
difference in fat fraction between the supraclavicular fossae and subcutaneous WAT 
using this technique. It is possible that in our hands this technique is insufficiently 
sensitive to identify the very small changes reported previously. Although we also used 
a 3 Tesla scanner, we adopted a spin echo sequence, rather than a gradient echo 
sequence, which would affect tissue contrast. Although this technique provides a semi-
quantitative measure of fat fraction within the defined space, it does not quantify BAT 
volume per se, which limits its wider appeal in testing the response of BAT to 
pharmacological stimulation. 
Our second method in which 18F-FDG BAT ROIs were transposed from PET/CT onto 
MR did show a significant difference in fat fraction between BAT and WAT, albeit with 
considerable variation in fat fraction between individuals. WAT fat fraction, which 
served as the standard, remained constant across serial scans for many patients (most 
notably BAT13 in whom WAT fat fractions were 83.1%, 82.0% and 83.3% 
respectively). A stable fat fraction within WAT provides a benchmark against which 
BAT may be compared. In some patients however (most prominently in BAT20, 06) 
WAT fat fraction varied considerably across serial scans. This may be due to genuine 
seasonal variation in WAT composition. In both BAT20 and BAT06, the dorsal 
subcutaneous fat layer was thin which would be particularly susceptible to the effects of 
volume averaging artefact and motion artefact, compared with thicker fat layers in other 
patients. This inter-subject variability coupled with the plasticity (in terms of activity 
and morphology) of both BAT and WAT makes it unlikely that a single universal cut-
off point to differentiate between BAT and WAT on the basis of fat fraction alone 
would be appropriate in all cases. 
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T2* relaxation time has been suggested as a potential means of identifying BAT [274] 
due to its greater vascularity and mitochondrial content, although we identified no 
significant difference between BAT and WAT. 
10.5.3.1 Limitations of our approach to image registration and segmentation 
Each of the techniques we used to identify BAT have advantages and disadvantages. 
The probabilistic technique in which the supraclavicular fat is manually segmented does 
not require a concomitant PET/CT scan, and is independent of the activation state of 
BAT. This technique does, however, require manual segmentation (albeit of a well 
defined anatomical compartment) which may introduce an element of operator bias. The 
ROIs defined within the supraclavicular fossae and neck were large, and will 
predominantly comprise WAT. Therefore small changes in fat fraction within BAT may 
be diluted, which would reduce the sensitivity of this technique. This is borne out by our 
results which showed no significant difference in mean fraction within these 
supraclavicular ROIs between 18F-FDG BAT positive and negative subjects. 
The technique of transposition is heavily dependent on there being metabolically active 
BAT on PET/CT, which we have shown to be highly variable in both prevalence, 
volume and activity. Transposing ROIs from PET/CT to MR minimises operator bias 
but is heavily reliant on accurate image registration, therefore there is the potential for 
non-fat tissues to be mis-registered resulting in spuriously low mean fat fraction within 
ROIs. Conversely the mean fat fraction within transposed ROIs may be increased by the 
presence of interspersed WAT, as well as being spuriously increased by the presence of 
mis-registered areas of adjacent WAT. The comparatively long image acquisition times 
of PET/CT and MR will inevitably result in some mis-registration due to respiratory and 
cardiac motion, therefore it is likely that both confounders co-exist, which will reduce 
reliability of fat fraction measurements within transposed 18F-FDG BAT ROIs on MR. 
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10.5.3.2 Prospective identification 
Building on these findings from chapter 8, we sought to identify in vivo BAT on MR on 
the basis of its imaging characteristics. We then tested the accuracy of theses techniques 
quantitatively against our standard of PET/CT by using a novel implementation of 
object-based colocalisation techniques developed in light microscopy. 
Visual inspection was moderately successful in identifying BAT in some cases, 
particularly in the hands of a radiologist. This technique did tend to underestimate 
volume in patients with larger volumes of 18F-FDG BAT on PET/CT however. 
Although we discovered significant differences in fat fraction between BAT and WAT 
in adult humans in vivo (chapter 8), it was not possible to define a single cut-off point to 
differentiate these tissues. Therefore we used receiver operator curve analysis to 
heuristically identify optimum thresholds for each patient. This technique was 
moderately effective in a small number of patients but produced inconsistent results, 
with fairly poor levels of colocalisation against 18F-FDG BAT uptake. Although we 
were not able to reliably identify BAT on MR in all cases, this technique may be useful 
in identifying a research group, amongst those without co-morbidities in whom PET/CT 
scans may not be a viable option. 
Both techniques underestimated BAT volume – particularly in those patients with 
higher 18F-FDG BAT volumes. BAT is dynamic, therefore it is possible that it involuted 
in the interval between the PET/CT sand MR scans. Conversely, in cases where these 
techniques appear to have overestimated BAT volume, it is possible that this 
represented hitherto unidentified BAT (particularly given that BAT on the PET/CT 
scans was not maximally stimulated). This is considered unlikely as many BATprosp foci 
lay within the dorsal subcutaneous adipose or tissue layer which is not known to contain 
BAT. 
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We have published a case report of an exemplar patient in whom we were fortunate to 
be able to identify BAT in vivo on MR with a high degree of colocalisation with 
PET/CT. We were also fortunate to be able to obtain immunohistochemical 
confirmation of BAT – one of the first groups to do so. We recognise that this was a 
fairly unique case with very large quantities of BAT, and that this method did not allow 
us to consistently demonstrate BAT on MR in a larger sample. 
Although our human sample was small (n=24), the population from which we were able 
to recruit was limited to the 152 patients with evidence of 18F-FDG BAT on PET/CT. 
Most PET/CT scans were performed in older patients for oncological disease, many of 
whom had died in the interim. 
Our initial phase of recruitment was opportunistic and yielded a sample with a mean age 
of 50.3 years, many of whom showed low BAT volumes on PET/CT (and 2 did not 
undergo concomitant PET/CT). Therefore for our second wave of targeted recruitment 
we approached younger patients (mean age 36.7 years) in whom we would expect BAT 
prevalence and volume to be higher.  
Of the 24 human subjects, 21 either had cancer or were being investigated for suspected 
oncological disease. As discussed above, the consensus is that cancer status is not a 
significant determinant of BAT. Therefore our findings should be generalisable to the 
wider population. As this was a retrospective study we were not able to control for 
certain potential confounders including medication status. This is a potential confounder 
as many commonplace pharmacological agents have been shown to modulate BAT 
activity including spironolactone [353], baclofen [106], propranolol [183], ephedrine 
and nicotine [357]. 
In most cases there was a considerable temporal gap between the PET/CT and MR 
scans being performed, often within different seasons and at different ambient 
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temperatures. BAT could vary considerably in the intervening period, potentially even 
involuting altogether.  
We could convincingly demonstrate a difference in fat fraction between BAT and WAT 
identified a priori. What is more difficult is to identify BAT prospectively without prior 
knowledge. We found that the difference in fat fraction between BAT and WAT was 
typically small in humans, and certainly not large enough to robustly differentiate 
between these tissues using these techniques. Methods to enhance signal contrast 
between these tissues may enhance the accuracy of this technique. 
10.5.3.3 Choice of MR sequence 
The multi-peak fat spectral model used by IDEAL is able to discriminate between fat 
and water pulses, and provides accurate fat fraction from 0 to 100%. Fat contains 
multiple spectral peaks [241, 350], therefore IDEAL is intrinsically better than the 
traditional Dixon method as it models multiple peaks of the fat spectrum, while the 
traditional Dixon chemical shift method only models a single fat peak corresponding to 
the methylene group. The accuracy of fraction may be confounded by T1 and T2* 
effects [236, 358]. T1 effects may be reduced by using low flip angles (i.e. by adopting 
a GRE sequence rather than spin echo sequence). BAT and WAT have different spectral 
signatures in terms of their chemical composition, lipid profile, and the proportion of 
saturated and unsaturated fats [244, 350]. Hamilton et al. [244] found that murine BAT 
and WAT had different MR spectral signatures, with a prominent water peak indicating 
high water content in BAT. In addition the spectral peaks within BAT were slightly 
broadened possibly due to higher iron content or magnetic field inhomogeneities within 
the sample. Therefore the accuracy of IDEAL in separating BAT from WAT could be 
improved by adopting a spectral profile unique to BAT [241]. The accuracy of Dixon-
based methods assume a pre-defined spectral model of triglycerides in order that water 
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and fat signal may be separated within a voxel. It is recognised that susceptibility 
artefact and temperature changes can shift the fat spectrum with respect to the water 
peak [359], although this effect only becomes significant as the fat-fraction approaches 
50%, and for large temperature offsets [360]. The temperature difference between BAT 
and WAT is likely to be small (in the order of a few degrees) [238], and is unlikely to 
impact upon the accuracy of Dixon-based imaging.  
Traditional Dixon methods are adequate for separating fat and water signals, and are 
sufficient for qualitative use [361], but using three or more echoes improves accuracy in 
water-fat separation. Our choice of scanning technique was pragmatic as we only had 
access to the 3-point IDEAL sequence. Although this performs well against 
spectroscopy it may not identify all fat spectral peaks, therefore most studies have 
adopted 6-echo Dixon methods due to their superior accuracy [362] and enhanced 
separation of BAT and WAT. 
Many studies have also employed gradient echo (GRE) MR sequences to demonstrate 
differences in fat fraction between BAT and WAT [241]. T1-weighted sequences 
provide the best anatomical definition of the structures [245], and although spin-echo 
(SE) sequences may yield lower contrast between the tissues, FSE sequences have been 
used to identify BAT with some success [261]. Spin-echo IDEAL sequences are less 
effective at separating fat and water peaks than GRE [255], particularly for those fat 
peaks which lie close to the water peak such as the olefinic acid groups [363] which 
may erroneously be identified as water, potentially underestimating the true fat fraction 
[364]. GRE sequences are sensitive to susceptibility effects which perturb the local 
magnetic field, including that generated by haemoglobin [262] which is abundant on 
brown adipocyte mitochondria. Susceptibility effects are less of a problem for SE 
sequences due to the 180° refocussing pulse which counteracts the susceptibility 
gradients. Indeed the best way to minimise susceptibility effects is to use a spin-echo 
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sequence [365] (hence the decreased sensitivity in BAT identification on spin echo 
IDEAL). In addition the short acquisition time of GRE sequences means that T2* 
measurements may be performed in a single breath-hold [262], thereby minimising the 
effects of respiratory motion. 
10.5.3.4 Technical scanning factors 
Image contrast in our study was potentially limited by a variety of other factors. Our 
first wave of volunteers underwent MR scanning at a slice thickness of 5mm. The 
choice of slice thickness in MR scanning is a compromise; larger slice thicknesses are 
susceptible to volume averaging artefact, whereby multiple tissue types occur within a 
voxel, which generates an averaged MR signal. This may be particularly problematic 
when attempting to identify BAT which tends to occur in small foci within larger 
expanses of WAT [36, 37]. We found that reducing slice thickness to 2.5mm in six 
patients contributed to a reduced contrast-to-noise ratio which may negate any 
improvement in volume averaging artefact. Fat fraction using IDEAL MR has been 
used successfully to identify BAT interspersed within the interscapular fat in rats [241]. 
In adults, however, necessity dictated that we adopted a larger field of view, with a 
corresponding reduction in spatial resolution. Although large confluent BAT deposits 
would still be evident, small islets may not. Even with a resolution of 0.6mm, Hu et al. 
[241] recognised the potential impact of partial volume effects - particularly at tissue 
interfaces. To guard against potential false-positive identification of BAT at tissue 
interfaces, it has been suggested that it may be necessary to rely on a priori knowledge 
of common sites of BAT deposition [2, 37]. 
Images were acquired during free breathing which occasionally resulted in blurred 
images. This may be addressed by acquiring images whilst the patients hold their breath 
which is better suited to the faster GRE sequences. Respiratory gating (in which images 
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are acquired at a fixed point in the respiratory cycle) may minimise motion artefact from 
breathing, although this would render the scanning time prohibitively long. A third 
alternative would be to reorder the phase-encoding steps according to the phase of the 
respiratory cycle [366]. MR data are collected during each stage of the respiratory cycle 
thereby limiting variation to a single cycle of respiration, rather than several cycles, 
without increasing scanning time. This technique of respiratory-ordered phase encoding 
(ROPE) works well in patients with regular respiratory cycles, but less well in those 
with irregular breathing pattern. 
Although we sought to use PET/CT to identify areas of likely BAT on MR, the scans 
were not performed concurrently; they were often performed in different seasons, and in 
some cases years (mean interval 47.8 ± 50.5 weeks, range 1.4 – 258.1 weeks). As BAT 
is dynamic it is not possible to exclude hyperplasia or involution in the intervening 
period between the two scans.  
Quantitative MR using proton density fat fraction derived from chemical-shift water-fat 
MR has been validated as a means of quantifying fat mass in pigs [367], with high 
levels of reproducibility [368]. Although we demonstrated significant differences in the 
fat fraction of BAT and WAT in both rats and humans, our attempts to identify BAT on 
the basis of fat fraction did not yield consistently reliable results. Although our 
technique, which utilised the 3-point IDEAL FSE sequence at 3T did not work 
consistently in our hands, we present a novel implementation of quantitative 
colocalisation analysis which may assist in validating future work. 
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Chapter 11: Future directions 
In this thesis we explored the role of two imaging modalities in the detection and 
quantification of in vivo BAT in humans. We demonstrated the highly variable nature of 
18F-FDG PET/CT, and the comparatively poor sensitivity and specificity of MR 
imaging in detecting BAT. Future BAT research requires an accurate means of 
quantifying BAT, and there is a need for imaging techniques with superior accuracy to 
those explored in this thesis. 
11.1 The future of PET/CT in BAT detection and quantification 
Most studies evaluating BAT prevalence on PET/CT are retrospective, which hinders 
direct comparison between studies. The adoption of standardised protocols (i.e. 
standardised temperature, diet, clothing) for calculating BAT prevalence, mass and 
activity in PET studies would facilitate comparison of PET/CT studies. 
A potential limitation of 18F-FDG PET/CT is that glucose is not the preferred substrate 
of BAT, therefore the development of PET radiotracers specific to fatty acid uptake 
within BAT may be more appropriate [5]. Novel radioactive tracers have been 
developed which are preferentially taken up by BAT. One such novel radiotracer is 4-
18F-fluorobenzyltriphenyl phosphonium (18F-FBnTP) which accumulates in 
mitochondria as a function of uncoupling, and is washed out during thermogenesis 
[369]. This radiotracer has the potential to detect inactive BAT as well as quantifying 
thermogenic activity. 
As discussed at length above 18F-FDG PET/CT reflects metabolic activity of BAT. The 
sensitivity of these techniques may be enhanced by stimulating BAT beforehand. Thus 
far dedicated prospective studies of BAT prevalence have sought to stimulate the dense 
sympathetic innervation in order to activate BAT. The commonest means of stimulating 
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sympathetic BAT is cold, including intermittently dipping feet in cold water [44, 125], 
although it has been suggested that this method is not physiological as BAT is 
selectively activated through dedicated sympathetic nerve fibres activated by cold-
sensitive centres in the brain rather than through general sympathetic outflow [2]. 
Consequently administration of systemic non-selective β-adrenergic agonists (e.g. 
isoprenaline) which successfully mimics sympathetic stimulation does not result in an 
increase in BAT activity [370]. 
11.2 Alternative imaging techniques in BAT detection and 
quantification 
As the primary function of BAT is non-shivering thermogenesis, temperature presents 
an alternative route for identifying BAT. 
Infrared thermography has been used to measure BAT in humans in a pilot study of 87 
human adults [371]. This showed highest temperatures within the supraclavicular 
fossae, in which BAT is most prevalent. After exposure to cold, skin temperature within 
the supraclavicular fossae showed a smaller decrease (0.9°C) than other skin sites (2°C) 
although further work is required to determine whether this reflects changes in blood 
flow or true thermogenesis within BAT [371, 372]. 
Recently real-time 3D microwave imaging based methods have been used to 
successfully monitor subcutaneous heat deposition in breast-mimicking phantoms 
during microwave ablation therapy [373]. Although sub-centimetre spatial resolution 
was reported, with a sensitivity of 0.5°C, the technique was only found to be effective 
over hyperthermia and ablation temperature ranges, which are all higher than healthy 
tissue. It would be worth exploring whether this technique could allow dynamic in vivo 
monitoring of BAT following stimulation. 
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These methods, which use temperature increase as a surrogate marker for BAT, may not 
be identifying true brown or beige adipose tissue. Although BAT is recognised as the 
primary effector organ for non-shivering thermogenesis, this is not exclusively the case, 
for example non-shivering thermogenesis has been described in the Tasmanian bettong 
(Bettongia gaimardi) which is not attributable to BAT [374]. Although these techniques 
may provide indirect quantification of BAT activity they do not enable quantification of 
BAT volume. 
11.3 The future of MR in BAT detection and quantification 
The mainstay of non-invasive BAT imaging has been PET/CT, although this has several 
practical and ethical limitations including the administration of expensive short-lived 
radiotracers into several subjects, potentially on several occasions. A drive towards 
developing alternative means of identifying BAT has focussed on MR, which may able 
to detect BAT regardless of its state of activation [189]. MR studies have largely 
focussed on using chemical shift MR techniques to identify differences in fat fraction as 
a means of differentiating BAT and WAT (with BAT fat fraction being lower than that 
of WAT). Chemical shift techniques may be combined with a spectral pre-saturation 
inversion recovery (DUAL-SPIR) pulse to suppress fat signal [243]. Due to the high 
water content of BAT, MR signal persists even with fat saturation and could be used to 
mask out WAT in a similar manner to that described by Chen et al. [261], thereby 
potentially increasing accuracy. This technique has shown better correlation with 
histological findings than either 18F-FDG PET/CT or chemical shift MR. 
Initial hopes that fat fraction would allow the identification of anatomical BAT deposits 
have been undermined by the discovery that fat fraction varies within BAT, reflecting 
its functional status. 
  268 
Contrast between BAT and WAT may be enhanced by increasing field strength, or by 
administering agents to amplify signal from the tissue of interest. One such technique 
uses hyperpolarised gas (typically noble gases e.g. 129Xe) as a contrast agent. The 
hyperpolarised gas dissolves avidly in blood and shows a large chemical shift. As a 
result this can enhance signal to noise ratio even at low field strengths. Hyperpolarised 
13C has also been used to identify activated BAT in rodents [375]. Activated BAT is 
characterised by increased levels of oxidative phosphorylation and pyruvate 
metabolism. The incorporation of hyperpolarised 13C into pyruvate and its metabolites 
allows their spatial distribution to be visualised using a dynamic chemical-shift-specific 
13C-imaging MR sequence [376]. 
The thermogenic ability of BAT may be targeted using MR. Proton resonance 
frequency (PRF) based techniques have been used for the non-invasive measurement of 
temperature changes in vivo during thermal ablation therapies [377]. The temperatures 
experienced during such therapies are likely much higher than that generated by BAT, 
and therefore these techniques may be insensitive to the small changes in temperature 
generated by BAT. 
Gifford et al. [238] showed that MR temperature mapping may be used at physiological 
temperatures to identify activated BAT in adult humans in vivo. A temperature change 
of between 2.1°C and 6.2°C was reported in cold activated BAT (16°C), compared to -
1.6°C to 4.1°C in inactive BAT at thermoneutrality (24°C).  
BAT is highly vascular due to the need to transport nutrients and dissipate the heat 
generated by non-shivering thermogenesis. BAT perfusion has been shown to more than 
double following cold exposure [125, 378]. Basal oxygen consumption within BAT has 
been shown to be approximately 300% higher than subcutaneous WAT [379]. 
Techniques that aim to differentiate BAT and WAT have been be developed to exploit 
differences in local perfusion and oxygen consumption, and is exemplified by the 
  269 
functional MR technique blood-oxygen-level dependent (BOLD) imaging [277]. This 
technique detects metabolic activity by measuring haemodynamic changes resulting 
from changes in oxygen demand, which requires a measurement pre- and post-stimulus. 
This would rely on differences in magnetic susceptibility between oxyhaemoglobin (in 
oxygenated blood) and deoxyhaemoglobin (in deoxygenated blood), which becomes 
more apparent with increased blood flow. This techniques has shown promise in BAT 
research, with an increase in MR signal strength by 10.7% ± 1.8% following a decrease 
in temperature from 22-24°C to 13-16°C – higher than the MR signal changes seen in 
typical functional MR brain studies. Unfortunately this technique is limited to in vivo 
imaging.  
The incorporation of superparamagnetic iron oxide nanocrystals into the lipoprotein 
cores has been suggested [22] as novel MR tracers although this may be insufficiently 
sensitive to detect inactive BAT. 
A novel technique using intermolecular zero-quantum coherence transitions (iZQC) has 
been used to differentiate BAT and WAT in rats [380], and potentially overcome the 
problem of partial volume (or volume averaging) artefact. Large differences in the 
water–methylene and the olefinic–methylene peak ratio in the iZQC spectrum of BAT 
and WAT have been reported. This technique has shown the methylene-olefinic iZQC 
signal to be strong both in BAT and WAT, but that the water-methylene iZQC signal is 
specific to BAT. 
In the field of BAT research, a variety of imaging technique have been suggested, all of 
which have their limitations. Their accuracy may be improved by adopting a multi-
parametric approach in which multiple sequences are combined, although this would 
necessitate highly accurate co-registration of images using both rigid and non-rigid 
registration to allow for multimodality and temporal variation. 
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Appendix A: Supplementary tables 
Supplementary table 1: Binomial univariate logistic regression analysis of patients’ first 
scans (n=2,685), showing predictors of 18F-FDG BAT. 
Characteristic B (SE) P-value 95% CI for odds ratio 
Odds ratio Lower Upper 
Age -0.051 (0.005) <0.001 0.950 0.940 0.960 
Sex (M compared to F) -1.451 (0.196) <0.001 0.234 0.160 0.344 
BMI (kg/m2) -0.094 (0.019) <0.001 0.911 0.878 0.945 
Lean body mass (kg) -0.072 (0.010) <0.001 0.931 0.913 0.949 
Basal metabolic rate -0.001 (0.000) <0.001 0.999 0.998 0.999 
Fasting serum glucose (mmol/l) -0.293 (0.082) <0.001 0.746 0.635 0.876 
Injected 18F-FDG dose (MBq) 0.000 (0.003) 0.967 1.000 0.995 1.005 
Time of scan 0.000 (0.000) 0.006 1.000 1.000 1.000 
Temperature on scan date (°C) 
Minimum 
Mean 
Maximum 
 
-0.064 (0.016) 
-0.068 (0.015) 
-0.064 (0.013) 
 
<0.001 
<0.001 
<0.001 
 
0.938 
0.934 
0.938 
 
0.909 
0.907 
0.914 
 
0.967 
0.962 
0.963 
Temperature on preceding day 
(°C) 
Minimum 
Mean 
Maximum 
 
-0.064 (0.016) 
-0.069 (0.015) 
-0.059 (0.013) 
 
<0.001 
<0.001 
<0.001 
 
0.938 
0.934 
0.943 
 
0.909 
0.906 
0.919 
 
0.967 
0.962 
0.968 
Preceding 3 days’ temperature (°C) 
Minimum 
Mean 
Maximum 
 
-0,.065 (0.016) 
-0.076 (0.016) 
-0.062 (0.013) 
 
<0.001 
<0.001 
<0.001 
 
0.937 
0.926 
0.939 
 
0.909 
0.898 
0.915 
 
0.967 
0.955 
0.964 
Preceding week’s temperature (°C) 
Minimum 
Mean 
Maximum 
 
-0.040 (0.015) 
-0.072 (0.016) 
-0.060 (0.014) 
 
0.009 
<0.001 
<0.001 
 
0.961 
0.931 
0.941 
 
0.932 
0.901 
0.916 
 
0.990 
0.961 
0.967 
Mean monthly temperature (°C) -0.063 (0.017) <0.001 0.939 0.908 0.971 
Hours of sunlight on scan date -0.074 (0.017) <0.001 0.928 0.899 0.959 
Total monthly hours of sunlight -0.005 (0.002) 0.004 0.995 0.992 0.998 
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Supplementary table 2: Binomial multivariate logistic regression analysis (forced entry 
method) of patients’ first scans (n=2,685), showing predictors of 18F-FDG BAT. 
Characteristic B (SE) P-value 95% CI for odds ratio 
Odds ratio Lower Upper 
Constant 6.010 (1.020)     
Age (years) -0.046 (0.006) <0.001 0.955 0.944 0.966 
Sex (M compared to F) -1.429 (0.205) <0.001 0.240 0.160 0.358 
BMI (kg/m2) -0.085 (0.018) <0.001 0.919 0.887 0.952 
Fasting serum glucose 
(mmol/l) 
-0.168 (0.088) 0.057 0.845 0.711 1.005 
Time of scan 0.000 (0.000) <0.001 1.000 1.000 1.000 
Temperature on scan date 
Minimum 
Mean 
Maximum 
 
-0.018 (0.081) 
0.041 (0.070) 
-0.111 (0.065) 
 
0.824 
0.555 
0.089 
 
0.982 
1.042 
0.895 
 
0.838 
0.909 
0.788 
 
1.152 
1.194 
1.017 
Temperature on preceding day 
Minimum 
Mean 
Maximum 
 
0.065 (0.055) 
0.131 (0.169) 
0.036 (0.092) 
 
0.239 
0.438 
0.696 
 
1.067 
1.140 
1.036 
 
0.958 
0.818 
0.866 
 
1.189 
1.588 
1.241 
Preceding 3 days’ temperature 
Minimum 
Mean 
Maximum 
 
0.004 (0.069) 
-0.359 (0.186) 
0.025 (0.088) 
 
0.948 
0.054 
0.780 
 
1.004 
0.698 
1.025 
 
0.878 
0.485 
0.863 
 
1.150 
1.006 
1.218 
Preceding week’s temperature 
Minimum 
Mean 
Maximum 
 
0.046 (0.030) 
0.036 (0.118) 
-0.004 (0.071) 
 
0.127 
0.758 
0.960 
 
1.047 
1.037 
0.966 
 
0.987 
0.823 
0.867 
 
1.110 
1.307 
1.145 
Mean monthly temperature 0.018 (0.057) 0.754 1.018 0.911 1.138 
Hours of sunlight on scan date 0.023 (0.115) 0.841 1.023 0.817 1.282 
Total monthly hours of sunlight 0.000 (0.003) 0.981 1.000 0.995 1.005 
R2 goodness of fit tests= 0.079 (Cox and Snell), 0.228 (Nagelkerke).  
 
Supplementary table 3: Correlation matrix of 18F-FDG BAT determinants. 
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Appendix B: Articles, abstracts and presentations 
arising from this work 
Peer-reviewed articles 
• Reddy, N.L., Jones T.A. et al., Identification of brown adipose tissue using MR 
imaging in a human adult with histological and immunohistochemical 
confirmation. J Clin Endocrin Metab, 2014. 99(1): E117-E121. 
 
Abstracts 
• Jones, T.A., et al., Visual identification of brown adipose tissue in adult humans 
using Dixon MRI. Proc. Intl. Soc. Mag. Reson. Med., 2014. 22: 2144. 
• Jones T.A., Reddy N.L. et al., Unequivocal identification of brown adipose 
tissue in an adult human using MRI. Clinical Radiology 2013. 68 (Suppl 1): S2. 
• Wayte, S.C., Reddy, N.L., Jones. T.A. et al., Identification of brown adipose 
tissue using Dixon imaging in a human adult with histological confirmation. 
Proc. Intl. Soc. Mag. Reson. Med., 2013. 21: p. 4052. 
• Reddy, N.L., Jones. T.A. et al., Brown adipose tissue identification in an adult 
human using IDEAL MRI. Endocrine Abstracts., 2013. 31: P221. 
• Reddy, N.L., Jones. T.A. et al., Unequivocal identification of brown adipose 
tissue in an adult human using Magnetic Resonance Imaging. Proc. Physiol. 
Soc., 2012. 29: C11 and PC11. 
 
Presentations and posters 
• Jones, T.A., et al., Visual identification of brown adipose tissue in adult humans 
using Dixon MRI. Poster presentation at ISMRM, Milan, 10-16th May 2014. 
• Jones T.A., Tissue characterisation: brown fat and myositis. Oral presentation at 
the West Midlands Association of Radiologists Autumn Scientific meeting, 
Coventry, 26th September 2013. 
• Wayte, S.C., Reddy, N.L., Jones. T.A. et al., Identification of brown adipose 
tissue using Dixon imaging in a human adult with histological confirmation. 
Poster presentation at ISMRM, Salt Lake City 2013. 
• Jones T.A., Reddy, N. L. et al., Unequivocal identification of brown adipose 
tissue in an adult human using MRI. Poster presentation at the Royal College of 
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Radiologists Clinical Radiology Annual Scientific Meeting, London, September 
2013. 
• Reddy, N.L., Jones. T.A. et al., Identification of brown adipose tissue using MR 
imaging in a human adult with histological and imunohistochemical 
confirmation. American Diabetes Association 73rd Scientific Sessions, Chicago, 
21-25th June 2013. 
• Reddy, N.L., Jones. T.A. et al., Brown adipose tissue identification in an adult 
human using IDEAL MRI. Oral presentation and poster at the Society for 
Endocrinology/British Endocrine Society annual meeting, Harrogate, 18-21th 
March 2013. 
• Jones T.A., Reddy, N. L. et al., Unequivocal identification of brown adipose 
tissue in an adult human using MRI. Poster presentation at the West Midlands 
Association of Radiologists Spring Scientific meeting, Stoke-on-Trent, 16th 
April 2013. 
• Reddy, N.L., Jones. T.A. et al., Unequivocal identification of brown adipose 
tissue in an adult human using Magnetic Resonance Imaging. Oral presentation 
and poster at the Physiological Society annual meeting, London 2012. 
 
Other media 
• Basset, M. Use of MR to Identify Brown Fat Could Fuel Obesity Therapies. 
RSNA News, 2014, 24 (12): 7-8. 
• Key milestone for brown fat research with a ground-breaking MRI scan. 
University of Warwick website. URL: 
http://www2.warwick.ac.uk/newsandevents/pressreleases/key_milestone_for/. 
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